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Abstract
Since the original isolation of pyridoxine 1 (a member of the vitamin B6 group), 
many analogues have been designed in an attempt to affect the biological and 
biochemical systems involving vitamin B6. The analogues of pyridoxal 5’-phosphate 
are of particular interest because pyridoxal 5’-phosphate, as a coenzyme, is involved 
in a number o f bio-catalytic reactions (e.g. transamination and decarboxylation of 
amino acids).
This study involves the design and synthesises of pyridoxal 5’-phosphate 
analogues using two approaches:
a) The modification of pyridoxine; and
b) Total synthesis via Diels-Alder reaction.
a) The modification of pyridoxine 1 involved using a series of blocking and 
deblocking procedures. The synthesis of 3,5 ’-O-dibenzylpyridoxine 127 obtained 
through multiple steps allowed for selective modification of the 4-position o f the 
pyridoxine derivative. Oxidation of 127 afforded the aldehyde derivative 128 in high 
yield. Subsequent Grignard reaction and hydrolysis afforded the alcohol 241, which 
was subjected to oxidation to give the corresponding ketone 242 in high yield.
HC1
127 R = -CH2OH
128 R = -CHO
OBn 0 H
241 R = — C—CH3
O
„ „ „  'I242 R = — C -C H ,
The removal of the benzyl groups from compound 241 afforded pyridoxine derivative 
243 in 75 % yield.
OH
243
vi
b) The Diels-Alder reaction of oxazole 222 with dienophile, a,P-unsaturated 
nitrile 223, was another approach for preparing vitamin E*6 analogues. The Robinson- 
Gabriel cyclodehydration of a-acylamino carbonyl compound produced the oxazole 
222 in good yield. However, difficulties were associated with synthesising the a,p- 
unsaturated nitrile 223.
NC
t h 2o h
223
Therefore, addition of protective groups to the p-hydroxy nitrile prior to the formation 
of a,p-unsaturated nitriles was investigated and did produce a more stable derivative 
in the form of 4-(ter/l-butyldimethylsilanyloxy)but-2-enenitrile 261 and 4- 
benzyloxybut-2 -enenitrile 268.
/NC
261
OTBDMS
268
The Diels-Alder reaction of oxazole 222 with commercially available dienophiles, 
dimethyl maleate and acrylonitrile, was attempted as model reactions. The model 
reactions afforded dimethyl 5-hydroxypyridine-3,4-dicarboxylate 274 in 36 % yield 
and 4-cyano-3-hydroxy-2-methylpyridine 276 in 34 %  yield. However, Diels-Alder 
reaction of oxazole 222 with dienophile 268 failed to give the desired pyridine 224 
with benzyl protection at C5-hydroxymethyl.
CN
c h 2o h
CN
Vll
Abbreviations
Bold Arabic numerals in the text refer to the diagrams of the structural formulae and 
the Arabic superscripts indicate references. The following abbreviations have been 
used in the text.
ADP Adenosine diphosphate
ATCase Aspartate transcarbamoylase
ATP Adenosine triphosphate
Bn -CH2C6H5 group (Benzyl)
bp Boiling point
ca. Circa
CAD The multifunctional polypeptide containing the activities o f  ATCase, CPSase II and 
DHOase.
CDC13 Deuterated chloroform
CNS Central nervous system
CPSase II Carbamoyl-phosphate synthetase
d Doublet
dd Double doublet
dt Double triplet
DHOase Dihydroorotase
DMF yV,A^-Dimethylform amide
DMSO-d6 Deuterated dimethyl sulphoxide
E Energy (in eV)
E Entgegen = opposite
EA Electron affinity
E. coli Escherichia coli
e.g. For example
Et -CH2CH3 group (Ethyl)
FAD Flavine adenine dinucleotide, oxidised form
FMN Flavine mononucleotide
FMO Frontier molecular orbitals
g
h
grammes
Hour(s)
[H]
Hb
Reduction
Haemoglobin
'HNMR (NMR) Proton nuclear magnetic resonance spectrum
HOMO Highest occupied molecular orbital
vm
Hz Hertz
IP Ionisation potential
IR Infrared spectrum
J Coupling constant
L Leaving group
LUMO Lowest occupied molecular orbital
m mutiplet
m 2+ Metal ion
MCPBA /wetar-Chloroperbenzoic acid
Me -CH3 group (Methyl)
MEM -CH2OC2H4OCH3 group (2-Methoxyethoxymethyl)
min Minute(s)
mL Millilitre(s)
mmol Millimole(s)
mol Mole(s)
mp Melting point
MS Mass spectrum
Ms -S (0 ) 2CH3 group (Mesyl)
N Normal
NA D+ Nicotinamide adenine dinucleotide, oxidised form
NADH Nicotinamide adenine dinucleotide, reduced form
[0 ] Oxidation
P -P 0 3H2 group (Phosphates)
4-PA 4-Pyridoxic acid
PDC Pyridinium dichromate
PG Protecting group
Ph -C6H5 group (Phenyl)
PH Expressing the acidity or alkalinity o f  a solution
PL Pyridoxal
PLP Pyridoxal 5 ’-phosphate
PM Pyridoxamine
PMP Pyridoxamine 5’-phosphate
PN Pyridoxine
PNP Pyridoxine 5 ’-phosphate
PRPP 5-Phosphoribosyl 1-pyrophosphate
q Quartet
R Alkyl group (-CH3, -C2H5 etc.)
RBC Red blood cell
s Singlet
IX
t Triplet
TBDMS -Si(C H 3)2C(CH3) 3  group (fert-Butyldimethylsilyl)
THF Tetrahydrofuran
tic Thin layer chromatography
TOSMIC Tosylmethyl isocyanide
TPP Thiamine pyrophosphatase
Ts -S(0 )2C6H4CH3 group (Tosyl)
UTP Uridine triphosphate
UV Ultraviolet (spectrum)
X Electron-releasing group
z Electron-withdrawing group
z Zusammen =  together
5 Chemical shift (parts per million)
°C Degrees Celsius
V Frequency
cm ' 1 Wavenumber
X
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1. Introduction
Vitamin E*6 consists of three related pyridine vitamers: pyridoxine 1, pyridoxal 
2, and pyridoxamine 3, and their phosphate esters 4, 5 and 6 . Vitamers are chemical 
compounds structurally related to a vitamin, and converted to the same overall active 
metabolites in the body. They thus possess the same kind of biological activity, 
although sometimes with lower potency. The catalytically active form of vitamin B6 
is pyridoxal 5’-phosphate 5. The term “vitamin Be” is used to refer to all 3-hydroxy- 
2-methyl pyridine derivatives 7 that can mimic the biological activity o f pyridoxine.
* Pyridoxine (PN)
1 R = H
a Pyridoxine 5-phosphate (PNP)
r  = p o 3h 2
2 Pyridoxal (PL) 
R = H
s  Pyridoxal 5'-phosphate (PLP)
r = p o 3h 2
R1
7
3 Pyridoxamine (PM) 
R = H
/: Pyridoxamine 5'-phosphate (PMP) 
R = P 0 3H2
Since the isolation of pyridoxine, many analogues were designed to influence 
the diverse biological and biochemical systems involving vitamin B6. In particular, 
the analogues of pyridoxal 5’-phosphate 5 are of interest because as a coenzyme form 
of vitamin B6 it is a constituent of a number of enzymes that catalyse diverse 
reactions, such as transamination and decarboxylation of amino acids. Thus, the use 
of coenzyme analogues could provide information on the significance of certain 
chemical groups in effecting the enzymatic reaction and in binding with the protein 
moiety. Analogues were utilised in the biochemical area to investigate the substrate 
specificity and inhibition of enzymes involved in vitamin B6 metabolism1. Also, 
analogues provided understanding of the structure and synthesis of vitamin B6, the 
mode of binding of the coenzyme to the apoenzyme and the structural requirements
1
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for its coenzyme functions. Apoenzyme is the protein component of an enzyme, to 
which the coenzyme attaches to form an active enzyme. Furthermore, vitamin B6 
analogues revealed the importance of various functional groups in reactions catalysed 
by pyridoxal m nonenzymatic and enzymatic systems. The involvement of 
pyridoxal 5’-phosphate analogues in various enzyme systems has offered an 
opportunity for rational design of inhibitors against various biological systems, such 
as the 4-vinylpyridoxol 5’-phosphate 8 which inhibits pyridoxine oxidase from rabbit 
liver4.
8
Furthermore, inhibition of growth in micro-organisms5 and tumours6 has been 
observed with analogues of vitamin Bg. Therefore, analogues containing reactive 
groups may react irreversibly with enzymes, and thus provide information regarding 
the nature of active sites.
This study involves the design and preparation of pyridoxal 5’-phosphate 
analogues, as earlier research has shown that pyridoxal 5’-phosphate does have an 
effect on the activity of the enzymes involved in pyrimidine biosynthesis in 
mammalian cells7. Thus, pyridoxal 5’-phosphate analogues will act as substrates to 
develop an understanding of the interaction between the enzyme-substrate complexes 
in the enzymatic binding sites of pyrimidine biosynthesis in mammalian cells.
The biosynthesis of pyrimidine nucleotides d e  novo  is a crucial pathway in 
growing and dividing cells, and thus the enzymes that catalyse these reactions are of 
interest in cancer chemotherapy and drug regimens against parasites. In mammalian 
cells, the three enzyme activities found in the multifunctional polypeptide CAD 
initiates pyrimidine biosynthesis. The three enzymes are the glutamine-dependent 
carbamoyl-phosphate synthetase (CPSase II), aspartate transcarbamoylase (ATCase) 
and dihydroorotase (DHOase). The key enzyme, CPSase II is regulated in the cell 
negatively by uridine triphosphate (UTP) and positively by 5-phosphoribosyl 1- 
pyrophosphate (PRPP) which increases the overall synthesis o f the carbamoyl- 
phosphate tenfold at low concentrations of ATP and magnesium ion ’ . As
2
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biosynthesis of pyrimidine nucleotides is essential for most growing cells, the 
application of potential analogues will contribute further understanding on the binding 
sites of UTP and PRPP in the mammalian multifunctional polypeptide CAD.
Earlier research has shown that UDP-pyridoxal and pyridoxal 5'-phosphate 
have similar activating activity on the CPSase II suggesting that the effector-binding 
site is common to the UTP, PRPP and to analogues of these metabolites7’10. Thus, 
designing pyridoxal 5'-phosphate analogues and the application in the study of the 
mammalian multifunctional polypeptide CAD binding sites will be important for the 
development of antiproliferative agents. Hence, in this research the pyridoxal 5’- 
phosphate analogues will be synthesised using two approaches:
a) The modification of commercially available pyridoxine hydrochloride; 
and
b) The Diels-Alder cycloaddition of substituted oxazole with dienophile.
1.1. Pvridoxine: discovery.
It was first observed in 1926 that rats with vitamin B complex deficiency 
showed poor growth and development. Even before the general availability of 
thiamin (vitamin Bj) and riboflavin (vitamin B2) in pure form, it became evident that 
the addition of these two vitamins to the diet failed to permit normal growth and 
development of rats. After several weeks, these animals developed a type of 
dermatitis (termed acrodynia) characterised by redness and swelling of the tips o f the 
ears, nose and paws which eventually led to necrosis of these parts. It was not until 
1934 that Gyorgy11 prevented these symptoms by feeding yeast or other sources o f the 
vitamin B complex to rats, and named the acrodynia-preventing factor as vitamin B6. 
Within 5 years, vitamin B6 obtained from rice bran and yeast was isolated and 
characterised by several laboratories ’ as 3-hydroxy-4,5-dihydroxymethyl-2-methyl 
pyridine 1  (subsequently named as pyridoxine).
3
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1.1.2. The structural elucidation o f vvridoxine.
Pyridoxine 1 behaves as a weak base and when treated with diazomethane it 
forms monomethyl ether, which, on acetylation, gives a diacetyl derivative. It 
therefore appears that the three oxygen atoms in pyridoxine are present as hydroxyl 
groups, and since one is readily methylated, this one is probably phenolic. This is 
supported by the fact that pyridoxine produces the ferric chloride colour reaction of 
phenols. Thus, the other two hydroxyl groups are alcohols.
Pyridoxine’s ultraviolet absorption spectrum was shown to be similar to that of
3-hydroxypyridine. This similarity gives the indication that pyridoxine is a pyridine 
derivative with the phenolic group in the 3-position. Since lead tetra-acetate has no 
action on the monomethyl ether of pyridoxine, this leads to state that the two alcoholic 
groups are not on adjacent carbon atoms in a side-chain13. When this methyl ether is 
carefully oxidised with alkaline potassium permanganate, the 
methoxypyridinetricarboxylic acid (C9H7NO7) was produced which gave a blood-red 
colour with ferrous sulphate (a characteristic reaction of pyridine-2 -carboxylic acid). 
Therefore, one of three carboxyl groups is in the 2-position.
When the methyl ether of pyridoxine was oxidised with alkaline permanganate 
under the usual conditions, the products were carbon dioxide and the anhydride of a 
dicarboxylic acid (C8H5NO4), this indicates that these two carboxyl groups are in the 
o rth o -p o sitio n . This anhydride, on hydrolysis to its corresponding acid, did not give a 
blood-red colour with ferrous sulphate, thus confirming the absence of a carboxyl 
group in the 2-position. It therefore follows that, on decarboxylation, the tricarboxylic 
acid eliminates the 2-carboxyl group to form the anhydride. The tricarboxylic acid 
could have been either structure 9 or 10.
As pyridoxine methyl ether contains three oxygen atoms (one as methoxyl and the 
other two alcohols), it is possible that two carboxyl groups in the tricarboxylic acid
4
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could arise from two CH2OH groups, and the third from a methyl group. Therefore, 
the pyridoxine could be either 1 1  or 1 2 .
The structure of pyridoxine was definitively determined when pyridoxine 
methyl ether was oxidised with barium permanganate to afford a dicarboxylic acid 
(C9 H9NO5), which did not give a red colour with ferrous sulphate. Thus, there is no 
carboxyl group in the 2-position. Also, since the dicarboxylic acid readily formed an 
anhydride and gave a phthalein on fusion with resorcinol, the two carboxyl groups 
must be in the or/Zzo-position. The analysis of both the dicarboxylic acid and its 
anhydride showed the presence of a methyl group; thus, the structure o f the 
dicarboxylic acid could be 13 or 14. Eventually, it was shown that the anhydride was 
13 from its formation by the oxidation of 4-methoxy-3-methylisoquinoline (scheme
i).
Scheme 1
Introduction
In addition, the structural elucidation of pyridoxine 1 (3-hydroxy-4,5- 
dihydroxymethyl-2-methyl pyridine) was confirmed by synthesis. For example, Harris 
and Folker14 used acyclic precursors, cyanoacetamide and ethoxyacetylacetone, to 
produce pyridoxine 1  as shown in scheme 2 :
Another synthesis15,16 involves Diels-Alder reaction of 5-ethoxy-4-methyloxazole 15 
with diethyl maleate 16 to give 17, which after treatment with acid followed by 
reduction with lithium aluminium hydride was converted into pyridoxine 1  (scheme
3).
6
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Scheme 3
1.1.3. The vitamin group.
Although pyridoxine 1 has vitamin activity, it was revealed that 2-methyl-3- 
hydroxy-4-formyl-5-hydroxymethylpyridine (pyridoxal 2) and 2-methyl-3-hydroxy-4- 
aminomethyl-5-hydroxymethylpyridine (pyridoxamine 3) also contributed to the 
vitamin B6 activity in animals and lactic acid bacteria17’18. Observation in rats 
revealed that ingested pyridoxine 1 was converted to compounds 2 and 3. Pyridoxal 
and pyridoxamine have been shown subsequently to comprise most of the vitamin B6 
in natural materials19. These three compounds are interchangeable and approximately 
equally active in supporting growth of rats, dog, and chicks fed with vitamin B 6 
deficient rations and in supporting growth of vitamin B6 dependent fungi and some 
bacteria. In synthesis, pyridoxine 1 could be converted to compound 2 or 3 by partial 
oxidation or by amination to yield an aldehyde or amine, respectively20. The inter­
relationship between pyridoxine 1, pyridoxal 2 and pyridoxamine 3 was established by 
transformations (scheme 4) . In scheme 4, careful oxidation of pyridoxine 1 with 
potassium permanganate isolated pyridoxal 2 as its oxime 18. Treatment of oxime 18 
with nitrous acid gives pyridoxal 2, whereas catalytic reduction forms pyridoxamine 3. 
Pyridoxamine 3 was treated with nitrous acid to form pyridoxine 1, and this can be 
acetylated followed by amination to regenerate pyridoxamine. Eventually, pyridoxine 
1, pyridoxal 2, pyridoxamine 3, and all 3-hydroxy-2-methyl pyridine derivatives that
7
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can mimic the biological activity of pyridoxine were collectively referred to as 
‘vitamin B65.
2  18
" h n o 2
Scheme 4
Most of the vitamin B6 in natural materials are present as phosphorylated 
derivatives of compounds 1, 2, and 3. In 1944, a compound required for enzymatic 
decarboxylation of amino acids was isolated from yeast21. It was subsequently shown 
that the compound was pyridoxal-5-phosphate 5 (also referred to as codecarboxylase) 
through comparison with the synthetic material prepared in low yield by 
phosphorylation of pyridoxal using phosphoryl chloride in the presence of water .
8
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5
The low yield of the phosphorylated derivative is due, presumably, to the fact that 
pyridoxal 2 exists largely in its cyclic hemiacetal form (scheme 5).
Scheme 5
A better preparative route lies in phosphorylation of pyridoxamine 3 to yield 
pyridoxamine-5-phosphate 6 , which is readily oxidised to pyridoxal-5-phosphate 5 
with manganese dioxide23,24. The precise location of the phosphate residue was 
established by an elimination procedure and the structure 5 was eventually confirmed
“jgZby the unambiguous synthesis set out in scheme 6 . Vitamin B6 in the form of their 
phosphates is inter-convertible in the body, and has been shown that the aldehyde and 
the amine are the main constituents.
Scheme 6
9
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1.2. Biosynthesis of vvridoxine.
D e  n o vo  biosynthesis of pyridoxine (vitamin Be) is a process peculiar to 
micro-organisms and attempts to establish the nature of precursors, intermediates, and 
biosynthetic pathways were complicated by the very small quantities o f the vitamin 
produced by most organisms. Since the 1960s, the pathway leading to pyridoxine 1 
synthesis has been largely defined in E sch erich ia  co li through the study of tracer 
experiments using radio-labelled precursors and pyridoxine auxotrophic mutants.
1
Tracer experiments have provided an understanding of the biogenetic anatomy 
of the pyridoxine skeleton, in terms of its derivation from glucose, glycerol, and 
several other primary metabolites26. Most of the tracer studies were performed with 
cultures of E. c o li mutant WG2, which lacks the enzyme pyridoxine 5’-phosphate 
oxidase27. This mutant was used as it synthesised pyridoxine and its 5’-phosphate 
ester at a rate that is four or five times that of the wild-type . Early 
studies29,30exploited non-randomly 14C-labelled substrates as tracers and 3H were used 
on occasion (as a secondary tracer) in conjunction with I4C as an internal standard. In 
recent studies31,32 stable isotopes such as 13C or 2H were employed. In particular, the 
application of substrates that are fully I3C enriched at contiguous carbon atoms31,33 
(called ‘bond-labelled’ samples) enables the observation of intact multicarbon units 
transferred from precursor into biosynthetic product.
1.2,1. Glucose as the primary precursor.
In an experiment with D-[l,2,3,4,5,6-13C]glucose 19, the 13C NMR spectrum 
of the isolated sample of pyridoxine 2 0  demonstrated that only two carbon-carbon 
bonds, those between C-2 and C-3 and between C-4 and C-5, are newly formed in the 
course of the biosynthetic derivation of pyridoxine from glucose . Hence, glucose 
supplied three intact multicarbon units, as the building blocks of the three fragments, 
C-2,2’, C-3,4,4’, and C-6,5,5’, of pyridoxine (scheme 7).
10
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Schem e 7
Although the experiment identified that glucose supplies three multicarbon units and 
the sites into which these are introduced, however, it does not provide evidence 
concerning the following:
(i) The identity of the 3 C and 2 C intermediates.
(ii) The fragments of glucose that supply them.
(iii) The sequence of events whereby these fragments are generated.
(iv) The sequence and the mechanism whereby these fragments combined to yield 
the pyridoxine skeleton.
The probable identity of the glucose-derived intermediates that serve as the 
precursors of the 3 C and 2 C fragments was provided from the results o f experiments 
with 14C-labelled samples of glucose, glycerol, and pyruvic acid. It had been shown29 
that the 3 C and 2 C units in the carbon skeleton of pyridoxine 20 to be derived from 
glycerol in a very specific manner. The chemical degradation o f the pyridoxine 
sample 21 isolated from an experiment using [2-14C]glycerol revealed that 
radioactivity was distributed equally over three sites, C-2, C-4, and C-5, of the 
vitamin (33 % of total label of pyridoxine at each of three sites). The companion 
experiment with [l,3-14C]glycerol displayed 20 % of total label of pyridoxine at each 
of the location of C-2’, C-4’, and C-5’. Also, the 13C NMR spectrum of the 
pyridoxine sample 22 that was isolated from the incubation with [1,3- C]glycerol 
demonstrated signals due to C-2’, C-3, C-4’, C-5’, and C-6  with each showing 
approximately 2 0  %  enrichment.
Labelling patterns within samples o f  pyridoxine derived from various labelled substrates.
* [2-1 4C]glycerol ■  [ l ,3 - 1 3 C]glycerol
11
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Thus, when glycerol serves as the carbon source, five of the eight carbon atoms of 
pyridoxine (C-2’, C-3, C-4’, C-5’, and C-6 ) are derived from its primary carbon atoms 
and three (C-2, C-4, and C-5) from its secondary carbon. The 8 C skeleton of 
pyridoxine must be constructed from three glycerol units, one of which loses a 
primary carbon on the route to the product.
In an experiment employing 3H/14C double labelling34, it was demonstrated 
that six of the eight hydrogen atoms of pyridoxine are represented by hydrogen atoms 
directly derived from the methylene hydrogen atoms of glycerol. It was shown by 
chemical degradation that the hydrogen atom at C- 6  of pyridoxine did not retain a 
tritium label. As the two terminal CH2OH groups of glycerol are stereochemically 
distinct, one or the other of the two terminal groups can be labelled to generate chiral 
samples. The enantiomeric compounds («S)-[1,1- H]- and (i^)-[1,1- H]-glycerol was
ifutilised to observe their mode of incorporation into pyridoxine . In an experiment 
using the (i?)-[l,l- H]-glycerol, the site of the six glycerol-derived hydrogen atoms 
was determined. The glycerol deuterium atoms were retained within pyridoxine 
sample 23 in pairs located at the CH2OH group, C-4’, another at the CH2OH group, 
C-5’, and the third representing two of the three hydrogen atoms at the C-methyl 
group, C-2\ Thus, the three pairs of hydrogen atoms retained at C-2’, C-4’, and C-5’ 
were derived from the (^)-terminus of glycerol.
The (iS)-terminus of glycerol did not contribute deuterium to the biosynthetically 
generated pyridoxine. Thus, the findings illustrate that glycerol enters each of the 
three subunits of pyridoxine in a stereo specific manner, in which the intact carbon 
chain of glycerol (pro-i?)CH2(OH)-CH(OH)-(pro-1S}CH2 0 H would yield the carbon 
atoms C-4’,4,3 and C-5’,5,6, respectively, of each of the two 3 C units. Finally, the 
C-2’,2 unit originates from the (pro-7?)CH2(OH)-CH(OH)- unit of glycerol.
Glycerol itself lacks the chemical and biochemical reactivity that is required to 
create the vitamin skeleton. It is more likely that the reactive species is one or both of 
the two triose phosphates, dihydroxyacetone 1-phosphate and D-glyceraldehyde 3-
12
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phosphate, that are generated from glycerol in the course of its metabolism, and that 
the intact units, C-3,4,4’ and C-6,5,5’, of pyridoxine are derived from them. When 
glycerol is phosphorylated on its route into the triose phosphates, only the p r o -R  
hydroxymethyl group is phosphorylated . Thus, if glycerol does indeed enter 
pyridoxine by way of these triose phosphates, the prochiral carbon atoms of glycerol 
must be incorporated into the vitamin in a regiospecific manner. The suggestion of 
triose phosphates as intermediates in pyridoxine biosynthesis came from the 
experiments29 with [ l- 14C]glucose and [6 -14C]glucose isolated pyridoxine samples 24 
and 25, respectively. Glycolytic breakdown of each of [ l - 14C]glucose and [6 - 
14C]glucose yields triose phosphates that are singly labelled at the terminal carbon that 
carries the phosphate group. Incorporation of these labelled triose phosphates derived 
from glucose would expect to deliver the label into each of the three sites that are 
derived from the p ro -R  hydroxymethyl group of glycerol, that is C-2’, C-4’, and C -5\ 
Hence, the observation from the chemical degradation of the pyridoxine samples from 
the two experiments showed, in each case, that labels at C-2’, C-4’, and C-5’ 
accounted for all the radioactivity within the two samples of the vitamin that were 
derived from [ l- I4C]glucose and from [6 -14C]glucose.
Labelling patterns o f  pyridoxine samples derived from labelled glucose.
24 25
* [ l - 1 4C]glucose * [6 - 1 4C]glucose
The source of the C-2’,2 unit was identified as the CH3CO fragment arising by 
decarboxylation of pyruvic acid . Tracer experiments with pyruvate revealed that the 
carboxyl group was lost and that the CH3CO unit gave rise to C-2’,2 of pyridoxine 
sample 26.
OH
Labelled pyridoxine sample 26 derived from 
* [3-14C]pyruvic acid and ■  [2-1 4 C]pyruvic acid.
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These results are consistent with the generation of the C-2’,2 o f pyridoxine from 
glycerol, via triose phosphate. It is the p r o - S  hydroxymethyl group of glycerol that is 
transformed into the aldehyde group of D-glyceraldehyde 3-phosphate and then into 
the carboxylic acid group of pyruvic acid, which is lost. It is likely that the C-2’,2 of 
pyridoxine is not generated by direct entry of a two-carbon precursor. Instead, the 
removal of the carboxyl group of pyruvic acid takes place at an earlier stage, in the 
course of the synthesis of a 5 C intermediate. Therefore, the 5 C unit must be derived 
from the CH3CO fragment of pyruvate plus a triose phosphate. The reaction of a 
triose phosphate, D-glyceraldehyde 3-phosphate (or of D-glyceraldehyde itself), with 
pyruvic acid, catalysed by pyruvate dehydrogenase, occurs in many micro-organisms, 
including E. c o li ’ . The reaction is accompanied by loss of the pyruvic acid 
carboxyl group, to yield a 5 C compound, 1-deoxy-D-xylulose 5-phosphate 27 (or 1- 
deoxy-D-xylulose 28, respectively). As tracer experiments revealed that the 5 C 
compound, 1-deoxy-D-xylulose, serves as an intermediate on the route from glucose 
into pyridoxine, thus the remaining 3 C, N unit was derived from 4-hydroxy-L- 
threonine 4-phosphate 29 (or 4-hydroxy-L-threonine 30, respectively).
OH
OR
H 0 2C H
27 R = P 0 3H2 29 R = P 0 3H2
1 -Deoxy-D-xylulose 4-Hydroxy-L-threonine
5-phosphate 4-phosphate
28 R = H
1 -Deoxy-D-xylulose
30 R = H
4-Hydroxy-L-threonine
1.2.2. 1-Deoxy-D-xylulose and 4-hydroxy-L-threonine as the acyclic 
precursors.
Indications that 1-deoxy-D-xylulose 28 serves as the precursor of the C- 
2 ’,2 ,3,4,4’ fragment of pyridoxine were observed in the experiments using 1 - 
deoxy[l ,1 ,l-2H,(ftS)-5-2H]-D-xylulose 31 and 1 -deoxy[ 1,1,1 -2H,(^ ,S>5-2H]-L-
xylulose samples administrated to mutant E. c o li . Deuterium NMR spectroscopy 
revealed that only the D isomer was incorporated into pyridoxine. Pyridoxine from
14
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the experiment with the labelled 1 -deoxy-D-xylulose contained deuterium at C-2’ and 
at C-4’, and the ratio of deuterium at these two sites corresponded to the ratio of  
deuterium at C-l and C-5 of the substrate (scheme 8)32.
3 1  1 -Deoxy[ 1,1,1 -2H ,(/tf>5-2H]-D-xylulose
Schem e 8
Another tracer experiment observed that the presence of unlabelled 1-deoxy-D- 
xylulose partially inhibited the incorporation of C from D-[l,2,3,4,5,6- CJglucose 
into C-2’,2,3,4,4’, but not into C-6,5,5’ of pyridoxine . These inferences supported 
1-deoxy-D-xylulose as a basic building block of the C-2’,2,3,4,4’ fragment of  
pyridoxine in E. co li. Additional evidence that the compound supplies the 5 C 
fragment as an intact unit came from the experiment with [2,3-13C]-l-deoxy-D- 
xylulose which revealed that the bond was labelled at C-2-C-3 of pyridoxine sample 
32, proving incorporation of the substrate without cleavage of its C-2,3 bond40.
OH Labelled pyridoxine sample 32
derived from [2,3-1 3C]-l-deoxy-D-xylulose.
The participation of 1-deoxy-D-xylulose in pyridoxine biosynthesis has also 
been examined in a nonbacterial system, using protein fraction derived from spinach 
chloroplasts41. When this soluble protein fraction was incubated in the presence of 
glyceraldehyde 3-phosphate, pyruvate, glycine, ATP, and Mg2+, vitamin B6 
biosynthesis took place but biosynthesis was inhibited by omission of any one of 
these substrates. In the absence of pyruvate, biosynthesis was restored by the addition 
of 1-deoxy-D-xylulose. These results inferred the view that 1-deoxy-D-xylulose 28 is 
implicated as a precursor of the C-2’,2,3,4,4’ fragment in pyridoxine biosynthesis. It
15
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is of interest that 1-deoxy-D-xylulose has been implicated also in the biosynthesis of  
thiamin in E. c o li37’38.
OH
28 1-Deoxy-D-xylulose
h o 2c
30 4-Hydroxy-L -threonine
The remaining segment of pyridoxine, N-l,C-6,5,5’, is provided by 4- 
hydroxy-L-threonine 30. The pyridoxine sample 33 isolated from the experiment 
with [2,3-13C]-4-hydroxy-L-threonine revealed that the C-6-C-5 was labelled33. 
Furthermore, the presence of unlabelled 4-hydroxy-L-threonine totally suppressed the 
incorporation of 13C from D-[l,2,3,4,5,6-I3C]glucose into C-6,5,5’ but not into C- 
2’,2,3,4,4’ of pyridoxine. 4-Hydroxy-L-threonine is thereby shown to lie on the route 
from glucose into the C-6,5,5 ’ unit of pyridoxine.
Labelled pyridoxine sample 33 derived from 
[2,3-1 3C]-4-hydroxy-L-threonine.
33
1.2.3. Metabolic steps leading from glucose to 1 -deoxy-D-xylulose and 
to 4-hydroxv-L-threonine.
Pyridoxine samples 24 and 25 isolated from the tracer experiments29 with [1- 
14C]glucose and [6 -14C]glucose, respectively, contains all their radioactivity at the C- 
2’, C-4’ and C-5’. However, the three centres were not equally labelled. In the case 
of pyridoxine sample 24 derived from [ l- 14C]glucose, the C-5’ contained 2 6  ± 2 %  of 
the total specific activity, while C-2’ and C-4’ each contained a higher level (36 ± 1 % 
and 38 ± 4 %, respectively). Conversely, in the case of pyridoxine sample 25 derived 
from [6 -14C]glucose, half (48 ± 4 %) of the label resided at C-5’, while C-2’ and C-4’ 
each contained only one quarter of the total activity (26 ±  2 %  and 27 ± 4 %, 
respectively). In both instances, the level of specific activity at C-2’ and C-4’ was 
similar, but different from that at C-5\
16
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Labelling patterns o f  pyridoxine derived from labelled glucose.
OFT OH
HO
OH
HO
48%
* 5'
OH26%
36% * 2' 24
* [ l - 14C]glucose * [6 - 1 4C]glucose
Therefore, the C-6,5,5’ unit o f pyridoxine could have derived from glucose in a 
different manner than the C-3,4,4’ unit and that the C-2,2’ unit shares its origin with 
the latter 3 C unit (presumably derived from it). Two different interpretations have 
been placed on these inferences, in terms of the known processes o f the primary 
metabolism of glucose. One interpretation was based on the assumption that all three 
fragments were derived by the glycolytic route . Another, more recent, interpretation 
suggested that only the C-3,4,4’ unit and consequently the C-2,2’ unit are of 
glycolytic origin, whereas the C-6,5,5’ unit is a product of the pentose phosphate 
pathway42. Genetic evidence strongly supports the latter interpretation42,43,44.
1.2.4. The origin of 1-deoxy-D-xylulose.
If all three fragments are derived by the glycolytic route, then the glycolytic 
cleavage of [ l-14C]fructose 1,6-biphosphate, derived from [ l-14C]glucose, yields 
[14C]dihydroxyacetone 1-phosphate 34 and unlabelled glyceraldehyde 3-phosphate 
35, the latter which receives the label later by triose phosphate isomerase-catalysed 
equilibration. In the case of [6-14C]glucose, it is glyceraldehyde 3-phosphate 35 that 
is labelled first followed by the dihydroxyacetone 1-phosphate 34 (scheme 9). Thus, 
the two subunits C-2’,2 and C-3,4,4’, which were equally and more highly labelled (at 
C-2’ and C-4’) in pyridoxine sample 24 isolated from an experiment with [1- 
14C]glucose, must both be derived from C-1,2,3 of glucose via dihydroxyacetone 1- 
phosphate. On the other hand, the C-6,5,5’ unit which receives a larger fraction of 
label in pyridoxine sample 25 isolated from an experiment with [6-14C]glucose than in 
pyridoxine sample 24 isolated from an experiment with [ l-14C]glucose, is derived 
from C-4,5,6 of glucose via glyceraldehyde 3-phosphate.
17
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1 *CH2OP
H-
HO-
H-
H-
-OH
-H
-OH
-OH
6 ■  CH2OP
34
Dihydroxyacetone 1-phosphate
35
-OH Glyceraldehyde 3-phosphate
Equilibration o f  label from C -l to C-6 o f glucose.
Schem e 9
This means a route to pyruvic acid from dihydroxyacetone 1-phosphate is 
required, as the normal glycolytic route to pyruvate proceeds via glyceraldehyde 3- 
phosphate. Such a route, via pyruvaldehyde and D-lactate, does exist in E. coh45,46,47. 
The observation that [2-14C]pyruvaldehyde yielded pyridoxine sample 36 that was
labelled exclusively at C-2 was taken as evidence for the involvement o f this route in 
pyridoxine biosynthesis34.
OH
Labelled pyridoxine sample 36 derived from 
■  [2-14C]pyruvaldehyde.
36
If dihydroxyacetone 1-phosphate 34 is indeed the precursor o f the C-3,4,4’ 
unit then the formation o f the acyclic precursor o f the C-2’,2,3,4,4’ unit o f pyridoxine 
must take place by condensation o f dihydroxyacetone 1-phosphate with pyruvate- 
derived acetylthiamin pyrophosphate , followed by hydrolysis. This would yield the 
(R)-1 -deoxy-2,4-dioxopentane-3,5-diol 37 which is the C-4 dehydrogenation product 
o f 1-deoxy-D-xylulose 2849. Since these two 5 C compounds are interconvertible by 
oxidation/reduction, either one or the other can serve as intermediate precursor o f  the 
5 C fragment o f pyridoxine (scheme 10).
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OH
1 -Deoxy-D-xylulose 
28
[O]
[H]
H0V S )
(R) -1 -Deoxy-2,4-dioxopentane-3,5-diol 
37
Scheme 10
The other interpretation was that the C-6,5,5’ o f pyridoxine is derived from 
glucose by way o f the pentose phosphate route, whereas the C-3,4,4’ originates via 
glycolytic intermediates. The uneven distribution o f label in the pyridoxine samples 
24 and 25 derived from [ l -14C]glucose and [6-14C]glucose respectively into C -5’, on 
the one hand, and into C-2’ and C-4’ of pyridoxine, on the other, suggests that the C- 
5 ’ unit is derived from the pentose route.
Labelling patterns o f pyridoxine derived from labelled glucose.
36% * 2’
24
* [ l - 14C]glucose
26% ' N  * 2' 25
* [6-14C]glucose
This lead to the assumption that the C-3,4,4’ unit could originate from glyceraldehyde
3-phosphate. Also the pyruvic acid, the precursor o f the C-2,2 ’ unit, is derived from 
glyceraldehyde 3-phosphate in the normal course o f glycolysis. Hence, the 
condensation o f  D-glyceraldehyde 3-phosphate 38 with pyruvic acid 39 are catalysed 
by the pymvate dehydrogenase, and accompanied by decarboxylation yields 1-deoxy- 
D-xylulose 5-phosphate 27 (scheme l l ) 50. This enzymic process, which occurs in E. 
coli51, requires thiamine pyrophosphatase as a coenzyme. 1-Deoxy-D-xylulose 28 is 
derivable from 27 by phosphatase-catalysed hydrolysis and convertible into it by 
kinase catalysed phosphorylation.
19
Introduction
HO H H OH
O
121
k T
H
o
o
28 37
Biosynthesis of 1-deoxy-D-xylulose 28. 
Scheme 11
1.2.5. The origin o f 4-hydroxy-L-threonine.
If all three fragments are o f glycolytic origin, the 3 C unit, C-6,5,5’, o f  
pyridoxine is derived intact from C-4,5,6 o f glucose via D-glyceraldehyde 3- 
phosphate. However, another source o f two o f these carbon atoms, C-5,5’, was 
discovered in another E. coli mutant (mutant WG3). This mutant is a pyridoxine- 
requiring strain, which can utilise glycolaldehyde to satisfy its pyridoxine 
requirement . Labelled glycolaldehyde was incorporated into pyridoxal 5 ’-phosphate 
isolated from this organism . Furthermore, isolated pyridoxine sample 40 revealed 
the sites o f incorporation o f the two carbon atoms o f glycolaldehyde were shown to be 
the carbon atom o f the CH2OH group, and the C-5 from the aldehyde carbon atom.
Labelled pyridoxine sample 40 derived from 
■  [ l - 14C]glycolaldehyde and 
* [2-,4C]glycolaldehyde.
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It was shown subsequently that the same process occurred also in the E. coli mutant 
WG2, which lacks the pyridoxine 5 ’-phosphate oxidase, as a minor pathway 
contributing to the formation o f the C-5,5’ o f pyridoxine, but its major source is a 
component o f the C-6 ,5,5’ fragment which is derived as an intact unit from glucose54.
That the two processes were entirely distinct from one another was shown by 
the fact that whereas C-6 o f pyridoxine, in mutant WG2, originates from a terminal 
carbon atom o f glycerol when glycerol is the sole primary precursor o f  the vitamin, 
the same carbon atom arises from the central carbon atom o f glycerol, when C-5,5’ 
originates from glycolaldehyde54. This contradiction was explained by the finding 
that, in mutant WG3, C-6 o f pyridoxine sample 41 was supplied by the methylene 
carbon o f [2-14C]glycine and that the N -l,C -6 fragment arises from glycine as an 
intact unit . It was shown by CNMR spectroscopy that pyridoxine sample 41, 
isolated from a culture o f mutant WG3, which had been incubated with bond-labelled 
glycine, 15NH2-13CH2C02H, maintained the intact 15N -13C bond o f  the substrate at N- 
l,C -655.
OH
41
OH
Labelled pyridoxine sample 41 derived from 
■  [2-14C]glycine and
■ [2-13C,15N]glycine.
Therefore, 4-hydroxy-L-threonine 30 generated by condensation o f glycine 42 
with glycolaldehyde 43 (scheme 12), in a reaction analogous to that catalysed by 
threonine aldolase or serine hydroxymethylase, might be an intermediate in 
pyridoxine biosynthesis serving as the precursor o f the N -l,C -6,5,5’ unit.
HO
h 2n ^
h o 2c ^  h
4-hydroxy-L-threonine
30
Scheme 12
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In an attempt to rationalise this duality o f origin o f the N -1 ,0 6 ,5 ,5 ’ o f pyridoxine, the 
l-aminopropane-2,3-diol (or its phosphate) was postulated to serve as the ultimate 
intermediate on the route into the N -1 ,0 6 ,5 ,5 ’ fragment o f pyridoxine26. (iS)-l- 
Aminopropane-2,3-diol is the decarboxylation product o f 4-hydroxy-L-threonine, but 
it may also be generated by transamination o f D-glyceraldehyde 3-phosphate followed  
by phosphate ester hydrolysis. If served as an intermediate, the dual origin o f  the 3 C, 
N unit either directly from D-glyceraldehyde 3-phosphate, or from glycolaldehyde 
plus glycine via 4-hydroxy-L-threonine, would be explicable. The attempt to support 
this notion experimentally failed, as the label from a 2H-labelled sample o f  1- 
aminopropane-2,3-diol 44 was not incorporated into pyridoxine (scheme 13)56.
Labelled l-aminopropane-2,3-diol 
44
Scheme 13
Another interpretation, based on genetic findings, suggests that the glucose- 
derived 3 C unit, C-6,5,5’, o f  pyridoxine was generated not by way o f a glycolytic 
triose phosphate intermediate, but via intermediates originating from the pentose 
phosphate pathway42. The key intermediate in the proposed formation o f 4-hydroxy- 
L-threonine from the 4 C fragment, C-3,4,5,6, o f  glucose by way o f  the pentose 
phosphate pathway is D-erythrose 4-phosphate 45, generated by a transaldolase 
reaction from D-sedoheptulose 7-phosphate as the 3 C donor, with D-glyceraldehyde
3-phosphate as the 3 C acceptor. D-erythrose 4-phosphate was further elaborated by 
oxidation at C-l to yield the corresponding D-erythronic acid 4-phosphate 46, which 
is followed by dehydrogenation at C-2 to produce a-keto acid 47. The a-keto acid 
undergoes transamination to give the corresponding 4-hydroxy-L-threonine 4- 
phosphate 29 and phosphate ester hydrolysis yields 4-hydroxy-L-threonine 30 
(scheme 14).
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HO
Hv \ ^
HO
OP
H ^ ^ C H O  
D-Erythrose 4-phosphate
45
HO
H c o 2h
D-Erythronic acid 
4-phosphate
46
HO 
H ^ \ / \ OH H+
H2N ^
h o 2ct h
4-Hyroxy-L-threonine
30
cr c o 2h  
47
4-Hydroxy-L-threonine
4-phosphate
29
Biosynthesis o f  4-hydroxy-L-threonine 30 
Scheme 14
Tracer evidence that supports this interpretation came from a sample o f pyridoxine, 
isolated from an experiment with [2,3- C]D-erythromc acid 48, which revealed that 
the bond-label had been transferred from the substrate into C-6,5 o f pyridoxine 
sample 49 (scheme 15)40.
48
Scheme 15
1.2.6. Genetic studies.
From the genetic findings, a sequence o f reactions was proposed for the 
conversion o f D-erythrose 4-phosphate 45 into 4-hydroxy-L-threonine 30 based on 
the similarity to the enzyme-catalysed reaction sequence from D-glyceraldehyde 3- 
phosphate 38 to L-serine 53 (scheme 16)42.
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In scheme 16, oxidation o f D-erythrose 4-phosphate 45 to D-erythronic acid 4- 
phosphate 46 requires a dehydrogenase similar to glyceraldehyde 3-phosphate 
dehydrogenase which catalyses 38 to 50. Evidence from crude extracts o f E. coli 
mutant have shown to contain the required D-erythrose 4-phosphate dehydrogenase 
activity42. The conversion o f D-erythronic acid 4-phosphate 46 into 2-ketoerythronic 
acid 4-phosphate 47 requires a second dehydrogenase. This step o f  the reaction is 
analogous to the transformation of D-glyceric acid 3-phosphate 50 into 3- 
hydroxypyruvic acid 3-phosphate 51 in serine biosynthesis. 3-Phosphoglycerate 
dehydrogenase, the enzyme that acts in the serine pathway, is the product o f the ser A 
gene57. The pdx B gene, which encodes one o f the enzymes that is required for 
pyridoxine biosynthesis in E. coli, had been isolated and sequenced58’59. Comparison 
o f pdx B gene product with that o f the ser A gene product, 3-phosphoglycerate 
dehydrogenase, revealed a similarity, and led to suggest that pdx B also encodes a 2- 
hydroxyacid dehydrogenase, such as the 4-phosphoerythronate dehydrogenase. 4- 
Phosphoerythronate dehydrogenase would be required for the production o f 2- 
ketoerythronic acid 4-phosphate 47. Demonstration o f a synthetic sample o f D- 
erythronic acid 4-phosphate as the substrate for pdx B gene product supports this 
suggestion60. Furthermore, when the gene product o f ser C, 3-phosphoserine 
transaminase, was present in the incubation, the reaction proceeded only in the 
forward direction to the keto acid60.
The route to 4-hydroxy-L-threonine was further supported from the fact that 
pdx F, another gene o f the pyridoxine biosynthetic pathway61, is in fact identical with 
ser C42. The ser C codes for 3-phosphoserine transaminase, the enzyme that catalyses 
the conversion o f 3-hydroxypyruvic acid 3-phosphate 51 into L-serine 3-phosphate 
52. Thus, ser C plays a dual role in participating not only in the serine biosynthetic 
pathway but also in the pyridoxine pathway (transamination o f 2-ketoerythronic acid
4-phosphate 47 to yield 4-hydroxy-L-threonine 4-phosphate 29).
The 3-phosphoserine phosphatase encoded by ser B is the final enzyme o f the 
serine biosynthetic pathway. The corresponding phosphatase activity that would 
hydrolyse 4-hydroxy-L-threonine 4-phosphate 29 to 4-hydroxy-L-threonine 30 has 
not been found in E. coli. Nor is there any evidence to equate the protein 
(polypeptide) products o f any o f the remaining identified pdx genes with that o f ser B. 
It must therefore be assumed that 4-hydroxy-L-threonine 4-phosphate is the 
pyridoxine precursor. This implies that pyridoxine 5’-phosphate is the first vitamin to
24
Introduction
be produced or that a non-specific phosphatase, which is not the product o f  a pdx 
gene, is responsible for the production o f the free 4-hydroxy-L-threonine 30 (scheme 
16).
CHO CH.,
H-
H-
-OH PentosePathway Glycolysis CHO
OH-<— Glucose
CH2OP
D-Erythrose 4-phosphate
45
| (i)
c o 2h
H-
H-
-OH
-OH
CH2OP
D-Erythronic acid 4-phosphate
46
I pdxB
c o 2h
H-
:0
-OH
CH2OP
2-Ketoerythronic acid 4-phosphate
47
I pdx F  = ser C
C 0 2H
h 2n -
H-
-H
-OH
CH2OP
4-Hydroxy-L-threonine 4-phosphate
29I 7
c o 2h
h 2n -
H-
-H
-OH
CH2OH
H- OH
CH2OP
HO-
H-
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-H
-OH
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c h 2o p
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27
C 0 2H
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CH2OP
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c o 2h  
=0
c h 2o p
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ser C
Pyruvic acid
39
h 2n -
c o 2h
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CH2OP
L-Serine 3-phosphate 
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ser B  |
c o 2h
h 2n - -H
4-Hydroxy-L-threonine
30
c h 2o h
L-Serine
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(1) = D-erythrose 4-phosphate dehydrogenase activity
(2) = glyceraldehyde 3-phosphate dehydrogenase
(3) = pyruvate dehydrogenase-catalysed acyloin-type condensation
Analogy o f the pathways to L-serine and to 4-hydroxy-L-threonine,
Scheme 16
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The pdx A, pdx B, pdx H, pdx J  and ser C, account for the pyridoxine 
biosynthetic genes that have been identified in E. coli. The organism uses only four 
dedicated enzymes, the products o f pdx B, pdx A, pdx J and ser C, to elaborate the 
pyridoxine skeleton from primary precursors. The fifth enzyme, derived from pdx H, 
catalyses the conversion o f pyridoxine 5 ’-phosphate 4 into pyridoxal 5 ’-phosphate 5 
(scheme 17) and is not implicated in the construction o f the ring system. Recent 
results44,62 confirmed that the pdx H gene is the sole source o f pyridoxine 5 ’- 
phosphate oxidase in E. coli. This enzyme is activated by flavine mononucleotide and 
oxygen under aerobic conditions and by FAD under anaerobic conditions.
+
pdx  A  
pdx  J
h 2n  c o 2h
27 R = P 0 3H2
1 -Deoxy-D-xylulose 
5-phosphate
29 R = P 0 3H2
4-Hydroxy-L-threonine
4-phosphate
28 R=H
1 -Deoxy-D-xylulose
30 R =H
4-Hydroxy-L-threonine
Genetic o f  pyridoxine biosynthesis : the final step
Schem e 17
There is a lack o f evidence for the role o f the proteins that are derived from 
pdx A  and pdx J. The fact that glycolaldehyde does not support the growth o f mutants 
with pdx A gene suggests that the pdx A gene product catalyses a step in the 
pyridoxine biosynthetic pathway which is not concerned with the formation o f  4- 
hydroxy-L-threonine56. Thus, pdx A  gene product may be implicated in the reaction 
sequence that generates pyridoxine from the intermediates, 4-hydroxy-L-threonine 
and 1-deoxy-D-xylulose. Similarly, pdx J gene product may be assigned to the 
formation o f the ring skeleton o f the vitamin. Recent findings demonstrated that pdx 
A is an NAD-dependent dehydrogenase which oxidises 4-hydroxy-L-threonine 4- 
phosphate 29 to 2-amino-3-oxo-4-(phosphohydroxy)butyric acid 54, followed by the
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assumption that it generates 1-amino-3-(phosphohydroxy)propan-2-one 55 by 
spontaneous decarboxylation . Furthermore, the incubation o f pdx J  with pclx A, 4- 
hydroxy-L-threonine 4-phosphate, NAD, and 1-deoxy-D-xylulose 5-phosphate 
demonstrated the formation o f pyridoxine 5 ’-phosphate64. A reaction mechanism was 
proposed for the final steps in pyridoxine biosynthesis (scheme 18), and implied that 
the first vitamin B6 synthesised is pyridoxine 5’-phosphate not pyridoxine.
pdx  A
HO > ^ 0 P 0 3 H 2
NJbLH C 0 2H -
29 4-hydroxy-L-threonine 
4-phosphate
° Y ' ^ O P 0 1H,
n , h -J 3 2
0 .
2I f " C 0 2H * H2N
54
° Y " ' ' o p o , h
55
pdx  J
55
4 pyridoxine 5'-phosphate
Reaction mechanism for the final steps in pyridoxine 5'-phosphate biosynthesis.
Scheme 18
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1.3. Catabolic pathways of vitamin B*.
By the 1960s it was clear that the three, natural, free forms o f vitamin B6, 
pyridoxine 1, pyridoxal 2, and pyridoxamine 3, could be transformed to the principal 
operating coenzyme pyridoxal 5’-phosphate 5. The inter-conversion o f various forms 
of vitamin B6 are due to the actions o f two types o f enzymes. The first type is a 
kinase that catalyses phosphorylation o f the 5-hydroxymethyl group o f all three 
vitamers. The second type is an oxidase that catalyses oxidation o f pyridoxine 5 ’- 
phosphate 4 and pyridoxamine 5’-phosphate 6 . Additionally recognised were the 
phosphatases that catalyse hydrolytic reversions o f the vitaminic phosphates to restore 
the free vitamers. The interactions involved are shown in scheme 19.
CHO
c h 2o p o 3h 2 HO
B
Pyridoxine 5'-phosphate (PNP) Pyridoxal 5-phosphate (PLP) Pyridoxamine 5'-phosphate (PMP)
A
V
c h 2o h
Pyridoxine (PN) 
1
A
CH2OH
D
COOH
4-Pyridoxic acid (4-PA) 
56
/
c h 2n h 2
c h 2o h
Pyridoxamine (PM) 
3
CH OH A = PL (PN, PM) Kinase 
B = PNP (PMP) Oxidase 
C = Phosphatase
D = Pyridoxal Dehydrogenase; 
Aldehyde Oxidase
The catabolism o f pyridoxal 5-phosphate. 
Scheme 19
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1.3.1. Role o f pyridoxal kinase.
Pyridoxal kinase catalyses the phosphorylation o f all three forms o f  vitamin B 6 
(1, 2, and 3) and appears to be present in all mammalian tissues. The kinases purified 
from liver, brain, and erythrocytes differ from each other in pH optima, metal 
requirements, and molecular weights. Pyridoxal kinase is not inhibited by pyridoxal 
5’-phosphate 5 in vitro65. However, the pyridoxal 5’-phosphate content o f an organ 
may be regulated by the rate o f phosphorylation o f free pyridoxal 2 by pyridoxal 
kinase. It was revealed in a study that daily administration o f 4 ’-deoxypyridoxine (7, 
R 1 = CH3; R2 = CH2OH) decreased the concentration o f pyridoxal 5’-phosphate and 
increased the activity o f pyridoxal kinase in rabbit brain66.
R1
The results indicated that the tissue availability o f pyridoxal 5’-phosphate regulated 
the activity o f pyridoxal kinase. In a study examining the activities o f  pyridoxal 
kinase, pyridoxine 5’-phosphate phosphatase, and pyridoxine 5 ’-phosphate oxidase in 
the brains and livers o f the controlled and vitamin B6-deficient rats’ revealed that only 
pyridoxal kinase responded rapidly to vitamin B6 deficiency . Therefore, tissue- 
specific responses o f pyridoxal kinase might serve to protect the pyridoxal 5 ’- 
phosphate content o f brain during periods o f B6 deprivation.
1.3.2. Role of pyridoxine 5 ’-phosphate oxidase.
Pyridoxine 5’-phosphate oxidase is an FMN-dependent enzyme that catalyses 
the oxidation o f derivatives 4 and 6 to pyridoxal 5’-phosphate 5. Pyridoxine 5 ’- 
phosphate oxidase, the second enzyme involved in the synthesis o f pyridoxal 5 ’-
/•Qphosphate 5, unlike pyridoxal kinase, is inhibited by pyridoxal 5’-phosphate , as 
confirmed for crude liver oxidase ’ and purified pig brain oxidase . Hence, some 
regulatory mechanisms must exist to prevent further formation o f pyridoxal 5 ’- 
phosphate. In a series o f kinetic and spectroscopic studies, pyridoxal kinase and 
pyridoxine 5’-phosphate oxidase was shown to form a complex71 according to the 
reaction in scheme 20 .
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PNP + PLP +
Pyridoxal 5'-phosphate oxidase Pyridoxal 5-phosphate oxidase
The formation o f pyridoxal 5'-phosphate by coupling o f pyridoxal kinase 
and pyridoxaine 5'-phosphate oxidase.
Scheme 20
£0 70 71Several reports ’ ’ have confirmed that pyridoxal 5’-phosphate inhibits the 
activity o f pyridoxine 5’-phosphate oxidase, which is a flavine mononucleotide 
(FMN)-requiring enzyme . Interestingly, pyridoxal 5’-phosphate formation was 
considerably impaired in the liver o f riboflavin-deficient rats73. Therefore, pyridoxine 
(pyridoxamine) 5’-phosphate oxidase could play a kinetic role68 in regulating the level 
o f pyridoxal 5’-phosphate formation in liver ’ and brain . However, the control o f  
pyridoxal 5 ’-phosphate formation at the level o f pyridoxine (pyridoxamine) 5 ’- 
phosphate oxidase would only be effective when pyridoxine or pyridoxamine was the 
substrate68.
1.3.3. Role o f phosphatase.
It has been postulated74’75 that the hydrolysis o f pyridoxal 5’-phosphate 5 by 
pyridoxal phosphatase plays a crucial role in the regulation o f the tissue content o f  
pyridoxal 5’-phosphate. Furthermore, there is evidence that newly synthesised 
pyridoxal 5’-phosphate is not freely exchangeable with endogenous pyridoxal 5’- 
phosphate but is preferentially released, converted to pyridoxal 2 by phosphatase, and 
then oxidised to 4-pyridoxic acid 56.
The inhibition o f phosphatase dramatically increases the concentration o f  
pyridoxal 5’-phosphate . The low plasma concentration o f pyridoxal 5 ’-phosphate m 
patients with liver disease is thought to result from enhanced degradation o f  pyridoxal 
5’-phosphate by the liver78. Also, children with Down’s syndrome have a greater
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tendency to be vitamin B6 deficient, a deficiency which may result from a greater than 
normal degradation o f pyridoxal 5 ’-phosphate79 (table 1).
Physiological or Pathological States Status of Vitamin B6
Alcoholics Higher degradation of PLP
Anaemia Elevated PL-kinase
Down's syndrome Greater susceptibility to B6 deficiency
Leukemia Reduced PLP in leukocytes
Peptic ulcer Lower serum PL
Physical stress in man Enhanced excretion of 4-PA
Physical stress in rats Exhanced excretion of 4-PA
Pregnancy Tendency to develop B6 deficiency
Speed running Elevated plasma PLP
PL = Pyridoxal, PLP = Pyridoxal 5’-phsophate, 4-PA = 4-Pyridoxic acid, 
PL-kinase = Pyridoxal phosphokinase.
Table 1
1,3,4, Absorption and transport of vitamin B*.
A series o f studies carried out in vivo and in vitro have provided
evidence80,81,82 that:
1) Pyridoxine, pyridoxal, and pyridoxamine have comparable affinity for 
transport to the CNS (central nervous system).
2) The entry o f H-pyridoxine into the brain was predominantly by a transport 
or enzymatic phosphorylation reaction.
3) The transport o f 3H-pyridoxine was inhibited by non-phosphorylated B6 
derivatives.
4) Addition o f unlabelled pyridoxine increased the percentage o f H-B6 
vitamers.
5) The non-phosphorylated B6 derivatives were not retained unless 
phosphorylated.
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These results were interpreted to indicate that the regulation o f pyridoxal 5 ’-phosphate 
in the CNS depends on the transport o f non-phosphorylated derivatives and their 
subsequent intracellular phosphorylation by pyridoxal kinase. Since the non- 
phosphorylated derivatives are not retained, the significance o f pyridoxal kinase 
becomes apparent. However, studies have shown that pyridoxal 5 ’-phosphate enters 
erythroid precursor cells without prior dephosphorylation83. Similarly, studies on the 
intestinal disappearance o f pyridoxal 5 ’-phosphate in rats seem to indicate that 
although a major portion o f pyridoxal 5’-phosphate is dephosphorylated (catalysed by 
intestinal phosphatases) and then transported as pyridoxal, a second mechanism also 
exists by which pyridoxal 5’-phosphate is transported unchanged84,85. The transport 
o f [14C]pyridoxal 5’-phosphate and [14C]pyridoxine into isolated rat mitochondria 
indicates that pyridoxal 5’-phosphate can rapidly enter the intermembrane space o f  
isolated mitochondria, but its penetration into the matrix occurs at a slower and more 
sustained rate66. Hence, the transport o f pyridoxal 5’-phosphate into isolated rat liver 
mitochondria is energy dependent, taking place by passive diffusion facilitated by 
protein binding66.
7.5.5. Role o f protein binding.
Protein binding o f pyridoxal 5’-phosphate, which has been postulated to be 
tissue specific, may regulate the steady-state concentration of pyridoxal 5’-phosphate. 
Studies have shown that in rat liver, 66 % o f pyridoxal 5’-phosphate is localised in the 
cytosolic fraction and this pool o f coenzyme is preferentially depleted under 
conditions o f vitamin B6 deficiency . Furthermore, up to 88 % o f cytosolic pyridoxal 
5’-phosphate is bound to proteins with molecular weights o f 1.2 x 105 daltons. 
Among five proteins that show high-affinity binding for pyridoxal 5’-phosphate, three 
were pyridoxal 5’-phosphate-dependent enzymes, alanine aminotransferase, aspartate 
aminotransferase, and glycogen phosphorylase (scheme 21).
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PL = pyridoxal
PLP = pyridoxal 5'-phosphate
PN = pyridoxine
PNP = pyridoxine 5'-phosphate
PM = pyridoxamine
PMP = pyridoxamine 5'-phosphate
4-PA = 4-pyridoxic acid
Hb = haemoglobin
RBC = red blood cell
Simplified representation of the transport of pyridoxal into liver
and conversion into pyridoxal 5'-phophate, and the release of pyridoxal into circulation.
Schem e 21
The storage and regulation o f pyridoxal 5’-phosphate in the liver and muscle are 
different. In the muscle, glycogen phosphorylase stores up to 90 % o f the pyridoxal 
5’-phosphate, whereas in the liver, this binding accounts for only 10 % o f  the bound
o/pyridoxal 5’-phosphate . Studies in human red blood cells have shown that pyridoxal
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and pyridoxal 5’-phosphate also binds to haemoglobin87. In general, the protein 
binding o f vitamin B6 is thought to accomplish the following objectives:76,86’87’88
1) The binding o f pyridoxal 5’-phosphate to proteins prevents its entry into 
the cells.
2) The bound pyridoxal 5’-phosphate is not hydrolysable.
3) The bound pyridoxal 5’-phosphate is physiologically inactive.
4) The bound pyridoxal 5 ’-phosphate is not available to pyridoxal 5’- 
phosphate-dependent enzymes.
5) The bound pyridoxal is not phosphorylated.
1.3.6. Pyridoxal as a major source o f circulating vitamin Br,.
Pyridoxal, the product o f phosphatase-mediated catabolism, has assumed a 
greater role in vitamin B6 metabolism than was once believed. The transport and 
accumulation o f pyridoxine and pyridoxal by erythrocytes have been studied using the 
rapid-mixing techinques with H-labelled substrates . These studies have shown that 
erythrocytes transport pyridoxine and pyridoxal by passive diffusion. Furthermore, 
the initial influx o f pyridoxine or pyridoxal is not saturated and is not affected by 
pyridoxamine or 4 ’ -deoxypyridoxine. The accumulation of [ HJpyridoxine against a 
concentration gradient was due to phosphorylation o f pyridoxine to pyridoxine 5’- 
phosphate, and the pyridoxal was accumulated by a kinase-independent mechanism. 
Gel filtration studies indicate that pyridoxal can accumulate by binding to an 
intracellular protein, most probably haemoglobin (see scheme 21).
Human erythrocyte have shown to take up [ HJpyridoxine, with at least 99 % 
o f the radioactivity appearing in the supernatant fraction90. Eighty percent o f that 
radioactivity was in pyridoxal 5’-phosphate and was bound. The newly synthesised 
pyridoxal 5’-phosphate was bound to haemoglobin90. Hence, pyridoxine is 
metabolised in human red cells91 according to scheme 22. However, the erythrocytes 
o f rats and some other species exhibits no oxidase activity ’ and the pyridoxine 5’- 
phosphate has no known fate other than hydrolysis back to pyridoxine, which finds its 
way to the plasma and then to other tissues for conversion to pyridoxal 5 ’-phosphate.
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PN enters ___ ^  Kinase
red cells + ATP
v
P N P ------►  Oxidase
+ FMN
v
PLP-------- ►  Phosphatase
PL enters 
plasma
Schem e 22
Studies with human platelets revealed that pyridoxal kinase has greater affinity for 
pyridoxal and pyridoxamine than for pyridoxine93. Therefore, pyridoxal kinase may 
play a role in regulating the synthesis o f pyridoxal 5’-phosphate in erythrocytes94. 
The transport and metabolism o f [ Hjpyridoxal and [ H]pyridoxal 5 ’-phosphate in the 
small intestine o f rats revealed that pyridoxal 5’-phosphate, after hydrolysis in the
Offlumen, is transported chiefly as pyridoxal . Since pyridoxine is not bound to any 
plasma proteins95, it could not serve as a storage form o f vitamin B6, therefore, the 
mammalian system tends to conserve pyridoxal. In the kidney, pyridoxine at high 
concentration is secreted from the kidney tubules by a saturable process whereas 
pyridoxal, in either physiological or pharmacological doses, does not undergo tubular 
secretion96. Liver and intestine are very active in their inter-conversion o f  B6 
vitamers. When pyridoxine is taken up by these cells, it is rapidly acted on by 
pyridoxal kinase and then converted to pyridoxal 5 ’-phosphate by pyridoxine 5 ’- 
phosphate oxidase . These two enzymes plus phosphatase provide a means o f  
converting dietary pyridoxine to circulating pyridoxal, which can then serve as a 
source o f the coenzyme pyridoxal 5 ’-phosphate in all tissues that contain pyridoxal 
kinase, whether they contain pyridoxine 5 ’-phosphate oxidase or not.
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1.3.7. Catabolism of pyridoxal to 4-vvridoxic acid in mammalian 
tissues.
4-Pyridoxic acid 56, the major vitamin E$6 excretory product, is formed from
Q7pyridoxal 2 by the action o f aldehyde oxidase or by the action o f  an NAD-dependent
QQaldehyde dehydrogenase (scheme 23). While pyridoxal is acted on by 
dehydrogenase from most tissues , pyridoxal is a substrate for the aldehyde oxidase 
only in the liver". Dehydrogenase activity is found in the mitochondria, cytosol, and 
microsomes in many tissues, and these enzymes have low substrate specificity. Under 
physiological conditions, it appears that the dehydrogenase is more involved in 
forming 4-pyridoxic acid than is the oxidase.
CHO
Aldehyde oxidase or pyridoxal dehydrogenase
COOH
2 Pyridoxal (PL) 56 4-Pyridoxic acid (4-PA)
Scheme 23
1.3.8. Role and properties of aldehyde oxidase.
One physiological role o f aldehyde oxidase is to catabolise the oxidation o f
Nl -methylnicotinamide. The second role o f aldehyde oxidase is to oxidise pyridoxal 
to 4-pyridoxic acid100’101.
Aldehyde oxidase (aldehyde-oxygen oxidoreductase) readily oxidises large 
numbers o f unsubstituted and carbon monosubstituted heterocycles and has preference 
for compounds with a substituted pyridine ring97,99. It is an exclusively cytoplasmic 
enzyme which contains non-heme iron, molybdenum, and flavine adenine 
dinucleotide in the ratios o f 4:1:1, along with a coenzyme Q-like quinone. In addition 
to molecular oxygen, the internal electron transport chain is capable o f functioning 
with a variety o f electron receptors .
Aldehyde oxidase is capable of oxidising pyridoxal to 4-pyridoxic acid, but 
pyridoxal 5’-phosphate does not serve as a substrate97,103. A^ 1-Methylnicotinamide is 
able to compete with pyridoxal for oxidation in vivo100. Inactivation o f  Nl- 
methylnicotinamide oxidase results also in an equal loss o f oxidase activity toward 
pyridoxal. A study with mutant rats endowed with high, low, or no aldehyde oxidase
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activity, revealed that when challenged with pyridoxine, animals with no aldehyde 
oxidase activity excreted as much 4-pyridoxic acid as animals with low  or high 
enzyme activity100. Therefore, an alternate pathway must be operational in the 
catabolism o f pyridoxal. Furthermore, although aldehyde oxidase is capable o f  
catabolising pyridoxal as a substrate, this pathway is o f dubious significance and plays 
a negligible role in physiological catabolism o f pyridoxal101.
1.3,9. Role and properties of pyridoxal dehydrogenase (aldehyde 
deh ydrogenase).
The NAD+-dependent aldehyde dehydrogenase (aldehyde-NAD+ 
oxidoreductase) is capable o f catabolising pyridoxal to 4-pyridoxic acid98. N AD+- 
Dependent aldehyde dehydrogenase with a broad affinity toward biological aldehydes 
has been detected in many mammalian tissues104. Since, mutant rats without aldehyde 
oxidase were able to catabolise pyridoxal, an alternate pathway must exist according 
to the following reaction (scheme 24):
Pyridoxal dehydrogenase
PL + NAD+ + H20 -------------------------------->- 4-Pyridoxic acid + NADH + H+
Scheme 24
1.3.10. Summary o f Catabolic Pathways.
The formation and degradation o f pyridoxal 5’-phosphate, and the circulation 
o f pyridoxal have been summarised in scheme 21. Factors such as the transport o f the 
precursors, the protein binding o f pyridoxal 5’-phosphate, the activity o f pyridoxal 
kinase and pyridoxal 5’-phosphate phosphatase regulates the concentration o f  
pyridoxal 5’-phosphate. In human, the catabolic pathways o f vitamin B6 are 
simplified in the following:
1) Phosphorylated forms o f B6 must first be dephosphorylated.
2) Absorption o f pyridoxal, pyridoxine, and pyridoxamine occurs primarily in 
the small intestine by passive diffusion.
3) Within intestinal cell, pyridoxine and pyridoxal are converted to 
pyridoxine 5’-phosphate and pyridoxal 5 ’-phosphate, respectively. 
Pyridoxine 5’-phosphate may be converted to pyridoxal 5’-phosphate.
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4) Pyridoxal 5’-phosphate, pyridoxal, and some pyridoxamine are bound to 
albumin for transport in plasma.
5) In the liver, unphosphorylated forms are phosphorylated and pyridoxine 
and pyridoxamine 5 ’-phosphate are generally converted to pyridoxal 5’- 
phosphate.
6) In the tissues, only pyridoxal is taken up and pyridoxal 5 ’-phosphate must 
be hydrolysed before uptake.
7) Within the cells, pyridoxal is phosphorylated by pyridoxal kinase.
8) Pyridoxine 5’-phosphate/pyridoxamine 5 ’-phosphate oxidase in tissues 
converts pyridoxine 5’-phosphate and pyridoxamine 5 ’-phosphate into 
pyridoxal 5’-phosphate, the coenzyme form o f vitamin B6.
9) Pyridoxic acid is the major excretory product in urine.
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1.4. Pyridoxal 5’-phosphate binding sites in enzymes.
Many enzyme-catalysed reactions require a substance to be present in addition 
to the enzyme and the substrate in order for the reaction may proceed. Such 
substances, known as coenzymes or cofactors, form an essential part o f  the catalytic 
mechanism. The intact enzyme system, or holoenzyme, is thus formed from a protein 
portion called the apoenzyme and a non-protein component referred to as a prosthetic 
group, a cofactor, or more commonly, a coenzyme. The combination o f the coenzyme, 
pyridoxal 5’-phosphate, with the protein apoenzyme creates a functional enzyme. It is 
the interplay between the coenzyme and the protein that leads specifically to the 
binding, hence the type o f reaction being catalysed.
Pyridoxal 5 ’-phosphate 5 and pyridoxamine 5 ’-phosphate 6 are the two central 
coenzymes o f amino acid metabolism105. The synthesis o f almost all amino acids is 
achieved by the biochemical reaction o f pyridoxamine 5’-phosphate with a a-keto 
acid in one o f the steps o f an overall process referred to as transamination. The 
pyridoxamine 5’-phosphate is converted to pyridoxal 5’-phosphate (the other 
coenzyme form) which can react with a second amino acid to regenerate 
pyridoxamine 5 ’-phosphate and convert the amino acid to its corresponding keto acid. 
As a result, a keto acid and an unrelated amino acid interchange functionality.
5 R =C H O  
Pyridoxal 5'-phosphate
6 R = CH2NH2 
Pyridoxal 5'-phosphate
Pyridoxal 5’-phosphate 5 has a number o f other functions as well. It is the coenzyme 
for most o f the interesting metabolic transformations o f amino acids, catalysing such 
processes as a-decarboxylation, a,p-elimination reactions, p-substitution reactions (as 
in the reaction o f serine with indole to form tryptophan). In the pyridoxal 5’- 
phosphate, certain functional groups are required specifically for binding to the 
apoenzyme. All pyridoxal 5’-phosphate-dependent enzymes bind the aldehyde
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component o f pyridoxal 5’-phosphate through the interaction with the e-amino group 
o f a lysine residue to form the Schiff s base. In the transaminases, there is an 
obligatory conversion o f the aldehyde to amine form as pyridoxamine 5’-phosphate. 
This reaction, however, may also occur as a side reaction with other enzymes such as 
glutamate decarboxylase106 and aspartate P-decarboxylase107. In all cases, the affinity 
for this form o f the coenzyme is reduced and reactivation o f the enzymes may be 
accomplished by addition o f pyridoxal 5’-phosphate.
The phosphate group, along with the aldehyde moiety, shows the uniform 
response needed for most pyridoxal 5 ’-phosphate-dependent enzymes. Enzymes such 
as aspartate transaminase, phosphorylase, and serine dehydratase108,109 have shown a 
preference for the dianionic state o f the phosphate, whilst the monoionic state suffices 
with other enzymes and even monomethyl esters are effective as coenzyme analogues 
in serine transhydroxymethylase110. In most cases, enzymes are quite sensitive to 
replacements in this region o f the coenzyme, and these effects are more likely to be 
due to steric protein requirements than specific needs o f particular states o f ionisation 
o f the phosphate for catalysis. In fact, sulphate in the form o f pyridoxal 5’-sulphate 
57 can substitute for pyridoxal 5’-phosphate in enzymes such as arginine 
decarboxylase and tryptophanase111. The presence o f the ester is not necessarily a 
requirement for efficient binding either and phosphonate analogues 58 also show  
efficient binding in serine dehydratase111 and aspartate transaminase112. In some 
enzymes, catalysis can be mediated when the pyridoxal is used alone. The removal o f  
the phosphate ester, however, greatly reduces the efficiency o f the catalytic events in 
enzymes such as the aspartate transaminase isozymes113 and lends support for the 
need o f phosphate as an anchor to bind pyridoxal 5’-phosphate in the proper catalytic 
arrangement o f enzyme-active sites .
57 R = CH20 S 0 3H
58 R = CH2OPO(OH)CH3
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In aspartate transaminase, the pyridine nitrogen group appears to be required 
for binding in its protonated form114. However, pyridoxal 5’-phosphate A-oxide 59 
and A-methyl pyridoxal 5 ’-phosphate 60 derivatives can be accepted as coenzyme 
analogues in some enzymes. These derivatives can even induce some coenzyme 
catalytic effect in aspartate transaminase and regenerate as much as 24% activity in 
glutamate decarboxylase115.
59 X = 0
60 X = CH3
The 2-methyl group was considered to take some part in the binding o f  
coenzyme to apoenzyme by hydrophobic interaction. Although this bond is not 
strictly necessary for the enzyme-catalysed reaction to proceed, it may assist in the 
fine adjustment o f the spatial interrelations between coenzyme and substrate116. The 
analogue, 2-norpyridoxal 5’-phosphate 61, which lacks a methyl substitutent, was a 
slightly better catalyst for transamination in aspartate transaminase . In other 
enzymes, 2-norpyridoxal 5 ’-phosphate varies, as it is a better aid for catalysis for 
arginine decarboxylase but less active than pyridoxal 5 ’-phosphate for 
tryptophanase118.
61 R 1 = H, R2 = OH
62 Ri = CH3, R2 = OCH3
However, the phenolic group at the 3-position o f the pyridine ring seems not to be 
necessary for enzymic binding purposes, since the 3-(9-methyl pyridoxal 5 ’-phosphate
11762 has been shown to bind efficiently to apoaspartate transaminase .
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1.4.1. The role of pyridoxal 5’-phosphate in model systems.
The general mechanism for enzymic reactions involving pyridoxal 5’- 
phosphate was proposed based on non-enzymatic reactions between amino acids and 
pyridoxal ’ . Early studies ’ showed the significance o f the various structural
features o f the pyridoxal molecule with respect to its ability to catalyse the 
transamination process in the presence o f metal-ions. The derivative 3-0-m ethyl 
pyridoxal 63 was not effective as a catalyst, and indicated a free hydroxyl group, 
ortho- to the formyl group, as necessary. 2-Formyl-3-hydroxypyridine 64 was active 
as a catalyst, as its structure is electronically similar to that o f pyridoxal. The methyl 
and the hydroxymethyl groups appear not to be important in non-enzymic reactions. 
In other reactions catalysed by pyridoxal, the pyridine ring may be replaced by a 
benzene ring carrying a nitro-group. This emphasises the role o f the heterocyclic ring 
as an electron-attracting species.
Model experiments typically involved pyridoxal 2, a polyvalent metal ion 
(Ca2+, Fe3+, Al3+), and the appropriate amino acid substrate 65. In non-enzymic 
transamination reactions, the motivating force for the reaction is the stabilisation o f  
the transition state for carbanion formation by delocalisation o f the charge through the 
conjugated system. The function o f the metal ion in these model systems appears to 
be stabilisation o f the intermediate imine, which increases the inductive effect on the 
a-carbon atom, thus facilitating release o f the proton (scheme 25). The model 
experiments suggest that the essential feature o f pyridoxal 5’-phosphate mediated 
reactions is the formation o f an imine (Schiff s base) between the a-amino group o f 
the amino acid and the aldehyde group o f pyridoxal 5’-phosphate .
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Quinonoid
intermediate
+ H+
+ h 2o
Pyridoxamine
3
Scheme 25
Using model systems similar to non-enzymic transaminations, pyridoxal is 
able to non-enzymically catalyse decarboxylation, racemisation, elimination, and 
condensation reactions . The proposed mechanisms all involve the prior formation
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o f pyridoxal-amino acid Schiff s bases as in the case o f the transamination reactions. 
In intermediate 67, the presence o f the protonated pyridine ring activates or labilises 
the carboxyl group, the a-hydrogen or the R group o f the amino acid species.
In the process o f decarboxylation, the a-amino acid undergoes elimination o f  
carbon dioxide and the molecule takes up a proton from the solvent. The a-amino 
acid reacts with pyridoxal 2 to give 68, which loses carbon dioxide to produce 
intermediate 69. The transitional form 69 may stabilise as 70, which hydrolyses to the 
corresponding amine and pyridoxal, or as 71, which hydrolyses to an aldehyde or 
ketone and pyridoxamine (scheme 26). The latter decarboxylation-dependent 
transamination reaction has no known enzymatic counterpart. The decarboxylation 
process differs from most o f the other pyridoxal-catlysed reactions in that the a- 
hydrogen o f the amino acid species remains attached to the carbon throughout. The 
absence o f any necessary reaction in which this a-hydrogen is lost, is shown by the 
observation that amino acids carrying substituents other than hydrogen undergo 
decarboxylation readily124. However, the presence o f metal ions actually inhibit the 
decarboxylation o f a-amino acids in these model systems, since the carboxyl group 
forms part o f the chelate structure where the pair o f electrons on the carboxyl anion is 
shared with the metal ion. These features would be expected to decrease the tendency 
for carbon dioxide to be eliminated, as the metal chelates would not be able to attain 
the preferred conformation for decarboxylation, It is most probable then that, even 
when metal-ions are present, decarboxylation occurs in the metal-free complex124,12S.
HC^ ".."M2+
HO
H
67
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In non-enzymic model systems, the nature o f the substrate and the 
experimental conditions determine which type o f reaction will occur. The use o f  an 
amino acid such as serine, with a leaving group in the P-position, in the presence o f  
indole as nucleophile will lead to the non-enzymic transformation o f  serine into
trytophan (scheme 27).
beta-carbon
+  Pyridoxal
COOH
Tryptophan 
+  Pyridoxal
Scheme 27
The pH o f  the reaction environment controls whether the proton returns to the a- 
carbon position (racemisation) or to the aldehyde carbon atom (transamination). The 
transamination reaction is favoured at lower pH values (ca. pH 5) and racemisation at 
higher pH values {ca. pH 10). Racemisation is the reversal o f the reaction from 73 to 
72 in scheme 28, where the de-protonated a-carbon is non-stereospecifically re- 
protonated. The intermediate imine 73 can undergo elimination reaction, leading to 
the intermediate 74. Hydrolysis o f this intermediate leads to pyruvate and ammonia. 
Alternatively, reaction between the intermediate and indole will lead to intermediate 
75 and hence to tryptophan.
The model systems used pyridoxal plus metal ions in duplicating many 
enzymic reactions o f a-amino acids and tend to suggest that metal ions might play an 
important part in the corresponding enzymic reactions. However, highly purified 
enzyme systems have been prepared which require pyridoxal 5’-phosphate and do not 
require metal ions for full activity125. In the model systems, the function o f  the metal 
ion is to maintain the correct geometry o f the intermediate imines and thus facilitate 
charge delocalisation.
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Pyruvate
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+  Pyridoxal
+ M2+
Schem e 28
In the enzymic reaction, the enzyme protein maintains the geometry. Thus, the role o f  
pyridoxal 5 ’-phosphate in the enzymic reaction is very similar to that o f pyridoxal in 
the model system. Since the initial reaction between coenzyme and apoenzyme is the
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formation o f  an imine between pyridoxal 5 ’-phosphate and the s-amino group o f  
lysine to give the holoenzyme, a transamination reaction must take place in the 
presence o f the amino acid substrate to give the imine 76 involved in the enzymic 
reaction (scheme 29).
R
\
+ h 2n - -H
COjH
Enzyme
NH.2 H
c o 2h
S c h e m e  2 9
1.4.2. Pyridoxal 5’-phosphate in enzymic reactions.
The coenzyme, pyridoxal 5’-phosphate, has two basic chemical properties; 
through its aldehyde group, it forms an imine with the amino group o f  substrate and, 
because it acts as an ‘electron sink’, it withdraws electrons from the substrate. In the 
absence o f apoenzyme, numerous different reactions would occur simultaneously, but 
the unique environment provided by the protein part o f each different pyridoxal 5 ’- 
phosphate-dependent enzyme directs the basic catalytic properties o f the coenzyme to 
provide the holoenzyme with its own substrate and reaction specificity.
The early steps in all reactions catalysed by pyridoxal 5 ’-phosphate-dependent 
enzymes on amino acids are essentially the same. The coenzyme is always bound as 
an imine to the s-amino group o f a lysine residue in a structure known as the ‘internal 
aldimine’ 77. After initial binding as a S ch iff s base, the amino group o f  the lysine 
residue is exchanged for the amino group o f the substrate amino acid to form the 
external aldimine 79, the process is also known as transaldimination. Transamination 
itself is not a single step process as it proceeds through a geminal diamine 78 in which 
both enzyme and substrate amino groups are bonded to C4’ (scheme 30). In this 
structure, the carbon atom has tetrahedral geometry. Both the external and internal 
aldimines have planar geometry about C4’ and their interconversion through the
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geminal diamine involve changes in geometry as well as proton transfer between the 
two nitrogens126.
77 Internal aldimine
79 External aldimine
Enzyme
Lys
\
n h 2
Schem e 30
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The next step allows for three possible reactions. The enzymatic reactions 
catalysed by pyridoxal 5’-phosphate have been shown to be under strict 
stereochemical control . Depending upon which of the three bonds break in
structure 80, other than the C-N bond to the chiral centre, amino acid can undergo 
transamination (bond a  breaks), decarboxylation (bond b), or retroaldol reaction (bond 
c ) .
R
Chemically, an obligatory requirement for electrons to be delocalised between two 71- 
electron systems is that the interacting atomic or molecular orbital components must 
be coplanar. Pyridoxal 5’-phosphate acts by delocalising electrons through the imine 
conjugated to the pyridine ring. The pyridine ring defines the appropriate plane, 
where its 7i-orbitals can be regarded as composed of overlapping p-orbitals at right 
angles to the plane of the ring and to become conjugated, the imine p-orbitals must 
adopt the same orientation . Hence, the electrons that come from the breaking bond 
a , b, or c must fit into the same plane to be accepted into the 7t-system of the pyridoxal 
5’-phosphate molecule. Loss of any of the three a-substituents results in a resonance 
stabilised carbanion-quinoniod structure 81, in scheme 31, which has been shown to 
be formed in many systems129.
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81 Quinonoid 
intermediate
S ch em e 31
1.4.2.1. Enzymic transamination and decarboxylation reactions.
Transamination between amino and oxo (keto) acids is catalysed by 
aminotransferases (scheme 32).
R1
+NH, QA  - + A
^  \ co2 R 2 H 2
CO,
0
r ' ^ C O ,
NH+
R^ H
4-
3
CO.
S ch em e 32
Aspartate aminotransferase, like all aminotransferases, requires pyridoxal 5’- 
phosphate as a coenzyme which catalyses the reaction in scheme 33.
PLP-enz + L-Aspartate ^  A  PMP-enz + Oxaloacetate
PMP-enz + 2-Oxoglutarate . A  PLP-enz + L-Glutamate
Sum m ary: L-Aspartate + 2-Oxoglutarate ~ ^  Oxaloacetate + L-Glutamate
S ch em e 33
The mechanism of action of this enzyme is essentially similar to the non-enzymic 
pyridoxal catalysed transaminations. After the initial transaldimination steps common 
to all pyridoxal 5’-phosphate dependent enzymes, the enzyme abstracts the proton
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from Ca of the aspartate substrate to form a quinonoid intermediate and subsequent 
protonation at C4’ of the coenzyme. This will liberate the oxaloacetate and the 
enzyme-bound pyridoxamine remains. The overall reaction is then completed by the 
occurrence of the reverse process. The enzyme-bound pyridoxamine binds to 2- 
oxoglutarate which forms the Schiff s base. The Schiff s base is de-protonated at the 
C4’, and then re-protonated at Ca of the amino acid substrate to give L-glutamate. 
Enzyme-bound pyridoxamines have been isolated as products of the first half reaction 
of a number of transaminases and the mechanism formulated above corresponds with 
the ‘ping-pong bi-bi’ kinetics (scheme 34) which has been observed for many 
transaminases130.
S1 pi S2
l
L  E i s i ^  E 1. P 1 — —  E 2 - —  E2 . S 2 ----------^  E ' . P 2 —1
E =  Enzym e  
S =  Substrate 
P =  Product
S ch em e 3 4
In decarboxylation reactions pyridoxal 5’-phosphate is present in enzymes, 
such as histidine decarboxylase, as an internal aldimine formed with the amino group 
of a specific residue. This internal aldimine group reacts with the amino acid 
substrate by transaldimination to form an external aldimine 79, which through the 
strongly electrophilic character of its pyridoxylidene moiety weakens the bond to the 
carboxyl group and results in loss of CO2. A proton adds to the resulting carbanion 82, 
and the product 84 is released (scheme 35). In enzymatic reactions, the incoming 
proton assumes the stereochemical position vacated by the leaving COOH group. All 
double bonds of the transition state are thought to lie in a plane that facilitates the 
indicated electron displacement; for efficient labilization in such a system the bond to 
the carboxyl group must lie perpendicular to this plane .
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7 9  E x tern a l a ld im in e 8 2  Q u in o n o id  
in ter m ed ia te
Scheme 35
The pyridoxal 5’-phosphate dependent enzymes are an important class of 
enzymes that catalyse a wide variety of biological transformations involved in the 
metabolism of amino acids and amines, such as transamination, decarboxylation, 
racemisation, P- and y-elimination, and substitution. Although, the catalytical roles of 
pyridoxal 5’-phosphate are amazingly versatile, its catalytical functions rely primarily 
on the ability of the coenzyme to act as an electron sink, temporarily storing the 
electrons that are later used for the cleavage and/or formation of covalent bonds.
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2.5. Synthesis o f vitamin B* analogues.
1.5.1, Manipulation of vitamin Ba and derivatives.
Manipulation of readily available pyridoxine hydrochloride, through blocking­
deblocking procedures, has been utilised for the preparation of vitamin E$6 analogues. 
This allows one or two functional groups to be blocked using another group such as 
isopropylidene, benzyl, or acyl, thus permitting the remaining functional groups in the 
vitamin B6 molecule to be modified selectively. After suitable modification, the 
blocking can be removed to give the desired compound. The success o f this approach 
depends on the ease with which the blocking group can be removed and be introduced. 
Many vitamin B6 analogues have been prepared by this method as it can conveniently 
transform selective functional groups of pyridoxine to the desired derivative.
Hence, a typical procedure in pyridoxine manipulation begins with the 
blocking of C-3, C-4’ or C-5’ hydroxyl groups. This is done commonly by the 
addition of an isopropylidene group to C-3 and C-4’ or C-4’ and C-5’ hydroxyl 
groups of pyridoxine. The treatment of pyridoxine 1 in acetone saturated with 
hydrochloride gas132 is generally used to achieve the 3,4’-0-isopropylidenepyridoxine 
85 (scheme 36).
S ch em e 3 6
On the other hand, treatment of pyridoxine with equimolar amount of p -  
toluenesulphonic acid in dimethoxypropane and acetone produces 4’,5’-0 -  
isopropylidenepyridoxine 8 6  exclusively. However, if the /?-toluenesulphonic acid is 
in a 4:1 ratio to pyridoxine then 3,4’-0-isopropylidenepyridoxine 85 was the only 
product132, as shown in scheme 37.
54
Introduction
The 4’ ,5 ’-O-isopropylidenepyridoxine 8 6  was considered as the initial product even 
when a large proportion of the catalyst was used and that the formation of 8 6  is 
followed by isomerisation to 3,4’-0-isopropylidenepyridoxine 85. Apparent 
isomerisation o f 8 6  to 85 has been reported to occur in acetone with HC1133. 
Isomerisation was examined in an experiment using labelled material 4’,5’-0 -  
isopropylidene-dtf-pyridoxine , prepared by reacting pyridoxine 1  with acetone-^. 
The labelled 4 ’,5’-0-isopropylidene-^-pyridoxine was subjected to ‘isomerisation 
procedure’ using />-toluenesulphonic acid in acetone and revealed that isolated 3,4’- 
O-isopropylidenepyridoxine 85 was unlabelled. The compound 85 was unlabelled 
suggest that the ‘isomerisation procedure’ first causes the isopropylidene group in 8 6  
to be completely hydrolysed off, and then the cyclic ketal 85, with a six-membered 
ring, is formed directly. This is probably a case of kinetic versus thermodynamic 
control, with compound 8 6  as a kinetic product and 85 as a thermodynamic product. 
However, increase in acidity favours the formation of ketals involving the phenolic 
OH group than to those involving only the alcoholic OH groups.
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1.5.1.1. Reaction at the 2-position.
The 4’,5’-0-isopropylidenepyridoxine 8 6  is particular useful in selective 
modification of pyridoxine at the 2 -position.
Analogues of vitamin B6 modified in the 2-position, such as 2’- 
methylpyridoxine (87, R = C2H5), have been of considerable biochemical interest 
regarding pyridoxal catalysis17, the mode of binding of the coenzyme analogue134, and 
in studies of the active sites of enzymes metabolising vitamin Be135. Studies with 
analogues that had the 2-methyl group replaced with 2 -CH2OH (8 8 , R = CH2OH) or 
with various other alkyl groups indicated that there is a certain bulk tolerance in the 2 - 
position with respect to several enzymes requiring pyridoxal 5’-phosphate and in 
metabolic interconversions of different forms of vitamin B61,136.
.OH
OH
87 R = C2H5
8 8  R = CH2OH
A general example of modifying the 2-methyl group of pyridoxine 1 proceeds by 
protecting the C-3 phenolic group by benzylation followed by isopropylidenylation o f  
the C-4’ and C-5’ hydroxyl groups to give the derivative 89. Protection o f the 
derivative’s nitrogen by N-oxidation allows modification of the 2-position without 
interference. The compound 90, treated with trifluoroacetic anhydride and subsequent 
hydrolysis of the 2  ’ -O-trifluoroacetyl group followed by oxidation with MnC>2 gives 
the 2-formyl group 91, as shown in scheme 38.
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.OH OH
Isopropylidenylation
90
The blocking groups of compound 91 removed by mild hydrolysis, heating with 1 N  
HC1 on a steam bath, will afford 2-formyl-2-norpyridoxine (92, R = CHO). The 2- 
formyl group in 91 can be converted into vinyl derivative 93 by means of a Wittig 
reaction in which the required ylide can be generated from triphenylphosphonium 
bromide, using either rc-butyllithium or potassium tert-butoxide as the base, and 
subsequent mild acid hydrolysis gives 2-vinyl-2-norpyridoxine 94 (scheme 39).
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t
92 R = CHO
f
94 R = CH=CH2
S ch em e 39
The Wittig reaction or Wittig olefination137 ’ 138 reaction is the interaction o f an 
alkylidene phosphorane 95 (i.e. a phosphorus ylide) with an aldehyde or ketone 96 to 
yield an alkene 97 (i.e. an olefin) and a phosphorus oxide 98 (scheme 40).
R2
R1
95
PR3 + ° = <
R :
R '
R^
R
96 97
R
+
R-
R3P“ 0
98
S ch em e 40
The most common route in preparing phosphorus ylides, like the 
triphenylphosphonium bromide used with carbonyl 91, is the reaction of 
triphenylphosphine 99 with an alkyl halide 100 to give a triphenylphosphonium salt 
101. The triphenylphosphonium salt 101 treated with a base give the corresponding 
ylide 102 (scheme 41). The triphenylphosphonium salt 101 is usually isolated, and in 
most cases is crystalline, while the ylide 1 0 2  is usually prepared in solution and used 
directly for reaction with the carbonyl substrate.
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(C6H5)3P +  
99
H
X- -R^
R1
100
B-
+ H
(c 6h 5)3p -R2 X -
Rl
101
Base (C6H5)3P-
R 1
J
■R2  — >  (C6H5)3P ^
Rz 
R 1
102
Scheme 41
Nucleophilic addition of the negatively polarised ylide carbon centre 95 (due to its 
resonance structure as in 1 0 2 ) to the carbonyl carbon centre of an aldehyde or ketone 
96 is the initial step of olefin formation. A betaine 103 is thus formed, which can 
cyclise to give the oxaphosphetane 104 as an intermediate. The latter decomposes to 
yield a trisubstituted phosphine oxide 98 and the alkene 97 (as shown in scheme 42). 
The driving force for the reaction is the formation of the strong double bond between 
phosphorus and oxygen.
R
R3
R4 £R,P-3jf -R2-R4
R3
103
RJ
R„P
o -1
-R
-R4
R J
104
R'
R
97
R
R 3
+ R3P~o
98
Scheme 42
The reactivity of the phosphorus ylide 95 strongly depends on its substituents (R1 and 
R2). When R1 or R2 is an electron-withdrawing group, the negative charge can be 
delocalised over several centres, and the reactivity at the ylide is reduced. The
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reactivity of the carbonyl compound towards addition of the ylide increases with the 
electrophilic character of the C=0 group. R 1 and R2 are often both alkyl, or alkyl and 
aryl. The Wittig reaction is one of the most important reactions in organic synthesis. 
The synthetic importance of the Wittig reaction and its variants and related reactions 
is based on the fact that the new carbon-carbon double bond in the product molecule 
is generated at a fixed position.
Both 2-formyl-2-norpyridoxine 92 and 2-vinyl-2-norpyridoxine 94 have 
shown to be inhibitors of mouse mammary adenocarcinoma cells in culture and the 
inhibition was not reversed by pyridoxine132. The availability of useful intermediates, 
such as the 2-formyl derivative 91, for modification of the 2-position made it possible 
to introduce other substituents as shown in table 2 .
Compound Biological Activity
2-Ethynyl-2-norpyridoxineuz; R = C= CH 
a2-Aminopyridoxine139; R = CH2NH2 
2-Amino-2-norpyridoxine139; R = NH2 
2-Norpyridoxine-2-carboxamide139; R = CONH2 
2-Chloro-2-norpyridoxine139; R = Cl
Inhibits mouse mammary 
adenocarcinoma cells in culture.
2-Norpyridoxine-2-carboxylic acid139; R = CO2H None
Table 2
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1.5.1.2. Reaction at the 3-position.
Modification of the 3-position has been of much less interest, as the 3-
to apoenzyme since 3-O-methylpyridoxal 5’-phosphate binds efficiently to
methods were concerned with modifying the 3-position to a halogen or thiol group, 
pyridoxine were inappropriate as a starting material due to complication in 
substituting the hydroxyl group at the 3-position.
Method for achieving modification at the 3-position are based on the 
established strategy of total synthesis using acyclic precursors to form the pyridine 
derivative for subsequent substitution reactions. Hence, condensation of 
cyanoacetamide and 2,4-dioxopentanoic acid ethyl ester1 4 1 ,143 forms 3-cyano-4- 
carboethoxy-6-methyl-2-pyridone 105 (scheme 43).
using phosphorous oxychloride afforded dinitrile 106. Nitration o f the dinitrile 106 
using fuming nitric acid in acetic anhydride forms nitropyridone 107. The 
nitropyridone 107 was subjected to phosphorus pentachloride in chlorobenzene to 
yield the chlorinated pyridine 108. Reduction of the nitro group by catalytic 
hydrogenation using platinum oxide as catalyst and subsequent conversion of the
hydroxyl group of the coenzyme of vitamin B6 appears to be insignificant for binding
• 112 •apoaspartate transaminase . Established methods in modifying the 3-position of 
vitamin B6 used acyclic precursors as the starting materials140,141’142. Since these140,141,142
o 0 ^ / O C 2H5
cyanoacetamide
+
O O
105
H
O
2,4-dioxopentanoic acid 
ethyl ester
Sch em e 43
Subsequent ammonolysis of pyridone 105 and dehydration of the obtained amide
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resulted nitriles to amines by catalytic hydrogenation using palladium catalyst 
afforded triamine 109, as shown in scheme 44.
o , _ o c 2h 5
IH
105
° ^ NH2
A m m o n o ly s is
M eO H , 
N H 3 (aq ) IH
D eh yd ra tio n  o f  
a m id e.
P O C l3
CN
N itra tio n
H N 0 3,
(C H 3C 0 ) 20
CN
CN C h lor in a tio n X N
O PC15, P hC l ^ TT X I
108107
R ed u ctio n  o f  
nitro .
H 2 +  Pt, 
(C H 3C 0 ) 20
R ed u ctio n  o f  n itr iles  
and e lim in a tio n  o f  
ch lo r in e .
H 2 +  P d C l2, 
M e O H 109
S c h e m e  4 4
Subsequent blocking of the two aliphatic amino groups at the 4- and 5-position 
in compound 109 allows selective substitution of the 3-amino group to a chloro 
substituent. The two aliphatic amino groups at the 4- and 5-position undergoes 
carbethoxylation144, where the nucleophilic amines attacks the carbonyl carbon atom 
of ethyl chlorocarbonates and the chlorines dissociate to form the carbamate 1 1 0 , as 
shown in scheme 45.
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EthylNa+ "OH chlorocarbonate
H
C 7 ,
oX
‘0 ' V ‘Cl
N.
h 2n .
‘H
'N' .H
O
i rO ^ C l
.  ^  H
N f109 VNa+ -OH
- 2H20
cO
O o c 2h 5
N.
h 2n .
r" " h o  cl
^o c 2h 5
N
N OC9H,I 2 5H
H9N.- 2NaCl 2
*H OXN OC9H,I 2 5HN
110
S ch em e 45
The compound 110 undergoes diazotization which results in the replacement of the 3- 
position diazonium group with a chloro substituent, to form derivative 1 1 1  (scheme
46).
% / O c 2h 5 ° < ^ O C 2H5
N OC2H5
Diazotization &
Sandmeyer
reaction
NaN02 , HC1, 
CuS04 
S ch em e 46
o c 2h 5
Diazotization145 of compound 110 illustrates the most important reaction of amines 
with nitrous acid. Compound 110, like primary arylamines, reacts with nitrous acid to 
give arenediazonium salts. The general mechanism proceeds in the presence o f strong
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acid, when nitrous acid dissociates to produce ^NO ions which react with the nitrogen 
of the amine 112 to form an unstable AAnitrosoammonium ion 113. The N -  
nitrosoammonium ion loses a proton to give an 7V-nitrosoamine 114, tautomerises to a 
diazohydroxide 115 and subsequently loses water to form the diazonium ion 116, as 
shown in scheme 47.
\  \  +HONO +  H30  ^  H20  ~rN O  ^  2 H20  +  N = 0
Nitrous acid \  I
H . aAr—N N = 0  /H
112 Primary 
arylamine
H v+ -*■  Ar—N —N = 0  ---------/H
113 N-Nitrosoammonium 
ion
+Ar—N t N = 0
hO
114 N-Nitrosoamine
- H+ _ + H+------- ►  Ar—N = N —O ^+ H+
+ H+
Ar—N —N~O H  ^ = =  
- H+115 Diazohydroxide
! l „ QAr—N = N -O H  +
+ + ~\Ar—N = N
0 ^  Ar—N = N +  H ,0
116 Diazonium ion 
Scheme 47
Subsequent replacement of the diazonium group in e.g. 116 with a chloro substituent 
is known as the Sandmeyer reaction146. The Sandmeyer reaction is used for the 
replacement o f the diazonium group in an arenediazonium compound by halide or 
pseudohalide, taking place in the presence of a metal salt (with the exception of iodide 
which is possible without a metal catalyst). The general reaction mechanism involves 
the diazonium ion 116 being reduced by the reaction with copper-(I) salt 117 to give 
an aryl radical 118. This radical then abstracts a halogen atom from the CuX2 119, 
which is thus reduced to the copper-(I) salt 117. Since the copper-(I) species is 
regenerated, it serves as a catalyst in the overall reaction (scheme 48).
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+ -
Ar—N 2 x  +  CuX  
116 117
Ar +  N2 +  CuX2 
118 119
Ar +  CuX2 --------------- Ar—X +  CuX
1 1 8  Aryl halide 1 1 7
Scheme 48
The obtained chloro compound 111 can be hydrolysed to remove the amino blocking 
groups at the 4- and 5-position to provide pyridoxamine derivative. Further 
diazotization and hydrolysis of the pyridoxamine derivative will give the pyridoxine 
analogue 120 with a chloro group at the 3-position as shown in scheme 49.
o > ^ , o c 2h 5
.N.
o c 2h 5
.NHL
Hydrolysis
HC1
Diazotization & Hydrolysis ----------------------------------------- >-
HC1, NaN02, H20
Scheme 49
Another example involves the condensation of cyanoacetamide and 
acetylacetone142 to form 2,4-dimethyl-5-cyano-6-hydroxypyridine 121. Nitration o f  
pyridine 1 2 1  and subsequent conversion of the 6 -position hydroxyl group to a chloro 
substituent yields compound 122. Reduction using tin(II) chloride in hydrochloric 
acid converted the nitro in compound 1 2 2  to an amino group, and subsequent 
treatment with zinc dust removed the chloro substituent to give aminonitrile 
compound 123. The compound 123 treated with barium hydroxide hydrolysed the
65
Introduction
nitrile group to the corresponding carboxyl group and esterification using ethanolic 
hydrogen chloride produced the ester compound 124, as shown in scheme 50.
Acetylacetone
O
+ h 2n
CN
Gyanoacetamide
Et2NH
CN
OH
Nitration ------------------>
h n o 3, h 2s o 4
Chlorination 
PC15, POCI3
122
Reduction 
of nitro group
SnCl2, HC1
Elimination 
of chlorine
Zn dust, H20
CN
Hydrolysis 
of nitrile
BaOH2, H20
COOH
Esterification
C2H5OH, HC1
124
c o o c 2h 5
Scheme 50
Reduction of the ester in compound 124 using lithium aluminium hydride and 
subsequent diazotization gives the corresponding diazonium intermediate. The 
diazonium intermediate was treated accordingly with potassium ethyl xanthate to 
form the xanthate 125. Subsequently, the xanthate ester was reduced with lithium 
aluminium hydride to produce the thiol compound 126, as shown in scheme 51.
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c o o c 2h 5
Reduction
LiAlH4
CH2OH
Diazotization 
NaN02, HC1
Diazonium
salt
Addition of 
xanthate group
+
HLCLCL JS KTs
Scheme 51
Compounds 120 and 126 with the 3-position hydroxyl group replaced with 
chloro and thiol substitutents, respectively, does not have significant effect on the 
implicated biological systems140,142.
1.5.1.3. Reaction at the 4-position.
A majority of vitamin B6 analogue syntheses have focused on manipulation of 
the 4-position, since the most important part of the active pyridoxal 5’-phosphate is 
the 4-position aldehyde group, where its main function is to bind to an amine substrate 
and form a Schiffis base which initiates subsequent catalytic reaction in biological 
systems. Thus, most vitamin B6 analogues were prepared in order to mimic or 
antagonize the catalytic ability of the biologically active form of vitamin B61. The 
replacement of the 4-position aldehyde group with an inert methyl group, the 4- 
deoxypyridoxine (7, R = CH3; R = CH2OH), has resulted in the classical and most 
widely studied antagonist of vitamin B66.
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r = c h 2o h
R =  CHO
The most general and convenient method for the modification o f the 4-position 
begins with the compound 3,5’-0-dibenzylpyridoxine 127 or 3 ,5 ’- 0 -  
dibenzylpyridoxal 128; the synthesis of these will be detailed in later discussion. The
3,5 ’ -O-dibenzylpyridoxal 128 undergoes a variety of substitution reactions to modify 
the 4-position without affecting neighbouring functional groups. For instance, the 
application of the Wittig reaction to derivative 128 affords compound 129. The 
subsequent removal of the benzyl groups either by heating with dilute hydrochloric 
acid or, in the case of sensitive groups, with neat trifluoroacetic acid, produces the 4- 
vinyl-4-deformylpyridoxal (132, R = H) 147 and several o f its a,p-unsaturated 
derivatives4,148 as shown in scheme 52. These substituted vinyl analogues were found 
to be active as inhibitors of mouse mammary adenocarcinoma cells in culture148.
o
129 R = H
130 R = CH2CH3
131 R = CH = CH2
132 R = H
133 R = CH2CH3
134 R = CH = CH2
Scheme 52
1.5.1.4. Reaction at the 5-vosition.
Modifications at the 5-position are more accessible, primarily because o f the 
ease of preparation of the key compound, 3,4’-isopropylidenepyridoxine 85. It is 
possible that the phosphate group has a direct function in enzymic catalysis or that it 
plays an essential structural role in enzymes, thus various analogues with modified 
side chains in the 5-position were synthesised149,150. For example151, oxidation of the 
3,4’-isopropylidenepyridoxine 85 gives the 5-aldehyde compound 135 which 
undergoes a Wittig reaction to achieve the 5-vinyl compound, followed by mild acid 
hydrolysis to produce the 5-vinyl pyridoxine derivative 137 (scheme 53).
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Scheme 53
Alternatively, alkynes can be synthesised from the alkene by bromination to 
form a vzc-dibromo compound 138. The v/c-dibromo compound is 
dehydrohalogenated through its reaction with a strong base. The dehydrohalogenation 
occurs in two steps, and the first step yields a bromoalkene 139 as shown in scheme 
54. The basic ion brings about an E2 reaction. The E2 reaction proceeds by the 
removal of a proton from the ‘p-carbon’ whilst at the same time the electron pair of 
the p C-H bond begins to move in to become the 7r-bond of a double bond. 
Subsequently the bromine begins to depart with the electrons that bonded it to the ‘a- 
carbon’. A second E2 reaction produces the alkyne.
138 1 3 9
NH3 +  Br
O c _ C ' + ' N ~ H*Br R H 
Bromoalkene Amide ion 
139
R—CEEC—R +  NH3 +  Br
Alkyne
Scheme 54
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Depending on the conditions, these two dehydrohalogenations may be carried out as 
separate reactions, or they may be carried out consecutively in a single reaction. The 
strong base, sodium amide, is capable of producing both dehydrohalogenations in a 
single reaction.
Thus, bromination of the 5-vinyl compound 136 forms the 5-(dibromoethyl) 
derivative 140, which eliminates the bromide ions through dehydrohalogenation to 
give bromoalkene 141 and alkyne 142. Hydrolysis of the isopropylidene groups on 
compounds 141 and 142 gives the pyridoxine analogues 143 and 144, respectively 
(scheme 55).
136 Br2 140
CHBrCH2Br
Dehydrohalogenation 
NaNH2 - NH3
.OH
HOn A ^ RHydrolysis
H ,0+ N
141 R = CH=CHBr 143 R = CH=CHBr
142 R =  C=CH  1 4 4  R =  C=CH
Scheme 55
The 5-vinyl 137, 5-bromovinyl 143, and 5-ethynyl analogues 144 have all exhibited 
the ability to act as substrates of pyridoxine dehydrogenase151.
1.5.1.5. Reaction at the 6-position.
Halogenation at the 6 -position is one of the established routes in synthesising 
vitamin B6 analogues. In early studies152, the greater electron-withdrawing character 
of the 6 -halogen as compared with hydrogen offered an opportunity to correlate these 
factors with their effects on enzymes, cells, and tissues dependent on vitamin B6 for 
their functions. The general method starts with 6 -aminopyridoxine 146 which was 
obtained by hydrogenolysis of 6 -phenylazopyridoxine 145. The 6 -
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tphenylazopyridoxine 145 can be prepared by the coupling reaction of pyridoxine 1 
with benzenediazonium chloride (scheme 56).
HO
OH
Diazo coupling 
reaction
HO
\  / ) — N2 Cl,NaOH,H20
N N = N -A r  
145
Hydrogenolysis 
H2 + Pd-C
This electrophilic aromatic substitiution is often called a diazo coupling reaction154. 
The arenediazonium ions 147 undergo a coupling reaction with electron-rich aromatic 
compounds 148 like aryl amines and phenols to yield azo compounds 149 (scheme 
57).
+
Ar—N = N  +  Ar‘H -------------------- »- Ar—N = N —A r 1
147 148 149
Scheme 57
The substitution reaction at the aromatic system 148 usually takes place p a r a  to the 
activating group. If the p a r a  position is already occupied by a substituent, the new 
substitution takes place orth o  to the activating group. Therefore, phenols (like 
pyridoxine 1 ) are predominantly coupled in slightly alkaline solution, in order to first 
convert an otherwise unreactive phenol into the reactive phenoxide anion which 
initiates the coupling reaction, as shown in scheme 58.
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S ch em e 58
If the solution is too alkaline (pH > 1 0 )  the arenediazonium ion itself reacts with 
hydroxide ion to form a relatively unreactive diazohydroxide or diazotate ion, shown 
in scheme 59.
+ OH OH
Ar—N = N  ^ ^  Ar—N = N —OH •< ...... * Ar—N = N ~ O
H+ H+Arenediazonium Diazohydroxide Diazotate ion
ion
S ch em e 59
The 6 -aminopyridoxine 146 can undergo the Sandmeyer reaction to yield 6 -chloro 
150 or 6 -bromopyridoxine 151. Alternatively, the 6 -amino compound 146 undergoes 
the Schiemann reaction to afford the 6 -fluoro 152 (scheme 60).
OH
Sandmeyer
reaction
NaN02, HC1 or HBr, 
CuCl or CuBr 150 R = Cl
151 R = Br
.OH
Schiemann
reaction
NaN02, HBF4
S ch em e 60
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The Schiemann reaction155 is very similar to the Sandmeyer reaction. The 
diazotization o f aryl amine 153 in the presence of tetrafluoroborate leads to formation 
of an aryldiazonium tetrafluoroborate that can be converted into aryl fluoride 154 by 
thermolysis (scheme 61).
Ar—NH2 
153
h n o 2 / h b f 4 ---------------- >.
- 2 H20
+ - - n 2Ar—N 2 BF4 -------------
-B F3
Aryldiazonium
tetrafluoroborate
Ar— F 
154
Scheme 61
Only the 6 -amino 146 and the 6 -fluoro 152 analogues were found to be active 
as inhibitors o f mouse mammary adenocarcinoma cells in culture. Also, the 6 -chloro 
compound 150 showed that with the bulky substituent it precludes the compound 
from being phosphorylated by pyridoxal kinase .
Since the discovery that vitamin B6 exists in multiple forms, and that pyridoxal 
5’-phosphate has coenzyme functions in various enzyme systems, various compounds 
related to vitamin B6 have also been synthesised. The modification strategies 
mentioned are just some of the possibilities in achieving vitamin B6 analogues. 
Alterations have been made at every position of the pyridine ring and the effects of 
these alterations on diverse biological and biochemical systems have been extensively 
studied1’149.
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1,5,2. Synthesis of vitamin Ba analogues by the condensation o f  
oxazoles with dienoyhiles.
In the late 1950’s, it was discovered156 that the azadiene system o f oxazoles 
readily reacts with an activated double bond by the Diels-Alder mechanism. Since 
then, the Diels-Alder reaction of oxazoles 155 with dienophiles 156 has been applied 
extensively to the synthesis of substituted pyridine bases 157 (scheme 62), 
including biologically important compounds such as vitamin B6 and its analogues.
1.5.2.1. Oxazoles: synthesis.
Oxazole 158 has an oxygen atom and a pyridine-type nitrogen atom at the 1- 
and 3-position of the ring. The oxazoles are planar molecules with conjugated n - 
electron sextets in the cyclic system. Their chemical properties are aromatic in 
character. The lone-pair of electrons on nitrogen, which is coplanar with the 
heterocyclic ring and therefore not involved in delocalisation, present weakly basic 
properties as in pyridine.
1
158
One of the oldest and most useful syntheses of oxazoles is the reaction o f a- 
acylamino carbonyl compounds with a cyclodehydrating agent, such as PCI5, H2SO4, 
SOCI2, or POCI3. The cyclodehydration reaction is known as the Robinson-Gabriel 
synthesis158,159. The mechanism of the cyclodehydration was uncovered when it was 
found that labelling the a-acylamino ketones with lsO in the keto carbonyl group did 
not produce I80-labelled oxazoles. Conversely, when the amide carbonyl oxygen is 
labelled with the 180 , the label is found in the oxazole (scheme 63)160.
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Alpha-acylamino Labelled oxazole
carbonyl compound
Scheme 63
In many cases when the cyclodehydrating agents are PCI5, H2SO4, SOCI2, or POCI3, 
the Robinson-Gabriel synthesis affords low yields of oxazoles. However, when 
polyphosphoric acid is used, the yields of oxazoles can be increased to 50 -  60 %161. 
Anhydrous HF was also shown to efficiently cyclise ALaryl-a-amido ketones to 
oxazoles in yields up to 96 % . Also, methyl iV-methoxalyalaninate treated with
phosgene in triethylamine at room temperature for 10 min produced 4-methyl-5- 
methoxyoxazole-2-carboxylate in 80 % yield (scheme 64).
M e—CHCCLMe
1 2NHCOCOjMe
Methyl N-methoxalyalaninate
4-Methyl-5-methoxyoxazole-
2-carboxylate
Scheme 64
Also, acetic and trifluoroacetic anhydride have been utilised as cyclodehydrating 
agents for the conversion of secondary amides to oxazoles164 (scheme 65).
R
Scheme 65
Including the Robinson-Gabriel synthesis, there are various methods for 
oxazole synthesis. a-Haloketones and a-hydroxyketones condense with acid amides 
via an O-alkylation, to give 4- and 5-substitued oxazoles, but often in low yields 
(scheme 6 6 )165.
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R
h 2n Y 1
The synthesis also suffers from a lack of generality. Whereas 4- and 5-alkyl- or 
aryloxazoles can be prepared using this reaction, oxazoles bearing other functional 
groups at these positions generally cannot be synthesised. Often the relative 
inaccessibility of the starting a-functionalised ketone may be a major downside to the 
use of this method.
The use of isocyanides overcomes disadvantages associated with obtaining 
appropriate a-substituted ketones. The reaction of a-metalated isocyanides with 
carboxylic acid derivatives, via C-acylation and electrophilic C-0 bond formation, 
produced 2-unsubstituted oxazoles in moderate to high yield166,167(scheme 67).
H , IR 1— C -N C «-BuLi or K+0-f-Bir
H \ IR — C—NC
H M+
R2COX NC1 1 2 R 1— CHCOR
CN OH
1 I 1 2R 1— C = C — R 2
R1 = C 0 2Et R2 = Me X = C1 66%  
R1 =Ph R2 = H X = OMe 76%  
R1 = H R2 = Et X = N(Me)2 48 %
Scheme 67
A number of variations of this method have been developed. The commercially 
available tosylmethyl isocyanide (TOSMIC) and derived reagents add the CH-N=CH 
fragment to unsaturated substrates (e.g. aldehydes) to give oxazoles in good yield .
Synthesis which utilise amino-, imino-, and amido-nitriles produce a wide 
range of 5-substituted oxazoles from reactions with aldehydes169. The acid-induced 
cyclisation of a-amidonitriles yields the 5-aminooxazoles and subsequent reaction 
with aromatic aldehydes forms the 5-arylideneaminooxazoles (scheme 6 8 ) .
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Alpha-amidonitrile 5-Aminooxazole derivative
compound
5-Arylideneaminooxazole
Scheme 68
Nitrilium salts, generated by the reaction of the nitrile-SnCU complex with a- 
haloketone, cyclise to produce 2,4-disubsituted-5-phenyloxazoles (scheme 69)169. 
The reaction is general for the R = Ph, R1 = alkyl, alkoxyalkyl, benzyl, or aryl and 
give yields of 52 -  92 %.
+
H5C6— IP"™ 11 + R 1 —1C = N —SnCl4 ------------
O Cl
Alpha-haloketone Nitrile-SnCl4 complex
h 5c 6- TFo
CH
N = C —R1
+
Nitrilium salt 2,4-Disubstituted-5-
phenyloxazole
Scheme 69
Low yields of oxazoles can be obtained from carbonylcarbenes as shown in scheme 
70169. Upon heating, the diazo compound releases N2 to give the ionic intermediate, 
which reacts with the nitrile to form the desired product.
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ii2 Heat
r c o — —^ r 1 --------------
Alpha-diazocarbonyl m etal cat 
compound - N 2
Scheme 70
Although there are a variety of methods to choose from for oxazole synthesis, 
the Robinson-Gabriel synthesis is the most well known and convenient to use.
1.5.2.2. Oxazoles: reactions.
The electronegativity of the pyridine-like nitrogen atom causes the 7r-electron 
density to be low, especially on the C-2 atom169. As oxazoles 158 are weak bases, 
strong acids (e. g. H2 SO4 ) tend to protonate the N-atom resulting in oxazolium salts, 
which react faster with nucleophiles than oxazoles (scheme 71).
158 Oxazolium salt
Scheme 71
Electrophiles attack oxazoles preferentially at the 5-position, then the 4- 
position. The oxazole ring system does not undergo electrophilic attack readily unless 
electron-releasing substituents are present. Although electrophilic substitution 
reactions are possible with oxazoles, they are frequently accompanied by the addition 
reactions, as in furan. Bromination and mercuration are the most general electrophilic 
substitution reactions of oxazoles. Mercury (II) acetate in acetic acid 
acetoxymercurates 4-substituted oxazoles in the 5-position, 5-substituted oxazoles in
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the 4-position, and 4,5-disubstituted oxazoles 159 in the 2-position. The 
acetoxymercury group 160 can be substituted by electrophiles such as bromine, as 
shown in scheme 72.
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In general, the pyridine-like N-atom in the oxazole impedes electrophilic substitution 
reactions. This is evident when phenyloxazoles 161 are nitrated in the benzene ring 
rather than in the heterocycle giving oxazole 162 (scheme 73).
(p  or o)
161
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Nucleophilic substitution reactions on the oxazole ring are relatively 
uncommon; it will only occur if certain functional groups are present. Because of the 
low 7r-electron density on the C-2 atom, nucleophilic substitution reactions of 2-halo- 
oxazoles proceed rapidly. Thus, treatment of 2-chlorooxazole 163 with hydrazine 
readily affords the substituted hydrazine (scheme 74). The ease of nucleophilic 
displacement of halogens is hal-2 > hal-4 > hal-5.
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Cleavage of the oxazole ring by nucleophilic attack is a much more common reaction 
than nucleophilic substitution reactions. The initially formed acyclic intermediates 
derived from this type of ring cleavage may be stable toward further reactions, and in 
some instances, the acyclic product undergoes a subsequent cyclisation reaction
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whereby a new ring is formed165. The structure o f this new system is largely 
dependent upon the structure of the attacking nucleophile and on the functional 
groups on the oxazole. For example, on heating with ammonia, formamide or 
primary amines, oxazoles 164 undergo a ring transformation into imidazoles 165 
(scheme 75).
Acid-induced ring cleavage initiates the reaction by the formation of the oxazolium 
salts which react much faster with nucleophiles. Reaction of 2,4,5-triphenyloxazole 
with dilute acid forms the oxazolium salt 166 which decomposes to yield 
benzaldehyde, benzoic acid, and ammonium chloride (scheme 76).
^  2 C6H— CHO +  C6H5— COOH 
+ NH4C1
Scheme 76
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Oxazoles are stable towards a range of reductive conditions, but sodium in 
ethanol will convert oxazole to oxazolidines which may be reduced further to acyclic 
products165. A range of reductive ring cleavages is known; 2,5-diphenyloxazole 167 
is cleaved by lithium aluminium hydride171 or sodium in ethanol165 to give 2- 
benzylamino-l-phenylethanol 168 (scheme 77).
Ph Reductive ring cleavage
LiAlH4 or Na - EtOH
PHCH2NHCH2CH(OH)Ph
168
Scheme 77
When benzyl 5-phenyl-2-oxazolecarbamate 169 was subjected to catalytic reduction 
in the presence of Pd/C in ethanol, phenethylurea 170 was isolated169. Catalytic 
hydrogenation of 169 using a PtC>2 catalyst gives l-carbobenzyloxy-3-phenethylurea 
171, whereas Raney nickel was ineffective169 (scheme 78). Reductive ring cleavage 
reactions of oxazoles can be inhibited by base; however, in the presence of acid the 
reaction is enhanced.
H2
Pd/ C EtOH
h2 Pto2
Ph(CH2)2NHCONH2
170
Ph(CH2)2NHC0NHC02CH2Ph
171
Scheme 78
The thermal rearrangement of 4-carbonyl substituted oxazoles is known as the 
Comforth rearrangement165. When oxazole 172 is thermalised, the isomeric product 
174 is obtained. The mechanism proposed165 for the thermal isomerisation involves 
ring opening of the oxazole to the nitrile ylide intermediate 173 with subsequent ring 
closure to produce the rearranged oxazole 174 (scheme 79).
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The isotopic labelling experiments of base-induced isomerisation of 4- 
hydroxymethylene-5-oxazolones or their potassium salts 175 to oxazole-4-carboxylic 
acids 177 revealed the initial step of this base-induced rearrangement172. When the 
carbonyl carbon of the oxazolone ring was labelled with 14C and the compound 
treated with base, the rearranged oxazole-4-carboxylic acid was labelled only at the 
carboxyl carbon atom. Thus, the initial attack of the hydroxide ion at the 2-position of 
the oxazolone ring with subsequent ring opening affords 176, and ring closure yields 
the 14C-labelled acid 177 (scheme 80).
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1.5.2.3. Diels-Alder reactions.
Oxazoles undergo a variety of reactions mentioned above but one of the most 
important is the Diels-Alder reaction. Usually an electron-releasing substituent will 
facilitate the reaction with dienophiles. There are several variants of the reaction but 
the key step is the cycloaddition of an activated olefinic dienophile to an oxazole.
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The Diels-Alder reaction is a cycloaddition reaction of a conjugated diene with 
a double or triple bond (the dienophile). In the classic Diels-Alder reaction a 1,3- 
diene reacts with a dienophile to form an adduct with a six-membered aromatic ring 
(scheme 81). The reaction proceeds by the formation of two o-bonds and one 7r-bond 
at the expense of three 7r-bonds in the starting materials173. In general, the reaction 
takes place simply by mixing the components at room temperature or by gently 
warming in a suitable solvent. The Diels-Alder reaction is reversible, and many 
adducts dissociate into their components at quite low temperature. Heating is 
disadvantageous in these cases, however, using an excess of one of the components or 
a solvent from which the adduct separates readily will enhance the forward reaction 
and give better yields. Lewis acid catalysts are known to accelerate many Diels-Alder 
reactions, and there are a few instances where high pressures have been used to 
facilitate reactions which otherwise take place only slowly or not at all at room 
temperature174,175.
Diene Dienophile Adduct
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The importance of the Diels-Alder reaction is due to its versatility and its 
remarkable stereoselectivity. Many different types of ring structure can be developed 
by varying the nature of the diene and the dienophlie. In the majority of cases all six 
atoms involved in forming the new ring are carbon atoms, however, ring closure may 
also take place at atoms other than carbon to give heterocyclic compounds. Many 
dienes can exist in a cisoid and a transoid conformation (scheme 82), and it is only the 
cisoid form which can undergo addition. If the diene does not have, or cannot adopt a 
cisoid conformation no reaction occurs.
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Cisoid Transoid
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1.5.2.4. Dienophiles.
Dienophiles participate in the Diels-Alder reaction may be derivatives of 
acetylene (C2H2), ethylene (C2H4) or reagents in which one or both of the reacting 
atoms is a heteroatom. The reactivity of the dienophiles depends on its structure. In 
general, the greater the number of electron-attracting substituents on the double or 
triple bond the more reactive the dienophile is. Hence, the majority of the reactions 
involve an electron-rich diene and an electron-deficient dienophile. Dienophiles that 
contain one or more of CO, CO2R, CN, or NO2 groups in conjugation with a double or 
triple bond react readily with dienes. The most widely used dienophiles are probably 
the a,p-unsaturated carbonyl compounds, such as acrolein (propenal), acrylic acid and 
its esters, maleic acid and its anhydride, and numerous derivatives of 2 -cyclohexenone. 
For instance, acrolein 178 reacts rapidly with butadiene 179 in benzene solution at 0 
°C to produce tetrahydrobenzaldehyde 180 in quantitative yield (scheme 83).
.CHO ^
178 179 180
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The quinones are another important class of dienophiles of the a,p-unsaturated 
carbonyl class. ^-Benzoquinone reacts readily with butadiene at room temperature to 
give the mono-adduct, tetrahydronapthaquinone, in high yield. However, under more 
vigorous conditions a bis-adduct is obtained which can be converted into 
anthraquinone by oxidation of an alkaline solution with atmospheric oxygen176 
(scheme 84).
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The reaction of the carbonyl groups in aldehydes and ketones with dienes has 
been used to prepare derivatives of 5,6-dihydropyran. Formaldehyde reacts only 
slowly but reactivity increases with reactive carbonyl compounds such as esters of 
glyoxalic acid177 (scheme 85).
■ ^ o c 2h 5 0II+ c h 2
^ o c 2h 5 0II
k .  + c h c o 2c 4h (
180 °C
CH2C12
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The scope of this reaction is extended when zinc chloride or boron trifluoride etherate 
is present as catalyst. Under these conditions, oxygenated butadiene derivatives react 
readily with a wide range of aldehydes producing dihydro-y-pyrones (scheme 86). 
Zinc chloride catalysed reactions are cycloadditions and proceed through 1:1 cyclo­
adducts such as 181.
(CH3)3S i O . ^
, ^  ZnCl2, benzene
^  CHR --------------------- ►
OMe
S ch em e 86
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On the other hand, the boron trifluoride catalysed reactions appear to proceed to 
produce an open-chain aldol-like product178 182.
(CH3) 3
182
Another useful group of heterodienophiles are the imines, which contain the 
group —C=N-. The reaction of 2,3-dimethylbutadiene 183 and iminochloride 184 
produces 3,4,6-trimethyl-1,2-dihydropyridine by elimination of hydrogen chloride 
from the initial adduct179 (scheme 87).
h 3c ^
h 3c - ^ >
183
It was assumed that only ‘activated’ imines in which either the nitrogen or carbon 
atom of the imine linkage, or both, carried an electron-withdrawing group, would 
undergo the intermolecular Diels-Alder reaction readily. However, ‘ordinary’ 
Schiff s bases react readily with butadiene derivatives in the presence of zinc chloride
1520to form 2,3-dihydro-4-pyridones in good yield (scheme 88).
O M e
r + nL +  c h c 6h 5
(C H 3) 3SiO  ^
1) Z nC l2 , TH F
2 )H 20
O M e
r ^ N
0^
- c 6h 5
JL X " c 6H 5
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1.5.2.5. Dienes.
As mentioned earlier, the diene component must have or must be able to adopt the 
cisoid conformation before it can participate in Diels-Alder reactions with dienophiles. 
Dienes, which satisfy this condition, undergo the reaction more or less easily 
depending on their structure. Acyclic conjugated dienes react readily forming adducts 
in quantitative yield. Substituents in the diene can influence the rate of cycloaddition 
both through their electronic nature and by a steric effect on the conformational 
equilibrium. Electron-donating substituents (e.g. -Me, -OMe, -NMe2) in the diene as 
well as electron-attracting substituents in the dienophile often increase the rate of the 
reaction. Bulky substituents that prevent the diene from adopting the cisoid 
conformation can hinder the reaction. For instance, 2-methyl-, 2,3-dimethyl-, and 2-t- 
butylbutadiene react normally with maleic anhydride, whereas the 2,3-diphenyl 
compound is less reactive and the 2,3-di-t-butylbutadiene is completely unreactive. 
The 2,3-di-t-butylbutadiene is prevented from attaining the necessary planar cisoid 
conformation by the steric effects of the two bulky substituents. Conversely, the 
substituents in 1,3-di-t-butylbutadiene do not interfere with each other even in the 
cisoid form, hence reacts readily with maleic anhydride . Also, the Z-alkyl or aryl 
substituents in the 1-position of the diene 185 will reduce its reactivity by sterically 
hindering formation of the cisoid conformation through non-bonded interaction with 
the hydrogen atom at C-4. Thus, an ^-substituted 1,3-butadiene will react with 
dienophiles much more readily than the Z-isomer.
Derivatives of hydroxybutadienes, such as l-methoxy-3-trimethylsily- 
oxybutadiene 186 (Danishefsky diene) have been employed in several syntheses of 
natural products181. Thus, the diene 186 reacts with 2-methylpropenal 187 to afford 4- 
formyl-4-methylcyclohexenone 188 after acid hydrolysis of the initial adduct (scheme 
89)182.
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OMe
+
(CHj^SiO "'^
186 187
Benzene,
reflux
OMe
H30 +
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Heterosubstituted dienes such as the 1- and 2-acylaminobutadiene react readily with 
dienophiles to give substituted amino-cyclohexanes. The acylamino group is a 
powerful directing group and most reactions proceed with high regio- and stereo­
selectivity. Hence, styrene reacted with diene 189 gave the 1,2 (‘ortho’) addition 
product 190 almost exclusively, and with trans-crotonaldehyde the adduct 191 was 
obtained183 (scheme 90).
80 °C, neat
^ c 6H5
190
^  n h c o 2c h 2c 6h 5
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Heterodienes, in which one or more of the atoms of the conjugated diene is a 
heteroatom such as nitrogen, have provided very convenient access to some six- 
membered nitrogen heterocycles. Substituted l-dimethylamino-2-azabutadienes 192
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react with dienophiles 193 with loss of dimethylamine to give pyridines or 
dihydropyridines184 (scheme 91).
N(CH3) 2
192
CO-CH,I 2 3
C 
III cI
c o 2c h 3
193
Scheme 91
Cyclopentadiene, in which the double bonds are constrained in a planar cisoid 
conformation, reacts easily with a variety of dienophiles to form bridged compounds 
of the bicyclo[2,2,l]heptene series (scheme 92). The reaction of cyclopentadiene with 
mono- and cw-disubstituted ethenes can give rise to two stereochemically distinct 
products, the endo- and exo-bicyclo[2 ,2 ,1 Jheptene derivatives, however, the endo 
isomer always predominates in practice.
\\ h +
CHXIICHY
Scheme 92
Furan derivatives and related families, such as oxazoles, react with ethylenic 
and acetylenic dienophiles to form bicyclic compounds with an oxygen bridge 
(scheme 93). Usually adducts obtained from furans are thermally labile and dissociate 
readily into their components on warming.
O
Scheme 93
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Furan 194 and maleic anhydride give an adduct with exo structure 195, apparently, 
disobeying the rule that the endo isomer predominates (scheme 94). The reason is 
shown by the observation that the endo adduct formed from maleimide and furan at 
20 °C dissociates at temperatures above 20 °C, allowing conversion of the endo adduct 
formed in the kinetically controlled reaction into the thermodynamically more stable 
exo isomer173. In the case with the maleic anhydride adduct, equilibration takes place 
below room temperature so that the endo adduct produced under kinetic control is not 
observed.
O
194
O.
+
O .0
Maleic
anhydride Exo 195
Scheme 94
1.5.2.6. Stereochemistry of the Diels-Alder reactions.
The adduct stereochemistry obtained in many Diels-Alder reactions is based 
on two rules. The relative stereochemistry of substituents in both the dienophile and 
the diene is retained in the formed adduct on the basis of the 'cis principle’, also 
known as the syn addition . A dienophile with trans substituents will give an adduct 
in which the trans configuration of the substituents is retained. With a cis 
disubstituted dienophile the formed adduct will have substituents that are cis to each 
other. For instance, in the reaction of cyclopentadiene with dimethyl fumarate the 
trans configuration of the ester groups is retained in the adduct 196, while with 
diemethyl maleate the cis adduct 197 and 198 are formed (scheme 95).
Scheme 95
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Similarly, a trans, frYms-1,4-disubstituted diene will give an adduct in which the 1- and
4-substituents are cis to each other, and a cis, trans-1,4-disubstituted diene forms an 
adduct with trans substituents (scheme 96).
Scheme 96
According to Alder’s endo addition rule, in a diene addition reaction the two 
components arrange themselves in parallel planes, and the most stable transition state 
arises from the orientation in which there is ‘maximum accumulation of double 
bond’173,185. The 7u-bonds of the activating groups in the dienophile also take part in 
the addition. The rule appears to be strictly applicable only to the addition of cyclic 
dienophiles to cyclic dienes. Thus, in the addition of maleic anhydride to 
cyclopentadiene, the endo product, formed from the orientation with maximum 
accumulation of double bonds, is produced almost exclusively and the exo product in 
a yield of less than 1.5 % (scheme 97).
In addition of open-chain dienophiles to cyclic dienes, the endo rule is not always 
obeyed and the composition of the mixture obtained may depend on the precise
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structure of the dienophile and on the reaction conditions. Thus, reaction of acyclic 
acid to cyclopentadiene produced endo and exo products in the ratio 75:25 (scheme 
98).
Scheme 98
In reactions of open-chain dienes and open-chain dienophiles the endo adducts are the 
main products at moderate temperature, but in some instances the proportion of the 
exo isomer increases with the rise of temperature.
1.5.2.7. Regiochemistry of the Diels-Alder reactions.
From reaction of an asymmetrically substituted dienes 199 and 203 with 
dienophile 200, different regioisomeric products 201, 202 and 204, 205 can be formed 
(scheme 99).
203 200 204 205
Scheme 99
The so-called 4ortho’ 201 and the 4para’ 204 isomers are formed preferentially. The 
observed regioselectivity can be explained by taking into account the frontier orbital 
coefficient of the reactant186.
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In a typical alkene, the o and n orbitals form the bond. The molecular orbitals, 
o-orbitals (sp2 hybridised for alkenes, 206) and n orbitals 207, represent the electronic 
interactions. These orbitals take on a directional character (represented by + and -) 
when they are in close proximity to another orbital. When two sp2 hybridised orbitals 
come together, orbitals of the same sign can be directed towards each other, as in 208, 
or orbitals of opposite sign can be directed toward each other, as in 209. In 208, the 
electron density between the two nuclei is maximised (electronic attraction for the 
positive nucleus), but in 209 it is minimised. Since a strong covalent bond (mutual 
sharing of electron density between nuclei) is associated with significant electron 
density between the nuclei, 208 represents a bonding interaction and 209 an 
antibonding interaction.
(±xG)
206 207
g><±).GG>o GxC±) ©<+)
208 209
Similarly, the overlap of n orbitals to form a % bond with the same sign representing 
the maximum bonding interaction 210 (a bonding molecular orbital), and 2 1 1  
represents the antibonding molecular orbital. As with a o bond, the net energy of the 
bonding interaction in a % bond is lower than that of the antibonding interaction. An 
antibonding molecular orbital is higher in energy (less stable) than a bonding one.
210 211
The difference in energy between the two n molecular orbitals (210 and 211) 
can be represented in terms of their relative energies . The lowest energy orbital 
containing the bonding electrons is called the highest occupied molecular orbital 
(HOMO) and the ionisation potential (IP) of the molecule is a reasonable measure of 
the energy of this orbital188. In terms of chemical reactivity, the HOMO is the orbital 
which donates electrons. The higher energy orbital does not contain electrons, but is 
the next available energy level if electron is accepted. The energy which describes 
accepting electrons is the electron affinity (EA), and this orbital is called the lowest
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unoccupied molecular orbital (LUMO). The LUMO accept electrons from the 
HOMO of another % bond and the difference in energy between the LUMO and 
HOMO (AE = E lumo -  E homo) is determined by the difference of the EA and the IP. 
For ethene, the energy of HOMO is -10.52 eV, the LUMO is +1.5 eV therefore the AE 
is 12.02 eV (scheme 100).
h 2c = c h 2A
LUMO
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The reactive HOMO and LUMO of ethene (or of any other molecule) are 
referred to as frontier molecular orbitals (FMO)189. The HOMO was believed to 
deliver electrons to the LUMO of a reactive centre, which could accept the charge. 
FMO theory has now been shown to be “a first approximation to a perturbation 
treatment of chemical reactivity” 190. Perturbation theory191 treats the molecular 
orbital of two interacting components as a perturbation of the product of their 
individual orbitals . The theory fails to explain large perturbations and does not 
predict the transition state, but gives “an estimation of the slope of an early part of the 
path along the reaction coordinate leading to transition state”192. The transition state 
energies can be described as reactant-like or product-like. The Hammond postulate 
states, “The transition states for exothermic reactions are reactant-like, and for 
endothermic reactions are product-like” . Frontier orbital effects are therefore 
particularly important in exothermic reactions194.
In 212 and 213, the magnitude of each orbital, called the orbital coefficient, is 
shown. The + and -  signs correlate with the + (darkened) or -  (undarkened) 
symmetry of the orbital . When two % systems differ in their substitution pattern,
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there will be differences in the magnitude of orbital densities (‘larger’ or ‘smaller’ 
orbitals). The orbital coefficients of a symmetrical molecule such as ethene are 
identical in magnitude and sign for the HOMO. The LUMO coefficients are equal in 
magnitude but opposite in sign, also a result of this symmetry, and this leads to one 
node in 212 and no node in 213 (a node is a point of zero electron density, such as a 
nucleus). Low energy orbitals are associated with a minimal number of nodes, and 
higher energy orbitals with increasing numbers of nodes. If an electron-withdrawing 
group is attached to ethene, as in methyl acrylate, electron density is distorted away 
from the n bond of the alkene, towards the carbonyl. This will influence the energies 
of the HOMO and LUMO as well as the magnitude of the orbital coefficients. The 
electron-withdrawing group diminishes the size (orbital coefficient) of the orbitals 
closest (proximal) to the 8+ carbonyl carbon, leaving the most distant (distal) orbital 
with the largest coefficient. If an electron-releasing group is attached to ethene, as in 
methyl vinyl ether, the oxygen atom releases electrons toward the n bond, raising the
Changes in alkene HOMO and LUMO energies upon addition of substituents.
T a b le  3
In 1,3-butadiene, where the conjugated substituent is another ethene moiety, 
the HOMO energy is -9.03 eV (with coefficient of 0.57 and 0.41) and the LUMO
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energy is lowered to +1.0 eV (with coefficient of 0.56 and -0.42), relative to ethene195 
(scheme 101).
h 2c = c h 2 i-l c = c - c = c il
2 2 2 H H 2
LUMO
+  0.71 - 0.71 +  0 .5 6  - 0.42
HOMO
+  0.71 +  0.71 +  0 .5 7  +  0.41
S ch em e 101
Although the HOMO-LUMO coefficients for all four atoms of the conjugated system 
must be considered, only those at the termini will interact with the alkene in a Diels- 
Alder reaction. The 1,3-butadiene is symmetrical but the coefficients will reflect the 
electron-withdrawing effect invoked in the distribution of electron density in the 
orbitals. The largest concentration of electron density occurs at the terminal carbons, 
and these are expected to be the major sites of reactivity. Since there are four n 
orbitals and four n electrons, there are four molecular orbitals, as shown in scheme 
102. The lowest energy orbital has no nodes, the HOMO has one node, the LUMO 
has two nodes, and the highest energy orbital has three nodes. In scheme 102, the 
lowest two energy orbitals contain electrons, with the HOMO being the higher energy 
orbital. The HOMO will be more important for reactions than other orbitals, since it 
contains electrons which can be donated. Similarly, the LUMO is the lowest energy 
of unfilled orbitals and is more important for reactions, since it will preferentially 
accept electrons.
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0 n od e
Orbital diagram for 1 ,3 -butadiene
Schem e 102
The effects on the frontier orbitals in diene with attached substituents are similar to 
those observed in alkenes. Electron-withdrawing groups will decrease the energy of 
the HOMO and LUMO relative to butadiene. Conversely, electron-releasing groups 
will increase the HOMO and LUMO energies. In scheme 103, the substituent can be 
attached to C-l or C-2 of the diene, where the Z group is a generic electron- 
withdrawing group and the X group is a generic releasing group. The electron- 
withdrawing groups (Z) lower the HOMO and the LUMO. The C-l substituent 
lowers the energy more than a C-2 substituent and the orbital coefficients are larger 
on the orbitals distal to the Z group for C-l substituents, although they are larger on 
the proximal carbon for C-2 substituents. Electron-releasing groups (X) raise the 
energies of the HOMO and the LUMO. The orbital on the carbon distal to X is 
smallest for C-l substituents and largest for C-2 substituents in the LUMO. In the 
HOMO the orbital on the distal carbon is largest for C-l substituents and smallest for 
C-2 substituents186.
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1,3-butadiene 
+ 1.0 eV  J& )
( O
+ 2.5 eV
T )LUMO z
z-  0.3 eV
x
- 9.1 eV - O - 9.3 eV —
S d  •
HOMO
9.5 eV
V A o s >Z X
Z = electron withdrawing group 
X = electron releasing group
HOMO and LUMO energies of electron rich and electron poor dienes, 
compared with 1,3-butadiene.
S ch em e 103
Reactions that involve multiple n bonds can take many forms, but the number 
of 7E electrons in each substrate usually classifies the reaction. A single % bond can 
interact with another single iz bond of an alkene and the reaction of two alkene is 
classified as a 2 n + 2 n reaction. When a diene reacts with an alkene there are six n 
electrons, therefore, known as a 4 n + 2 n reaction (scheme 104). The Diels-Alder 
reaction is recognised as the [4 + 2] cycloaddition.
S ch em e 104
Furthermore, reactions can be classified as ‘allowed’ or ‘forbidden’ reaction in 
correlation with the symmetry of the frontier orbitals of substrates . In a reaction, 
maximum stability in the transition state is observed when the terminal carbons of the 
HOMOdiene interact with the termini of the L U M O aikene- These orbitals have the same 
symmetry, and such interaction is ‘allowed’ (scheme 104). If the orbitals have the 
opposite symmetry (and sign), the interaction is ‘forbidden’196. However, a reaction
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that is ‘forbidden’ may still take place if nothing easier is available. What is meant by 
‘forbidden’ is that the interaction of the orbitals presents an energy barrier which the 
‘allowed’ reactions do not have.
Therefore, in Diels-Alder reactions which involve an electron-deficient 
dienophile and an electron-rich diene, the main interaction is that between the highest 
occupied molecular orbital (HOMO) of the diene and the lowest unoccupied orbital 
(LUMO) of the dienophile. The smaller the energy differences between these orbitals 
and the better the overlap, the more readily the reaction occurs197. The orientation of 
the product obtained from an unsymmetrical diene and an unsymmetrical dienophile 
is governed largely by the atomic orbital coefficients at the termini of the conjugated 
systems concerned. The atoms with the larger termini coefficients on each add bond 
preferentially in the transition state, since this leads to better orbital overlap. This 
results to mainly the 1,2 (‘ortho’) adduct with 1-substituted butadienes and to the 1,4 
(‘para’) adduct with 2-substituted butadienes. For the reaction of butadiene-1- 
carboxylic acid with acrylic acid the frontier orbitals are polarised, where the size of 
the circles is roughly proportional to the size of the coefficients. Note; shaded and 
empty circles represent lobes of opposite sign; an ‘allowed’ reaction involves overlap 
of lobes of the same sign (scheme 105).
c ° 2h
c o 2h
Ortho adduct
Similarly for the reaction of 2-phenylbutadiene and methyl acrylate, preferential 
formation of the ‘para’ adduct is predicted (scheme 106).
C A V O
H O M O  L U M O  Para adduct
S ch em e 106
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1.5.2.8. Mechanism ofDiels-Alder reactions.
The rate-determining step in adduct formation is bimolecular, where 
dienophile and diene approach each other in parallel planes roughly orthogonal to the 
direction of the new bonds about to formed. Hence, formation of the two new a- 
bonds take place by overlap of molecular 7r-orbitals in a direction corresponding to 
endwise overlap of atomic p-orbitals. For most Diels-Alder reactions a concerted 
addition in which both of the new single bonds are formed at the same time is 
generally accepted (scheme 107).
S ch em e 107
In some cases, reactions may proceed via diradical intermediate in a two step 
mechanism185. The first step is the formation of a single bond between atoms of the 
reactants which is rate controlling. The addition is then completed by formation of 
the second bond in a fast reaction (scheme 108).
Schem e 108
The Diels-Alder reaction is of wide scope. The usefulness of the Diels-Alder 
reaction is based on its syw-stereospecificity, with respect to the dienophile as well as 
the diene, and its predictable regio- and e«c/o-selectivities. Not all of the atoms 
involved in ring formation have to be carbon atoms. Thus, the hetero-Diels-Alder 
reaction involving one or more heteroatom centers can be used for the synthesis of 
six-membered heterocycles, such as substituted pyridines with oxazoles as the active 
dienophile.
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1.5.2.9, Diels-Alder reaction o f oxazoles with dienoyhiles.
The Diels-Alder reaction of substituted oxazoles as diene with olefinic 
dienophiles to yield pyridine derivatives consists of two stages. The first stage results 
in the intermediate formation of bicyclic adduct 214 (scheme 109). Early studies 
assumed that the 7C-electron densities of the atoms, which participate in bonding in the 
transition state, governed the regioselectivity of the addition. However, consideration 
of the calculated 71-charge densities does not always lead to the correct prediction of 
the regiochemistry of the adduct157. It was localisation energy calculation that 
provided the correct prediction of the orientation of oxazole-dienophile systems198. A 
general rule for predicting the orientation of the addition is that the more 
electronegative substituent on the dienophile (Y) occupies the 4-position in the 
adduct199.
Scheme 109
Normally, the bicyclic adducts 214 are not isolated from the reaction, however, the 
reaction of 5-ethoxyoxazole-4-acetic acid and its esters with diethyl fumarate did give 
adduct 215 which is stable enough to be isolated . The conjugation of the exocyclic 
double bond with the carbonyl group of the ester made adduct 215 more stable than 
214 (scheme 110).
c h 3c h 2o
r o 2c h 2c
215
Scheme 110
The bicyclic adducts 214 normally undergo aromatisation, particularly in 
acidic conditions. Depending on the structure of the starting materials either one of 
four pathways can occur (scheme 1 1 1).
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S ch em e 111
The aromatisation of the adduct 214 depends on the nature of the groups at the 3- and
4-positions (R and Y). Pathway A is aromatisation with elimination of a water 
molecule and occurs when the substituents R and Y are not good anionic leaving 
groups (e.g. alkyl). Alkyloxazoles react in this way with maleic anhydride and maleic 
acid to form alkyl-substituted cinchomeronic acids 220 (scheme 1 12)200.
CO„H
R 2
A lkyloxazole M aleic acid 220
Sch em e 112
If a substituent which is readily eliminated in the form of an anion is present in the 3- 
position (R3 = OR, OCO2C2H5, or CN) of the adduct 214, then aromatisation takes
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place via pathway B and the final product being substituted 3-hydroxypyridine 217. 
The proposed mechanism for the aromatisation of the adducts begins with the 
dissociation of the C6-0  bond (scheme 113)157. Due to the a-n conjugation with the 
C =N bond, the C -O bond is the one weakened to the greatest extent. Under the 
aromatisation conditions, dry hydrogen chloride in alcohol, the heterolysis is favoured 
by the protonation of the adduct both at the nitrogen and at the oxygen atom. As the 
cycloaddition and the aromatisation takes place in the absence of water, it is unlikely
• • • "I •that the dissociation of the C -O bond with subsequent hydrolysis could occur.
Y
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In addition, the interaction of 5-cyano-oxazoles with dienophiles formed the 3- 
hydroxypyrdines exclusively; therefore, the dissociation of the C3-0 bond is unlikely
157to occur (scheme 114).
NC" t >  ' Y
'----- N X
? \ / C N IIO .
Y
-------->-
N
S ch em e 114
The aromatisation of adducts via pathways C and D is characteristic of the interaction 
of 5-unsubstituted oxazoles with dienophiles. If R = H and Y is a good leaving 
group, then pathway C leading to 218 arises. If R = H and Y is not a good leaving 
group, pathway D, oxidation of the adduct, can take place (scheme 115). Pathway C 
and D aromatisation of the adduct begins with the dissociation of the C6-0  bond of the 
oxygen bridge. In pathway D, R3 is removed as a hydride ion, and since this type of 
process is energetically unfavourable, the product is usually obtained in insignificant 
amounts. However, if a hydride acceptor such as nitrobenzene or H2O2 is present in
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the reaction mixture the yields of the corresponding pyridines 219 increased to 50 -60
%200.
c
R3 =  H  
-H Y
t
218
D
- h2
R3 =  H
t
IT YH+ o
t
Y
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The synthetic use of Diels-Alder condensation of oxazoles with dienophiles to 
form pyridines and especially of 5-alkoxyoxazoles, which react by pathway B to yield 
pyridoxine and pyridoxine derivatives, is well documented . Various combinations 
of 5-alkoxyoxazoles with dienophiles, which undergo the Diels-Alder reaction to form 
the corresponding 3-hydroxypyridines 217, are listed on table 4.
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Y
Substituents in oxazole Dienophile Pyridine product (217) Ref.
R1 R2 R3 X Y R1 R2 X Y
H ch 3 OEt C02Et C02Et H ch3 C02Et C02Et 201
H ch3 OEt CH2OR CH2OR H ch3 CH2OR CH2OR 201
H ch3 0C02Et C02Et C02Et H ch3 C02Et C02Et 202
H ch 3 0C02Et CN CN H ch3 CN CN 202
H ch2co2h OEt ch2oh CN H ch3 ch2oh CN 203
H CH2C02Et OEt ch2oh ch2oh H ch3 ch2oh CH2OH 203
H CH2C02Et OEt CN CN H ch3 CN CN 204
H CH2C02Et OEt C02Et C02Et H CH2C02Et C02Et C02Et 205
T ab le  4
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1.6. Aims.
This study involves the design and preparation of pyridoxal 5’-phosphate 
analogues 220. The analogues will be synthesised through the manipulation of 
commercially available vitamin B6 and via the Diels-Alder cycloaddition of the 
substituted oxazoles with dienophiles.
— O R
220
R = CH3, C2H5 or longer chain. 
R1 = H or P 0 3H2
Manipulation of readily available pyridoxine hydrochloride 1 begins by 
blocking the hydroxyl groups on the C-3 and C-5’ position with protection groups and 
allowing the hydroxyl group at C-4’ to be transformed into an aldehyde. The 
aldehyde derivative when subjected to a Grignard reaction and subsequent oxidation 
will give the desired ketone 221. The removal of the protection groups and 
subsequent selective phosphorylation will achieve the phosphate form of analogues 
220 (scheme 116).
OH
1) Regioselctive 
hydroxyl group 
protection
2) Oxidation o f  
alcohol
CHO
OPG 1) Grignardreaction and hydrolysis
2) Oxidation
R  =  CH3, C2H 5 
or longer chain.
221
R  =  CH 3, C2H 5 or longer chain. 
R 1 =  H  or P 0 3H 2
220
S ch em e 116
Synthesis of the analogues 220 using the Diels-Alder reaction begins with the 
preparation of 4-methyl-5-ethoxyoxazoles 222 and the dienophiles, 4-hydroxybut-2-
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enenitriles 223. The oxazole 222 will interact with the dienophile 223 to yield the 
substituted pyridine 224. The dienophile utilised in the Diels-Alder reaction should 
show a high degree of regioselectivity where the more electron withdrawing 
substituent of the dienophile ends up at the 4-position of the pyridine ring. The 
substituted pyridine 224 will then be subjected to modification at the 4-position via 
Grignard reaction. Subsequent phosphorylation will achieve the phosphate form of 
analogues 220 (scheme 117).
< w R
Grignard
reaction and hydrolysis
R = CH3, C2H5 
or longer chain.
Selective
phosphorylation
HO OR1
R =C H 3,C 2H5 
or longer chain.
R1 = H or P03H2
S ch em e 117
The desired pyridoxal 5’-phosphate analogues will act as substrates to develop 
understanding of the interaction between the enzyme-substrate complexes in the 
enzymatic binding sites of pyrimidine biosynthesis in mammalian cells. The three 
enzymes, glutamine-dependent carbamoyl-phosphate synthetase (CPSase II), 
aspartate transcarbamoylase (ATCase) and dihydroorotase (DHOase), found in the 
multifunctional polypeptide CAD initiates pyrimidine biosynthesis. The key enzyme, 
CPSase II is regulated in the cell negatively by uridine triphosphate (UTP) and 
positively by 5-phosphoribosyl 1-pyrophosphate (PRPP). Earlier research ’ showed 
that UDP-pyridoxal and pyridoxal 5'-phosphate have similar activating activity on the 
CPSase II of the multifunctional polypeptide CAD. As biosynthesis of pyrimidine is 
essential for most growing cells, designing pyridoxal 5'-phosphate analogues and the 
feedback information about the binding sites in the mammalian multifunctional 
polypeptide CAD will be valuable for the development of antiproliferative agents.
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2. Results and Discussion
The objectives of this study were to synthesise pyridoxal 5’-phosphate 
analogues 220 through the manipulation of commercially available pyridoxine and via 
the Diels-Alder cycloaddition of the substituted oxazoles with dienophiles.
O R
220
R = CH3, C2H5 or longer chain. 
R1 = H or P0 3H2
2.1. Modification of vvridoxine.
Pyridoxine analogues obtained by modification of the 4-position have been of 
considerable interest in enzymatic and pharmacological studies1,149. Compounds such 
as 4-deoxypyridoxine (7, R = CH3) are potent antagonists of vitamin B6 in some 
mammalian systems , but in some tissues are subject to demethylation .
7 R = CH3
225 R = CF3
226 R = H
227 R = OH
228 R = CH=NHNHR
Replacement of the C-4-methyl H’s in analogue 7 with F (225, R = CF3) renders the
compound less active in various systems , and replacement of the entire 4-side chain
with H (226, R = H)209 or with OH (227, R = OH) 210 considerably reduces inhibitory
potency in Saccharomyces carlsbergensis. On the other hand, replacement of the
aldehydic oxygen of pyridoxal with bulky nitrogenous groups, such as hydroximino,
azino, and various hydrazone groups (228, R = CH=NHNHR), makes them powerful
^11inhibitors of pyridoxal kinase in vitro . Compounds of this type are also of some
7 17biological interest as inhibitors of human neoplastic cells in vitro and retarders of 
tumour growth . Some pyridoxine analogues that have the C-5 -CH2OH group 
unchanged are susceptible to phosphorylation catalysed by pyridoxal kinase , and
OH
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the phosphorylated analogues are capable of effective competition with the coenzyme 
pyridoxal 5’-phosphate for the same site on the apoenzyme17.
One of the most convenient methods of obtaining selective modification of the 
C-4-CH2OH group of pyridoxine is via the use of 3,5’-0-dibenzylpyridoxine 127.
127
Preparation of this compound begins with the addition of the isopropylidene 
protecting group at the C-3- and C-4’- hydroxyl groups of pyridoxine. Thus, 
pyridoxine HC1 1 reacts with acetone saturated with hydrogen chloride gas132 and the 
resulting hydrogen chloride salt of 3,4’-0-isopropylidenepyridoxine 85 was converted 
to the free base form by washing with excess saturated NaHCC>3 solution. Pyridine 85 
was obtained in 92 % yield (scheme 118) as a white solid with mp 99-103 °C, which 
was slightly lower than the literature mp 110-111 0 C1. However, the IR analysis of 
the compound showed that the peak at 1054 cm' 1 indicates the presence of the C-0 
bond. Additionally, the 1HNMR spectrum in CDCI3 revealed that the peaks for the 
two isopropylidene methyl groups appear as a 6 H singlet at 8 1.55.
1) HC1 (g), (CH3)2CO  >»
2) sat. NaHC03 soln.
Schem e 118
The reaction proceeds in an acid-catalysed nucleophilic addition mechanism and the 
acidic conditions favoured the formation of the cyclic ketal involving the phenolic 
group. The acid donates its proton to the acetone to form an oxonium ion, which is 
highly reactive toward nucleophilic attack at the carbonyl carbon atom as shown in 
scheme 119.
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The 3,4’-0-isopropylidenepyridoxine 85 allows the C-5’- hydroxyl moiety to 
be protected by benzylation. Consequent removal of the isopropylidene group and 
selective benzylation of the 3-position phenolic group will leave the 4-position 
CH2OH group available for modification without affecting neighbouring groups.
Benzyl ethers as protecting groups of alcohols and phenols are widely used. 
The ease of removing the benzyl groups by hydrogenolysis, HC1, or trifluoroacetic 
acid is well known in organic synthesis214. Therefore, the C-5’- hydroxyl moiety of 
the resulting 3,4’-0-isopropylidenepyridoxine 85 was treated with sodium hydride, 
benzyl chloride and a catalytic amount of ferra-n-butylammonium iodide in DMF1. 
The benzylation of compound 85 afforded a yellow oil in 71 % yield after purification 
by column chromatography. The analysis by IR spectroscopy revealed the apparent 
peak of the C-0 bond at 1143 cm' 1 and the new aromatic C-H bend peaks at 739 and 
699 cm'1. More significantly, the !HNMR in CDCI3 showed a multiplet at 8 7.22-7.42 
indicating the 5 H of the phenyl group and the isopropylidene methyl groups have
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moved slightly upheld to 5 1.52. The spectroscopic data were sufficient to confirm 
that the oil is 3,4’-0-isopropylidene-5’-(9-benzylpyridoxine 229 (scheme 120).
85
BnCl, NaH, 
(Bu)4N+I% 
DMF, N2 atm.
229
S ch em e 120
The benzylation of compound 85 is a classic example of a Williamson 
synthesis of ether215. The reaction is initiated by the C-5’- hydroxyl group of 
compound 85 reacting with sodium hydride to generate an alkoxide ion. Addition of a 
catalytic iodide source such as te/ram-butylammonium iodide enables the reaction to 
overcome the sluggish reactivity of sterically hindered alcohols, toward benzyl 
chloride, by generating the more reactive benzyl iodide in situ. The alkoxide 
immediately reacts with benzyl iodide by a nucleophilic substitution mechanism 
(scheme 121).
229 
S ch em e 121
The mechanism is a typical Sn2 (substitution nucleophilic bimolecular) reaction that 
takes place in a single step in which the alkoxide ion attacks the carbon bearing the
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iodide (leaving group) from the backside and the iodide begins to move away with the 
pair of electrons. In the transition state, the bond between the oxygen and carbon 
grows and the bond between the carbon and the iodide weakens which leads to the 
inversion of configuration of the carbon. The formation of the bond between the 
oxygen and the carbon atom provides most of the energy necessary to break the bond 
between the carbon and the iodide resulting in compound 229.
The S ^ ’-O-isopropylidene-S’-O-benzylpyridoxine 229 undergoes mild acid- 
catalysed hydrolysis to remove the isopropylidene protecting group. When compound 
229 was hydrolysed by heating with formic acid and water , a yellow solid was 
obtained in 67 % yield after purification by column chromatography. The structure of 
5’-O-benzylpyridoxine 230 was confirmed by the presence of an -OH peak at 3032 
cm"1 plus the aromatic C-H bend peak at 728 cm' 1 on the IR. Relevant data from the 
1HNMR revealed a 1 H broad singlet at 5 8.40 to be from the phenolic group, a singlet 
peak for the C-4-CH?- group at 5 4.45, and the isopropylidene methyl groups around 8
1.5 no longer present. However, the compound 230 was obtained in 67 % yield only 
(scheme 122), whereas 94 % yield has been reported in the literature . Lower yield 
probably occurred during the work up section in the procedure where the pH of the 
environment can affect the solubility of compound 230 in non-aqueous solvent. Thus, 
the conditions being slightly acidic can render some of the compound 230 soluble in 
the aqueous environment.
229 230
Schem e 122
The hydrolysis of compound 229 was facilitated by the acidic conditions of the 
reaction. The protonated C-4’ oxygen of the cyclic ketal initiates the bond breakage 
between the carbon and the protonated oxygen. The carbon is stabilised by the 
transfer of a pair of electrons from the C-3 oxygen to the bond between the carbon 
and the C-3 oxygen. A molecule of water attacks the temporarily stabilised carbon
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and the pair of electrons returns to the C-3 oxygen. Subsequent protonation of the C-3 
oxygen releases acetone and resulted in compound 230 (scheme 123).
_rL 230
S ch em e 123
Since the yield of 5’-0-benzylpyridoxine 230 was moderately low, another 
direction was engaged with the investigation of N-oxidation to improve the yield. In 
addition, it was hoped that N-oxidation would prevent any problems that may arise 
with the nitrogen of the pyridine in later substitution reactions. 3,4’-0- 
Isopropylidene-5’-0-benzylpyridoxine 229 was chosen for N-oxidation as all the 
functional groups are blocked leaving the nitrogen of the pyridine to be readily 
oxidised and then hydrolysed afterward to remove the isopropylidene group. When 
pyridine 229 was N-oxidised with w-chloroperbenzioc acid (MCPBA) , a brown 
solid was obtained in 96 % yield as crude. Recrystallisation of a small amount of the 
crude brown solid from acetone provided a white solid with mp 151-153 °C. The 
analysis of the white solid established that it is the pure form of the 3,4’-0- 
isopropylidene-5’-0-benzylpyridoxine N-oxide 231 (scheme 124) as indicated by the
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N-0 peak at 1209 cm'1 and with the aromatic C-H bend peak at 754 and 700 cm'1 on 
the IR. In addition, the 1HNMR revealed that the multiplet peak for the phenyl group 
is at 5 7.22-7.44. Compared to the non N-oxidised compound 229, the N-oxide 
revealed that the singlet peak for the isopropylidene methyl groups had moved 
downfield to 8 1.58.
299 q  crude form
231
Scheme 124
Using MCPBA as the oxidising agent, the nitrogen of the pyridine 299 attacks the 
MCPBA at the oxygen next to the hydrogen and the m-chlorobenzoic acid is lost as a 
good leaving group to give the N-oxide 231(scheme 125).
Scheme 125
The S ^ ’-O-isopropylidene-S’-O-benzylpyridoxine N-oxide 231 undergoes 
mild acid-catalysed hydrolysis to remove the isopropylidene group. However,
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reaction of N-oxide 231 with formic acid and water only afforded a white solid in 
11 % yield after work up. The IR spectrum of the white solid revealed the presence of 
a hydroxyl group by the peak at 3030 cm'1 and the peak at 1109 cm'1 indicates that the 
N-0 bond remained, accompanied by the aromatic C-H bend peak at 741 cm'1. 
Comparison of the 1HNMR data of the white solid with the non N-oxidised 5 9-0- 
benzylpyridoxine 230 revealed downfield shifting of the broad singlet peak for the 
phenolic group to 6 9.80 and the singlet peak for the C-4-CH?- group to 5 4.49 
confirming that the white solid is 5’-0-benzylpyridoxine N-oxide 232 (scheme 126). 
While repeated attempts at the hydrolysis did not gain higher yields of N-oxide 232, 
the low yield obtained was probably due to its number of oxygen atoms in the 
structure, which could lead to its tendency to be more soluble in water and hence the 
desired product was difficult to isolate. Hence, the poor yield of N-oxide 232 resulted 
in abandoning any further reactions with N-oxide pyridoxine derivatives.
Scheme 126
Given that the N-oxide pyridoxine derivatives were unpromising, attention 
was focused on the selective benzylation of the C-3 phenolic group of 5’-0- 
benzylpyridoxine 230. The selective benzylation of the C-3 phenolic group of 
derivative 230 is achieved by making use of dimethylphenylbenzylammonium 
chloride reagent 233. The reagent was prepared as a chloride salt by allowing a 
mixture of N,N-dimethylaniline and benzyl chloride to stand for several days at room 
temperature218. Therefore, derivative 230 was treated with anhydrous sodium 
methoxide and reagent 233 in methanol. Purification by column chromatography of 
the resulting residue provided a yellow solid of 3,5’-0-dibenzylpyridoxine 127 in 85 
% yield (scheme 127) with mp 62-66 °C and the literature melting point is 64-69 °C \ 
The IR of the yellow solid revealed the essential functional groups present in 
compound 127, such as the OH group at 3125 cm'1, the C-0 bond at 1100 cm'1 along
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with the aromatic C-H bend at 744 and 696 cm'1. More importantly, the !HNMR 
showed the multiplet peak at 8 7.28-7.50 that represents the 10 H of the two phenyl 
groups and the broad singlet peak at 8 3.34 of the C-4 -CH2OH group.
OH OH
230
CH3ONa, MeOH, 
PhN (CH2)2CH2PhCl
127
Scheme 127
Pyridoxine derivatives benzylated by reagent 233 yield the corresponding 3-O-benzyl 
compound as the only product . In contrast to other alkylating agents, e.g. 
diazomethane, this reagent does not attack the pyridine nitrogen. The selectivity of 
the reagent towards the acidic hydroxyl groups (such as phenols and carboxylic acids) 
can be explained by the formation of an ion pair immediately on the addition of the 
reagent. On heating, the phenolate anion attacks the electron-deficient benzylic CH2 
group to form the derivative 127 (scheme 128). In order to interact with the 
dimethylphenylbenzylammonium chloride reagent, 5’-0-benzylpyridoxine 230 is first 
reacted with the base, sodium methoxide, to generate the phenolate anion and the 
reaction proceeds in a similar fashion as in the Williamson synthesis of an ether 
(scheme 128).
Scheme 128
127
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Selective modification at the C-4 position can be achieved by using the 3,5’- 
O-dibenzylpyridoxine 127, since the benzyl groups have blocked the two 
neighbouring hydroxyl groups from interfering with later reactions. In this study, the 
intention was to use pyridine 127 and substitute the C-4 -CH2OH by a C-4-C(0)CH3 
group, followed by deblocking of the benzyl groups, to achieve pyridoxine derivatives 
234 and with the phosphate group 235. Oxidation of the C-4’ hydroxyl group 
followed by Grignard reaction and further oxidation would afford the targeted 
modification.
234 R = H
235 R = P03H2
Therefore, 3,5’-O-dibenzylpyridoxine 127 undergoes oxidation to convert the 
C-4’ hydroxyl to an aldehyde group and one of the mild reagents for the oxidation of 
primary and secondary alcohols to carbonyl compounds is manganese IV oxide 
(Mn02) . Whether the actual oxidising agent is manganese IV oxide or some other
manganese compound adsorbed on the surface of the manganese IV oxide is not clear. 
However, the advantage of this reagent is that it is specific for allylic and benzylic 
hydroxyl groups, and reaction takes place under mild conditions (room temperature) 
in a neutral solvent (water, benzene, petroleum or chloroform). The general technique 
is simply to stir a solution of the alcohol in the solvent with the manganese IV oxide 
for some hours. Thus, the pyridine 127 was stirred with activated manganese IV 
oxide in CH2CI2 at room temperature and the reaction progress observed by tic 
analysis at intervals. After stirring for 24 h, tic revealed a strong presence of starting 
material even though a new spot was observed that could possibly be the newly 
oxidised compound. The reaction mixture was stirred for a further 24 h to continue 
the oxidation process, but the tic still revealed a spot for the starting material, which 
was more intense than the spot for the assumed oxidised compound. Thus, the 
reaction mixture was purified by filtering through a Celite pad followed by column 
chromatography to afford a light yellow solid in 10 % yield only, whilst unreacted 
starting material 127 was collected as the major compound in 75 % yield. Analysis of
117
Results and Discussion
the light yellow solid by IR revealed the peak of the C-0 bond at 1062 cm"1 and the 
aromatic C-H bend peaks at 740 and 698 cm'1. More importantly was the presence of 
the peak for C=0 bond at 1697 cm' 1 which represents a newly formed aldehyde group. 
The 1HNMR verified that the light yellow solid is 3,5 ’-O-dibenzylpyridoxal 128 
(scheme 129), by the singlet peak at 6 10.37 which represent the hydrogen of the 
aldehyde group and the multiplet peak at 5 7.12-7.48 for the 10 H of the two phenyl 
groups.
Scheme 129
Many factors during the reaction could contribute to the disappointing yield of 
compound 128 obtained from manganese IV oxide oxidation. Factors such as 
manganese IV oxide not being activated fully prior to use, the reaction not given 
satisfactory amount of time to proceed in oxidising the starting material 127, and the 
condition of the solvent could affect the overall reaction. In an attempt to improve the 
poor yield of compound 128, the manganese IV oxide oxidation was repeated but with 
no improvement. Thus, oxidation of pyridine 127 with an alternative oxidant was 
investigated.
Another common oxidant for conversion of alcohols to carbonyl compounds is 
pyridinium dichromate (PDC). Pyridinium dichromate is a solid obtained by 
dissolving chromium VI oxide in a minimum of water, adding pyridine, and collecting 
the precipitate. Unlike the mildly acidic pyridinium chlorochromate, it is nearly 
neutral. When used in DMF, pyridinium dichromate oxidises aldehydes and primary 
alcohols to carboxylic acids. However, allylic primary and secondary alcohols are 
oxidised only to the a,p-unsaturated carbonyl compounds. The behaviour of 
pyridinium dichromate in CH2CI2 is considerably different. Primary alcohols are 
oxidised only to aldehydes. Oxidation of secondary alcohols is also satisfactory, 
while allylic alcohols are oxidised readily (scheme 130).
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Scheme 130
Thus, pyridine 127 was treated with pyridinium dichromate in dry CH2CI2 under N2 
atmosphere, with powered 3A molecular sieves added to enhance the oxidation rate 
and a catalytic amount of sodium acetate added to reduce the oxidation time . The 
reaction mixture was stirred at room temperature and reaction progress observed by 
tic analysis at intervals. After 24 h, the tic revealed an intense spot indicating the 
newly oxidised compound, which is noticeably separated from the faint spot that 
corresponds to the starting material. Purification of the crude product by column 
chromatography afforded a light yellow solid in 96 % yield (scheme 131). Analysis 
of the light yellow solid by IR and 1HNMR revealed that the data are identical to the 
3,5’-0-dibenzylpyridoxal 128 obtained from the oxidation using manganese IV oxide. 
Repeats of the oxidation using pyridinium dichromate afforded satisfactory yields of 
compound 128.
127
PDC, CH3COONa, 
n molecular sieves, CH2C12
Scheme 131
The 3,5 ’ -O-dibenzylpyridoxal 128 was now treated with a Grignard reagent to 
form the secondary alcohol (C-4 -CH2OHCH3). The reaction of an alkyl or aryl halide
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RX 236 with magnesium metal (turnings) in an ether solvent produces 
organomagnesium compounds of the general structure RMgX 238. The formation of 
the organometallic species takes place at the metal surface where the transfer of an 
electron from magnesium to a halide molecule occurs to form an alkyl or aryl radical 
species 237. At the metal surface, the radical species R* and *MgX combine to form 
the Grignard reagent, which subsequently desorbs from the surface into solution 
(scheme 132).
R. 237 PMaY 238
Mg Mg Mg
Scheme 132
In an alkyl halide, the carbon-halogen bond is polarised, because of the higher 
electronegativity of the halogen. The carbon centre next to the halogen has a formal 
8+ charge, and is electrophilic in its reactivity. In the Grignard reagent however, the 
carbon centre next to the magnesium is carbanionic in nature and so has a formal 8- 
charge, thus behaves as a nucleophile. Such a reagent can add to a polarised double 
or triple bond in the so-called Grignard reaction . Suitable compounds for this 
versatile reaction are, for example, aldehydes, ketones, esters, nitriles, carbon dioxide, 
and other substrates containing polar functional groups such as C=N-, C=S, S=0, 
N=0. Most common, and of major synthetic importance, is the reaction of a carbonyl 
compound 239, to give a magnesium alkoxide, which yields an alcohol 240 upon 
hydrolytic work up (scheme 133).
0
+ RMgX
R f R 2
239 238
Rl
OMgX 
-R 2
R
Magnesium
alkoxide
H20 OHRl R2
R
240
Scheme 133
Such a reaction occurred readily in the treatment of carbonyl compound 128 with
H'Xmethylmagnesium bromide in ether under N2 atmosphere . After stirring the
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reaction mixture for 4 h, the alkoxide was protonated by addition of dilute aqueous 
ammonium chloride. IR analysis of the resulting yellow oil (in 85 % yield) after work 
up revealed the OH group at 3246 cm'1, the C-0 bond at 1069 cm' 1 and the aromatic 
C-H bend at 737 and 697 cm'1. Further support from the !HNMR verified that the 
yellow oil is 4,-methyl-3,5’-Odibenzylpyridoxine 241 (scheme 134), by the presence 
of a quartet at 5 5.27 (J = 6.7 Hz) as the hydrogen of the secondary alcohol and the 3 
H doublet at 8 1.53 (J = 6.7 Hz) of the secondary alcohol methyl group. Also, the 
obvious multiplet peak at 5 7.28-7.45 indicated the 10 H of the two phenyl groups are 
present.
128
1) MeMgBr, (C2H5)20, 
n N2 atm.
2) NH4C1 soln.
Scheme 134
OH
241
The reaction proceeds where the strongly nucleophilic methylmagnesium bromide 
uses its electron pair to form a bond to the carbon atom of the carbonyl compound 128. 
One electron pair of the carbonyl group shifts out to the oxygen. This nucleophilic 
addition to the carbonyl group leads to the formation of an alkoxide ion associated 
with Mg and Br\ The addition of NH4CI solution causes protonation of the alkoxide 
ion and results in the formation of the alcoholic derivative 241 (scheme 135).
241
Scheme 135
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Subsequently, the obtained 4’-methyl-3,5’-O-dibenzylpyridoxine 241 was 
oxidised to convert the secondary alcohol to a ketone group. Compound 241 was 
oxidised in the same procedure as in the oxidation of 3,5’-0-dibenzylpyridoxine 127 
by reacting with pyridinium dichromate . The crude residue was purified by column 
chromatography and the yellow oil obtained in 96 % yield was analysed by IR to 
reveal the C=0 bond at 1706 cm’1, the C-0 bond at 1091 cm’1, along with the 
aromatic peaks at 738 and 699 cm’1. The 1HNMR analysis provided additional 
evidence which verified the yellow oil is 4’-methyl-3,5 ’-O-dibenzylpyridoxal 242 
(scheme 136), such as the 10 H of the two phenyl groups represented by the multiplet 
peak at 8 7.29-7.40, also, the 3 H singlet of the ketone methyl group at 8 2.53. 
Particularly noteworthy is the absence of the quartet around 8 5 of the hydrogen of the 
secondary alcohol.
PDC, CH3COONa, 
molecular sieves, CH2C12
242
Scheme 136
Removal of the benzyl groups from the protected hydroxyl groups in 4’-methyl-3,5’- 
O-dibenzylpyridoxal 242 was the next objective in achieving the desired derivatives 
of pyridoxine. Deblocking of the benzyl groups in pyridoxine derivatives could be 
achieved with the use of HC1, hydrogenolysis with Pd-C, or trifluoroacetic acid. Thus, 
selecting the appropriate method in removing the benzyl groups from compound 242 
was important. Trifluoroacetic acid selectively cleaves benzyl ethers, as well as 
similar functions like benzylhydryl and trityl, without affecting methyl ethers or ester 
groups224. Thus, compound 242 was treated with trifluoroacetic acid148 for 24 h, 
during which tic analysis was performed at random intervals. Unfortunately, tic 
analysis did not show the presence of any compounds apart from a spot for the 
starting material 242. As the reaction proceeded, the presence of starting material 242 
diminished and a spread of a radiant cloud (under the UV) on the baseline of the tic 
plate appeared. This could be due to the polarity of the newly cleaved compound, as 
pyridoxine itself is soluble in water. Thus, the acid was evaporated from the reaction 
mixture and the residue purified by ion exchange chromatography eluting with water.
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The water fractions were evaporated to a residue and the addition of ether saturated 
with hydrogen chloride gas afforded a minute amount of an orange precipitate. 
Intentionally, it was hoped that the precipitation would be a solid once the solvent was 
removed; however, a sticky residue remained when solvent evaporated. Analysis of 
the sticky residue by IR spectroscopy remained ambiguous. Repeats of the reaction 
were unsuccessful. There is the possibility that the cleaved compound had remained 
on the ion exchange column longer than anticipated and the eluent failed to elute it. 
Also, it is possible that the presence of water makes it difficult to isolate the cleaved 
compound since vitamin f$6 derivatives are very soluble in water.
To demonstrate that using trifluoroacetic acid does cleave the benzyl groups 
from pyridoxine derivatives, 4’ -methyl-3,5 ’ -O-dibenzylpyridoxine 241 was treated 
with trifluoroacetic acid and as before the tic analysis revealed a radiant cloud 
(under the UV) on the baseline due to the polarity of the newly cleaved compound. 
The acid was evaporated from the reaction mixture and the residue purified by ion 
exchange chromatography eluting with water. Similar UV absorption of water 
fractions were combined and water evaporated. Ether saturated with hydrogen 
chloride was added to the residue and afforded a cream coloured hydrochloride salt in 
75 % yield when the solvent was removed and dried. The cream coloured salt had a 
mp 176-177 °C while the literature melting point of 4’-methylpyridoxine is in the 
range of 177-178 °C223. Analysis of the cream coloured salt by IR revealed the 
presence of the hydroxyl groups at 3326 cm' 1 but the peaks for the aromatics were no 
longer present. The 1HNMR analysis of the salt in DMSO-d6 verified that it is the 4’- 
methylpyridoxine 243 (scheme 137), since a quartet at 8 5.38 (J = 6.7 Hz) due to the 
hydrogen of the secondary alcohol is present, in addition to the presence of the 3 H 
doublet at 5 1.43 (J = 6.7 Hz) due to the secondary alcohol methyl group. The 
obvious 10 H multiplet peak around 8 7, which indicates the two phenyl groups, no 
longer exists. Repeat of the reaction give a similar yield of compound 243.
241 243
Scheme 137
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The reaction proceeds by the oxygen of the benzyl ether attacking the carbonyl carbon 
of the trifluoroacetic acid. Subsequently, the benzyl group is lost as a cation, which 
picks up an hydroxyl group. The benzyl group was removed at the 3-position in the 
same way to produce the trifluoroacetyl derivative. Thereafter, the trifluoroacetyl 
derivative was subjected to ion-exchange chromatography on a weakly acidic resin, 
and is hydrolysed to the 4’-methylpyridoxine 243 (scheme 138).
243
Scheme 138
The pyridoxine derivative 243 was treated with a mixture of phosphorus 
pentoxide and phosphoric acid24 in an attempt to achieve the phosphorylated form of 
derivative 243. After stirring for 4 h in an oil bath at 60 °C, the reaction mixture was 
purified by ion exchange chromatography, eluting with water. However, IR analysis 
of the crystals obtained after freeze-drying of the combined fractions remained 
ambiguous. There is the possibility that the collected crystals are a complex of the
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phosphorylating reagent and if the phosphate form was present, the IR spectrum 
should reveal some resemblance to the starting material 243.
Attempts at synthesising the phosphate form of 4’ -methylpyridoxine 243 were 
unsuccessful and due to the shortage of starting material further phosphorylation 
reactions were discontinued. Also, due to the lack of 4’-methyl-3,5’-O- 
dibenzylpyridoxal 242, additional study on removing the benzyl groups to form the 
pyridoxal derivative was not possible.
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2.2. Total syntheses o f vitamin B* analogues.
Total syntheses of vitamin 1*6 analogues via the Diels-Alder reaction of 
substituted oxazoles with dienophiles is an alternative route to the modification of 
commercially available pyridoxine. It was appropriate to select 4-methyl-5- 
ethoxyoxazole 2 2 2  as the azadiene to react with dienophile, 4-hydroxybut-2-enenitrile 
223, to form adduct 244. Aromatisation of adduct 244 will afford the substituted 3- 
hydroxy-2-methylpyridine 224 because the -OC2H5, as a good leaving group, will be 
eliminated from the adduct (scheme 139).
NC
+
CN
Scheme 139
Hence, selective modification can be made at the 4-position of the pyridine 224 by 
reacting with a Grignard reagent to form the ketone derivative. Subsequent 
phosphorylation could achieve the phosphate form of vitamin B6 analogues 2 2 0 .
O R
220
R = CH3, C2H5 or longer chain. 
R1 = H or P 0 3H2
In order to prepare vitamin B6 analogues 220, synthesis of the substituted 
oxazoles 222 and the dienophiles 223 is required.
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2.2.1, Preparation o f 4-methyl-5-ethoxyoxazoles.
One of the most common routes for preparation of 5-alkoxy oxazoles is via 
cyclodehydration of a-acylamino carbonyl compounds, known as the Robinson- 
Gabriel synthesis158’159, with reagents such as PCI5, P2O5, SOCI2, etc. Hence, N- 
formyl-(±)-alanine ethyl ester 245 undergoes cyclodehydration to form the 4-methyl-
5-ethoxyoxazole 222 (scheme 140).
245
Scheme 140
The preparation of the a-acylamino carbonyl 245 began with the N-formylation of 
(±)-alanine 246 followed by esterification. Reagents such as acetic formic anhydride 
have been shown to formylate amine derivatives efficiently . Acetic formic 
anhydrides, usually prepared by gently warming acetic anhydride with formic acid, 
are used immediately without isolation. Thus, (±)-alanine 246 was treated with acetic 
formic anhydride225 to give a white solid in 59 % after cystallisation with ethyl 
acetate/ethanol (scheme 141). The IR analysis of the white solid revealed the N-H 
bond at 3355 cm'1, the C=0 bond at 1702 cm'1, and the C-H bond peaks at 2854 and 
2924 cm'1. The melting point of the white solid in the range of 142-147 °C confirmed 
that it is the N-formyl-(±)-alanine 247 as the literature melting point is in 145-148
o^ 226
H
J ,  COOH (CH3C0)20, h c o o h
246
HIO ^ ^ N ^ X O O H
59%
247
Scheme 141
The N-formylation of (±)-alanine 246 with acetic formic anhydride proceeds via 
nucleophilic substitution where the nucleophilic amine 246 attacks the formyl carbon 
of the acetic formic anhydride to form the N-formyl-(±)-alanine 247 as shown in 
scheme 142.
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anhydride
Acetic formic 
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246
- CH3COOH
HI /COOH
247
Scheme 142
The N-formyl-(+)-alanine 247 subsequently underwent acid catalysed 
esterification with ethanol to give the desired N-formyl-(±)-alanine ethyl ester 245 
for cyclodehydration. Esterification of N-formyl amino acid 247 using ethanol under 
acidic condition afforded a residue which was distilled at 110 °C / 3 mm Hg to give a 
clear oil in 30 % yield only (scheme 143). The literature boiling point of N-formyl- 
(±)-alanine ethyl ester is 110 °C / 1 mm Hg226. The IR analysis of the clear oil 
indicated the presence of an ester group by the C-0 bond at 1205 cm'1, accompanied 
by the N-H bond at 3300 cm' 1 and the C=0 bond at 1740 cm' 1 of the N-formyl amino 
acid ester. The !HNMR spectrum of the clear oil verified that it is the N-formyl-(±)- 
alanine ethyl ester 245. The spectrum revealed the 1 H singlet of the formyl group at 
5 8.20, the broad peak of the amido group at 8 7.08 for 1 H, the quartet of the ester 
-CH?- group at 8 4.22 and the triplet of the ester -CEh group at 8 1.30.
CX
HI,N
O
247
c 2h 5o h ,
Cone. H2S04
Scheme 143
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In the reaction, the acid catalysed nucleophilic substitution occurs when the 
carboxylic acid part of 324 accepts a proton from the strong acid and initiates the 
ethanol attack on the protonated carbonyl group. Consequent loss of a water molecule 
leads to the ester form of N-formyl-(±)-alanine 245 (scheme 144).
" H20  
- H+
‘O'
Scheme 144
Since, the esterification reaction is reversible and the presence of water could easily 
hydrolyse the ester back to the carboxylic acid, hence, the low yield obtained. As the 
yield of the N-formyl-(±)-alanine ethyl ester 245 is relatively low via this route, a 
different approach was considered for preparation of the compound 245 in efficient 
yield for cyclodehydration. Hence, (±)-alanine 246 was esterified first via acyl 
chloride and then N-formylation afterward.
Therefore, (±)-alanine 246 was treated with thionyl chloride and ethanol228 and 
the resulting residue that was precipitated by the addition of ether was collected as a 
white hydrochloride solid in 98 % yield (scheme 145). The melting point of the white 
solid is in the range of 78-82 °C which is in close proximity to the literature value of
'j'jn(±)-alanine ethyl ester hydrochloride mp 87-88 °C . Additional information from 
the IR analysis of the white solid, revealed a peak at 2924 cm-1 for the C-H bond and
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the C=0 bond at 1746 cm' 1 for the ester group, were adequate to verify that it is the 
(±)-alanine ethyl ester hydrochloride 248.
1) SOCl2
2) C2H5OH
248
98%
Scheme 145
When the reaction was refluxed, the interaction of thionyl chloride and ethanol 
produces HC1. Accumulation of HC1 catalyses the esterification between compound 
246 and ethanol to afford the ester compound 248. The reaction proceeds by the 
carboxylic acid of compound 246 acceptting a proton from the HC1 and then the 
ethanol attacks the protonated carbonyl group to give a tetrahedral intermediate. 
Subsequent loss of a molecule of water affords the ester compound 248 as shown on 
scheme 146.
- h 2o H
O
N/ \ c f  H H U 248
O\
Scheme 146
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Subsequently, (±)-alanine ethyl ester hydrochloride 248 was subjected to N- 
formylation to give the N-formyl-(±)-alanine ethyl ester 245. However, compound 
248 in a mixture of acetic anhydride and formic acid, which generates the acetic 
formic anhydride225, afforded only a very small amount of clear oil after distilling at 
110 °C / 3 mm Hg. The IR spectrum of the clear oil is the same as the spectrum of N- 
formyl-(±)-alanine ethyl ester 245 from previous synthesis. Inadequate time given for 
the reaction to proceed or the insufficient generation of acetic formic anhydride could 
contribute to the extremely low yield.
Another method to N-formylate ester 248, using triethylamine with ethyl 
formate and catalytic amount of />-toluenesulphonic acid monohydrate 230 , also 
produced a very small amount of clear oil after distilling at 110 °C / 3 mm Hg. 
Comparing the IR spectra of the clear oil and the a-acylamino carbonyl 245 revealed 
it to be identical. However, the large accumulation of the triethylamine HC1 salt 
formed in the reaction made the purification process relentlessly difficult and repeated 
purification was required to remove all the salt fully, consequently, a low yield was 
obtained. The reaction proceeds by the interaction of the ethyl formate with the 
primary amine 325 through nucleophilic addition of the amine at the carbonyl of the 
ester, followed by protonation and elimination of alcohol. The triethylamine serves to 
free the amine from its hydrochloride (scheme 147).
- HOCH2CH3
Scheme 147
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When ester 248 was subjected to N-formylation using formamide in toluene231, 
a clear oil was obtained in 85 % yield after distillating at 110 °C / 3 mm Hg (scheme 
148). The IR analysis confirmed that the clear oil is the a-acylamino carbonyl 245. 
The reaction proceeds smoothly and fewer problems were associated with purifying 
the residue obtained, since the NH4CI salts formed did not create any difficulties 
during distillation. Repeats of the reaction produced N-formyl-(±)-alanine ethyl ester 
245 in reasonable high yield.
HCONH2 
Toluene
H OC2H5 
HC1
248
S ch em e 148
85%
The nucleophilic substitution of the reaction proceeds similarly as in the other N- 
formylation mechanisms, where the primary amine 248 attacks the carbonyl of the 
formamide and subsequently eliminates ammonium chloride salt (scheme 149).
-NH4C1
S ch em e 149
The prepared N-formyl-(±)-alanine ethyl ester 245 undergoes 
cyclodehydration, known as the Robinson-Gabriel synthesis, to form the 4-methyl-5- 
ethoxyoxazole 222. Compound 245 was stirred with cyclodehyrating reagent P2O5 in 
chloroform232 for 12 h under N2 atmosphere, and a clear liquid was obtained in 54 %
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yield after distilling the residue at 75-80 °C / 50 mm Hg. As the literature boiling 
point of 4-methyl-5-ethoxyoxazole is at 75-80 °C / 50 mm Hg232, it seems very likely 
that the clear liquid is the desired oxazole. The IR analysis of the clear liquid revealed 
peaks for the C-H stretch at 2929 cm'1, the C-H bend at 1336 cm'1, and the C-0 bond 
at 1221 cm'1. The !HNMR finally confirmed that the liquid is 4-methyl-5- 
ethoxyoxazole 222 (scheme 150) by the singlet at 5 7.40 for the -OCH-, the quartet at 
5 4.12 for the -CH?0- of the ethoxy group, the singlet at 5 2.04 for the methyl group, 
and the triplet at 8 1.38 for the CH3- of the ethoxy group.
S ch em e 150
The a-acylamino carbonyl 245 cyclised with the elimination of a water molecule to 
form 4-methyl-5-ethoxyoxazole 222 via the ring closure mechanism of the acylamino 
double bond attacking the carbon of the ester carbonyl group (scheme 151)160.
H+
S ch em e 151
The 4-methyl-5-ethoxyoxazole 222 was obtained only in modest yield and repeats of 
the reaction afforded relatively the same amount. An attempt to improve the oxazole 
yield by subjecting a-acylamino carbonyl 245 to triphenylphosphine with iodine and 
triethylamine233 were unsuccessful. As the IR and 1HNMR analysis of the resulting 
clear oil remained ambiguous and showed no presence of the oxazole 222. Repeat of 
the reaction failed to give the desired oxazole, therefore, this approach was abandoned. 
In this study, the Robinson-Gabriel synthesis using P2O5 in chloroform was a 
convenient method in obtaining the desired oxazole.
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2.2.2. Preparation of 4-hydroxybut-2-enenitriles.
Since the preparation of the 4-methyl-5-ethoxyoxazoles 222 was satisfactorily 
completed, the next objective was the synthesis of 4-hydroxybut-2-enenitrile 223 as a 
dienophile to be utilised in the Diels-Alder reaction with the oxazole 222 to form 
pyridine 224 (scheme 152).
NC
+
t h 2oh
223
CN
S ch em e 152
4-Hydroxybut-2-enenitrile 223 was chosen as the dienophile because in the Diels- 
Alder reaction the more electron withdrawing substituent (-CN) of the dienophile 
would end up at the 4-position of the pyridine ring. Hence, by blocking the 
neighbouring hydroxyl groups of the substituted pyridine selective modification at the
4-position can be conducted.
The preparation of the dienophile 223 began with epichlorohydrin 249 which 
on reaction with p-toluenesulphonic acid underwent opening of the epoxy ring234. 
The reaction was refluxed for 3 h to obtain a residue and subsequent purification by 
column chromatography provided a yellow oil in 72 % yield. The IR analysis of the 
oil revealed peaks for the hydroxyl group at 3515 cm'1, the alkyl C-H stretch at 2959 
cm*1, the C-H bend at 1358 cm'1, and the 1,4-distributed aromatic =C-H bend at 815 
cm'1. The !HMNR spectrum of the oil established it as the desired l-chloro-3- 
(toluene-4-sulphonyl)propan-2-ol 250 (scheme 153). The 1HNMR analysis showed 
the two doublets at 8 7.80 and 7.32 representing the two pairs of aromatic hydrogens, 
a multiplet in the range of 8 3.50-4.20 corresponding to the underlined hydrogens of 
ClQHbCHfOHICH?-, a doublet at 8 2.80 for the hydroxyl group, and a singlet at 8 
2.45 for the methyl group of the tosyl group.
O
249
.Cl
Scheme 153
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In the reaction, the epoxide 249 initiates the protonation of the epoxide oxygen that 
leaves the p-toluenesulphonate ion to attack the unsubstituted carbon atom of the 
epoxide, causing ring opening (scheme 154).
H
Cl
Cl
S ch em e 154
Replacement of the tosyl group of l-chloro-3-(toluene-4-sulphonyl)propan-2- 
ol 250 with a nitrile group will give the P-hydroxy nitrile 251. The p-hydroxy nitrile 
251 reacting with a base will eliminate the chlorine and subsequent rearrangement 
will form the desired a,P-unsaturated nitrile 223 (scheme 155).
Cl
OH
250
Replacement of 
tosyl with nitrile group.
Cl CN
OH
251
Formation of 
unsaturated nitrile.
HO
223
S ch em e 155
Therefore, the reaction of tosyl derivative 250 with potassium cyanide in 
methanol235 afforded a clear yellow liquid in 12 % yield after removal of the 
potassium tosylate salt and distillation at 115 °C / 4 mm Hg. The IR analysis of the 
clear yellow liquid showed the presence of a nitrile group by the peak at 2256 cm' 1 
corresponding to a nitrile attached to an alkyl component, accompanied by the 
hydroxyl group at 3430 cm*1 and the C-H stretch at 2962.0 cm'1. Additional
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information from the JHNMR revealed that the liquid is the desired 4-chloro-3- 
hydroxybutyronitrile 251 (scheme 156). The 1HNMR spectrum shows multiplet 
peaks at 6 4.28 for -CH-, a doublet at 8 3.65 (CH?CD. a singlet at 5 3.50 for the -OH 
group, and a multiplet at 5 2.70 assigned to CH?CN. However, the accumulation of 
the potassium tosylate salt formed made the purification process difficult and time 
consuming. Subsequent repetitive filtration and distillation resulted in low yield.
KCN,
C l ' ^ y ^ O T s  MeQH 
OH 
250
Cl CN
OH
251 1 2 %
S ch em e 156
In the reaction, the tosyl derivative 250 underwent nitrilation by reacting with an 
alkali metal cyanide such as potassium cyanide. Nitrilation proceeds by nucleophilic 
substitution where the tosyl group is displaced as a good leaving group and replaced 
by a nitrile group (scheme 157).
+K CN
0 = S = 0  OH
250
OH
251
+ K
S ch em e 157
The P-hydroxy nitrile 251 was immediately treated with a base to form the 
desired dienophile 223. Thereafter, p-hydroxy nitrile 251 was reacted with aqueous 
sodium hydroxide236 solution and the reaction mixture was worked up by continuous 
extraction. The aqueous solution of the reaction mixture in a round-bottom flask was 
stirred and heated to boiling. The vaporised aqueous mixture turned to liquid as it 
reached the condensing tube and flowed to the continuous extraction apparatus where 
it mixed with ethyl acetate by continuous stirring. Since the ethyl acetate is less dense 
than water, it, along with the desired compound, gradually floated on top of the stirred 
solution and flowed back to the original round-bottom flask. Eventually, the desired
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compound in ethyl acetate was collected in the round-bottom flask. The residue, 
obtained after the removal of the ethyl acetate, was distilled at 136-145 °C / 15 mm 
Hg to afford a yellow liquid in 30 % yield. The IR spectrum of the yellow liquid 
revealed the presence of the C=C bond by the peak at 1639 cm'1, along with the 
hydroxyl group at 3430 cm'1, the C-H stretch at 2920 cm'1, and the nitrile group at 
2227 cm _1 corresponding to a nitrile attached to vinyl component. The ^M N R  
analysis of the liquid showed the doublet at 6 6.92 (J=16 Hz) assigned to the =CH, the 
doublet at 5 5.68 (J=16 Hz) to =CH, the singlet at 6 4.20 to -CH?-. and the singlet at 5 
3.89 to the hydroxyl group. The IR and JHNMR analysis confirmed that the yellow 
liquid obtained is (ET)-4-hydroxybut-2-enenitrile 223 (scheme 158). However, the 
yield of the product from several attempts was low and in some instances, no product 
was obtained. The a, p-unsaturated nitrile 223 is soluble in water therefore continuous 
extraction to collect the compound from the aqueous environment to the solvent phase 
was necessary and the efficiency of the extraction process would affect the amount of 
the product obtained.
H CN
C l ^ ^ ^ C N  aq. NaOH 
OH 
251
HO H
(E )  223 30%
S ch em e 158
The reaction follows the E2 mechanism of elimination to form the unsaturated 
compound. The E2 mechanism is a bimolecular 1,2-elimination in which, in a single 
step, a base removes a proton and a leaving group (L) departs from the compound, 
resulting in the formation of a % bond (scheme 159).
J P Lf jc\
B
— C = C —  +  L" +  BH
Sch em e 159
The E2 mechanism is stereospecific where the five atoms involved (including the 
base) in the transition state must be in one plane. The requirement for coplanarity of
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the H-C-C-L unit arises from a need for proper overlap of orbitals in the developing n 
bond of the alkene that is being formed. There are two ways for this to happen. The 
H and L may be trans to one another (a), or may be cis (b). Conformation (a) is anti 
periplanar and this type of elimination, in which H and L depart in opposite direction, 
is called anti elimination. Conformation (b) is syn periplanar, and this type of 
elimination, with H and L leaving in the same direction, is called syn elimination.
H
\„c-c
7  'L
H L \ /C—C„
< / V"
(a)
Anti periplanar
(b)
Syn periplanar
The anti elimination is usually favoured over syn elimination because the anti 
periplanar is a staggered conformation and the molecule requires less energy to reach 
this transition state than it does to reach the eclipsed transition state of syn periplanar. 
The syn periplanar transition state occurs only with rigid molecules that are unable to 
assume the anti rearrangement.
Therefore, the formation of the a,p-unsaturated nitrile 223 under basic 
conditions allows the p-hydroxy nitrile 251 to form an epoxide by eliminating the 
chloro group. The formation of a,p-unsaturated nitrile 223 proceeds by an P~ 
elimination mechanism, where the -OH ion attacks a proton from the carbon bonded 
to the nitrile and simultaneously opens the epoxy ring (scheme 160).
H CN H CN
H HO
(E) 223
Scheme 160
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Crystals which appeared in the yellow liquid of 4-hydroxybut-2-enenitrile 223, after 
standing for several days, are due to the reactivity of the compound where it 
rearranges to form by-products. The 4-hydroxybut-2-enenitrile 223 is known to be
*y\(%remarkably reactive and unstable . Dimerisation occurs easily by the oxygen of the 
hydroxyl group attacking the P-carbon of another 4-hydroxybut-2-enenitrile molecule 
to form the ‘epicyanohydrin’, 2:5-biscyanomethyl l:4-dioxan 252. Also, the a,p- 
unsaturated nitrile 223 has a tendency to cyclise to the extremely unstable 2- 
aminofuran 253 (scheme 161).
CN
Since the procedure of using tosyl derivative 250 gave an extremely low yield 
of 4-chloro-3-hydroxybutyronitrile 251 (scheme 162), it was appropriate to examine 
other methods in order to obtain a better yield of the compound 251 for conversion 
into 4-hydroxybut-2-enenitrile 223.
C l'^ Y ^ O T s  
OH 
250
KCN,
MeOH OH
251 12%
Scheme 162
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An early report used epichlorohydrin 249 directly with a mixture of sodium cyanide
'j'ycand potassium cyanide in neutral conditions to form the p-hydroxy nitrile 251. An 
attempt to replicate this method provided a small amount of yellow liquid after 
continuous extraction with ethyl acetate and distilling at 136-145 °C / 15 mm Hg. The 
IR analysis of the yellow liquid revealed the presence of p-hydroxy nitrile 251 and of 
a,p-unsaturated nitrile 223 (scheme 163). During the reaction, the neutrality was 
maintained laboriously by the addition of standard dilute acetic acid, however, the pH 
was not always neutral and at a particular period it was basic enough for the formed p- 
hydroxy nitrile 251 to rearrange to a,P-unsaturated nitrile 223, as basicity of the 
reaction favours the formation of a,p-unsaturated nitrile 223. In addition, if the 
reaction was slightly acidic the cyanide ions could interact with the acid, giving HCN, 
and thus a low yield or no product was obtained in repeated attempts.
CN
/
249 251 223
S ch em e 163
O
/ A .Cl
NaCN, KCN, 
EtOH OH HO-
2.2.2.I. Addition o f protecting group.
The 4-hydroxybut-2-enenitrile 223 is extremely reactive and unstable where it 
dimerises or cyclises to its by-products 252 or 253. Therefore, it was appropriate to 
introduce a protecting group into the molecule to reduce the reactivity and instability 
of the structure. Furthermore, isolation would be a lot easier with a bulky protecting 
group attached to the molecule. Hence, the addition of a protecting group to the 
hydroxyl group of P-hydroxy nitrile 254 prior to the a,P-unsaturated nitrile formation 
might improve the instability of 223 (scheme 164).
H H
HO
OHH
254
Addition of 
CN protecting group.
H H
E2 elimination.
OHH PGO
PG = Protecting group
H CN
H
Scheme 164
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2.2.2.2. The 2-methoxyethoxvmethyl ether.
The 2-methoxyethylmethyl (MEM) group is a common protection of the 
alcohols214 and would appear to be a suitable functionality for the p-hydroxy nitrile 
254 (scheme 165).
H O ^ ^ ^ C N  __MEM group ^ M E M O " ^ |^ " C N
OH OH
254
S ch em e 165
The MEM group can be introduced as 2-methoxyethoxymethyl chloride (MEMC1) to 
alkoxide ion (prepared from sodium hydride reacting with the alcohol) to afford the 
MEM ether and can be removed under aprotic conditions. MEM ether is stable under 
a wide variety of conditions including those attending the use of strong bases, 
reducing agents, organometallic reagents, many oxidising agents and mild acids.
Since the P-hydroxy nitrile 254 has two hydroxyl groups, the P-hydroxyl 
group will also form the MEM ether when subjected to the MEM protection. 
Therefore, glycidol 255 was selected as the appropriate starting material given that the 
hydroxyl group at the end of the molecule will be MEM protected and subsequent 
ring opening with the addition of the nitrile group will afford the MEM protected p- 
hydroxy nitrile (scheme 166).
O
255
Addition of 
MEM group. OMEM
Ring opening and 
addition of nitrile group. NC OMEM
OH
S ch em e 166
Hence, glycidol 255 was treated with sodium hydride and 2-methoxyethoxymethyl 
chloride (MEMC1) in THF238 to give a light yellow oil in 37 % yield after extracting 
with ethyl acetate and removal of solvent. The IR analysis showed the presence of C- 
O bond by the peak at 1047 cm'1, also the C-H stretch at 2887 cm' 1 and the C-H bend 
at 1458 cm'1. The IR information was sufficient to accept that the 2-(2-
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methoxyethoxymethoxy)oxirane 256 (scheme 167) had been obtained and it was used 
without further purification.
O MEMO, NaH, o
- 3 2 ----------- » 2 \ ^ ^ 0mem 37 0/o
255 H 256 crude form
S ch em e 167
The reaction proceeds with the hydroxyl group of the glycidol reacting with the 
hydride ion to generate the alkoxide. The alkoxide then reacted with the 2- 
methoxyethoxymethyl chloride by nucleophilic substitution to form the 2 - 
methoxyethoxymethyl protected glycidol 256 (scheme 168).
O
255
- TL
'H
0
OZ A
.exNa+ H-
.oZsNa+
■ ° A C 1
-NaO
S ch em e 168
A simple and highly regioselective method for the synthesis of p-hydroxy 
nitriles is by direct opening of 1 ,2 -epoxides using potassium cyanide in the presence 
of metal salts as catalyst (such as lithium perchlorate) with non-protic solvent 
(CH3CN) . Therefore, the 2-methoxyethoxymethyl protected glycidol 256 was 
treated immediately with potassium cyanide in the presence of lithium perchlorate in 
CH3CN to give a yellow oil in 5.6 % yield after diluting the reaction mixture with 
water followed by extraction with ether and removal of solvent. The IR spectrum of 
the yellow oil revealed the hydroxyl group at 3448 cm'1, the C-H stretch at 2934 cm'1, 
the C-0 bond at 1039 cm'1, and most important of all, the nitrile group attached to 
alkyl component at 2254 cm'1. The IR analysis were sufficient to accept that 3- 
hydroxy-4-(2-methoxyethoxymethoxy)butyronitrile 257 was formed (scheme 169).
O KCN, LiC104, OH
CH3CN_______ ^  n c ^ T ^ o m e m  c5r6 % form
256 257
S ch em e 169
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Direct formation of p-hydroxy nitriles from epoxides was achieved when the 
nucleophilic cyanide ion attacked regioselectively on the less substituted epoxide 
carbon 256. The metal catalyst coordinated with the epoxide oxygen to form the 
alkoxide ion. Subsequently, the alkoxide ion then reacted with a hydrogen ion from 
water to give the P-hydroxy nitrile 257 (scheme 170).
OMEM
OMEM
-KOH
OH
NCT 'OMEM
257
S ch em e 170
Due to the extremely low yield of compound 257 it was decided not to do 
further analytical examination nor to continue further to attempt formation of the a,p- 
unsaturated nitrile. The reason for the low yield was probably of impurities in the 
starting material and perhaps loss of the protecting group under the reaction 
conditions.
2,2.23. The tert-butyldimethylsilyl ether.
Since the use of MEM group had given an extremely low yields after several 
attempt. The tert-butyldimethylsilyl (TBDMS) group was considered to be a better 
choice as the group is bulkier than MEM, and therefore might be easier to isolate. 
The tert-butyldimethylsilyl (TBDMS) group are one of the most useful protective 
groups for alcohols214. The TBDMS ether is more stable to hydrolysis than the 
trimethylsilyl or dimethylisopropylsilyl ether, and cleaved readily by mild acidic 
hydrolysis conditions. Silylation of the hydroxyl group of glycidol 255 with tert- 
butyldimethylsilyl chloride (TBDMSCl) and imidazole as catalyst in DMF240 failed to 
afford the tert-butyldimethylsilyl protected glycidol, given that the 1HNMR analysis 
of the obtained yellow oil showed no sign of the protected glycidol.
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However, another method of silylation of glycidol 255 using TBDMSC1 , 4- 
dimethylaminopyridine and triethylamine241 in CH2CI2 afforded a clear oil in 83 % 
yield after distilling the residue at 75-80 °C / 2 mm Hg. The IR spectrum of the clear 
oil showed the presence of alkyl C-H stretch by the peak at 2930 cm'1, the C-H bend 
at 1472 cm'1, and the C-0 bond at 1098 cm _1. Additionally, the 1HNMR analysis 
verified that the clear oil is l-O-tert-butyldimethylsilyl^,3-epoxypropane 258 
(scheme 171). The 1HNMR spectrum revealed that the two double doublets at 8 3.57 
and 5 3.77 are from either one of the hydrogens of the epoxide -CH?CK along with the 
multiplet at 8 2.98- 3.04 from the epoxide -CH-. The triplet peak at 8 2.69 and the 
double doublet at 8 2.55 are from either one of the hydrogens of -CH?-. The singlet 
peak at 8 0.8 is the 9 H of SiC(CH3)3, and finally the singlet at 8 0.5 represents the 6 H 
ofSi(CH3)2.
Q TBDMSC1, DMAP, Q
E^ CH^ _____^ ^ A ^ otbdms
255 H 258 8 3 %
S ch em e 171
The ability of the 4-dimethylaminopyridine to form a complex with the tert- 
butyldimethylsilyl chloride facilitates the silylation of glycidol, which reacts more 
efficiently with the hydroxyl group of the glycidol 255 to form the silyl ether 258 as 
shown on scheme 172.
S ch em e 172
Subsequently, the obtained tert-butyldimethylsilyl protected glycidol 258 was 
subjected to direct P-hydroxy nitrile formation using potassium cyanide and lithium
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perchlorate in CH3CN239 to afford a clear yellow oil in 70 % yield after distilling the 
residue at 125-130 °C / 3 mm Hg. The analysis of the clear yellow oil verified that it 
is the desired 4-(ter/-butylidimethylsilanyloxy)-3-hydroxybutyronitrile 259 (scheme 
173) as indicated by the hydroxyl group at 3453 cm"1, the C-0 bond at 1122 cm'1, and 
the nitrile group attached to alkyl component at 2254.6 cm' 1 on the IR spectrum. In 
addition, the 1HNMR revealed that the multiplet at 8 3.9 is the CH-, the multiplet at 
5 3.7 is the -CH?Q-, the doublet at 5 2.72 is the hydroxyl group, and the mutiplet at 
8 2.5 is the -CH?CN. The presence of the silyl ether is shown by the singlet at 8 0.85 
for the SiC(CH3)3 and by the singlet at 8 0 .02  for the Si(CH3)2.
O
258
.OTBDMS
KCN, LiC104, 
CH3CN
■ *- NC OTBDMS
70%
S ch em e 173
Repeats of the direct p-hydroxy nitrile formation from derivative 258 afforded 
the same reasonable yield, therefore, the removal the p-hydroxyl group to achieve the 
a,p-unsaturated nitrile was considered. The attempts at dehydration of the hydroxyl 
group of p-hydroxy nitrile 259 to afford the desired a,p-unsaturated nitrile proved to 
be problematic. Attempted reaction by heating p-hydroxy nitrile 259 with phosphoric 
acid242 at 200 °C afforded a dark residue. Further distillation at 130-145 °C / 3 mm 
Hg of the residue afforded a clear liquid, IR analysis of which revealed the absence of 
the nitrile group. The high temperature of the reaction probably caused the starting 
material to decompose. Dehydration of the hydroxyl group of p-hydroxy nitrile 259 
with thionyl chloride243 afforded a small amount of clear liquid after distilling at 70- 
100 °C / 4 mm Hg, however, the IR spectrum revealed that the nitrile group was also 
missing. Attempted dehydration of p-hydroxy nitrile 259 with phosphoryl chloride244 
afforded a thick dark brown crude oil after extraction and removal of the solvent. The 
IR spectrum of the crude showed no sign of the nitrile group. In addition, the reaction 
of p-hydroxy nitrile 259 with p-toluenesulphonic acid monohydrate245 provided a 
thick dark brown crude oil after extracting the refluxed reaction mixture and removal 
of the solvent. The thick crude oil appeared to polymerise on the sodium chloride 
plates and so an IR spectrum was not obtained. Furthermore, reaction of p-hydroxy 
nitrile 259 with /?-toluenesulphonic acid adsorbed on silica gel246 showed no evidence 
of the dehydrated compound. The resulting clear oil distilled at 120-150 °C / 4 mm
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Hg after column chromatography purification, showed no sign of the nitrile group in 
the IR spectrum.
Since several attempts, using different dehydration reagent, to synthesise the 
desired a,p-unsaturated nitrile were unsuccessful, an approach of using the tosyl 
derivative to form a better leaving group than hydroxyl group itself was attempted. 
Therefore, the P-hydroxy nitrile 259, treated with p-toluenesulphonyl chloride247 and 
pyridine in CHCI3 at room temperature, provided a white solid crude in 75 % yield 
after extracting the reaction mixture with ether and removal of the solvent. IR 
analysis of the white solid revealed the important nitrile group attached to alkyl 
component at 2254 cm*1, the C-0 bond at 1120 cm*1, and the 1,4-distributed aromatic 
=C-H bend at 839 cm*1 on the IR spectrum. Furthermore, the 1HNMR spectrum 
revealed two doublets at 8 7.30 and 7.91 representing the two pairs of aromatic 
hydrogens, the multiplet at 8 3.8 is the CH-, the multiplet at 8 3.6 is the -CH?Q-, the 
mutiplet at 8 2.61 is the -CH?CN. and the singlet at 8 2.52 is the methyl group of the 
tosyl group. The silyl ether protons are shown by the singlet at 8 0.89 for the 
SiCfCHOi and by the singlet at 8 0.02 for the Si(CH^)?. The analytical information 
was sufficient to confirm that the white solid crude is the toluene-4-sulphonic acid 4- 
(fe?t-butyldimethylsilanyloxy)-3-(toluene-4-sulphonyl)butyronitrile 260 (scheme 174). 
The replacement of the hydrogen of the hydroxyl group in p-hydroxy nitrile 259 with 
the tosyl group involved nucleophilic substitution as shown in scheme 174.
NC OTBDMS TsCl, pyridine, CHCk NC OTBDMSOH
259
OTs 75 %
260 crude form
Scheme 174
146
Results and Discussion
However, subsequent reaction of compound 260 with potassium hydroxide248 
indicated the presence of starting material after warming the reaction mixture to 40 °C 
and stirring for 2 days. The tic analysis of the reaction mixture at random intervals 
revealed that the starting material still remained and with no indication of a new 
compound, therefore, the reaction was abandoned. The formation of the a,p- 
unsaturated nitrile derivative was not achieved due to unsuitable reaction conditions.
Since the a,p-unsaturated nitrile formation via compound 260 were 
unsuccessful, direct dehydration of P-hydroxy nitrile 259 was attempted using 
methanesulphonyl chloride249. The reaction process is similar to the tosylation of p- 
hydroxy nitrile 259 except that the intermediate compound was not isolated. The p- 
hydroxy nitrile 259 was treated with methanesulphonyl chloride and 4- 
dimethylaminopyridine with triethylamine in CH2CI2 to afford a yellow oil in 2 1  % 
yield after distillation. The IR analysis of the yellow oil revealed the presence of the 
C=C bond by the peak at 1642 cm'1, the C-0 bond at 1134 cm'1, and the nitrile group 
attached to vinyl component at 2225.1 cm '1. The 1HNMR finally confirmed that the 
yellow oil is 4-(ter/-butyldimethylsilanyloxy)but-2-enenitrile 261 (E and Z forms in 
the ratio of approximately 1:0.4) (scheme 175). The E form of compound 261 
showed the two double triplets at 5 6.78 (J=16.3 Hz) and at 8 5.68 (J=l6.3 Hz) for the 
two =CH, the double doublet at 8 4.28 for the -CH?Q-, the singlet at 8 0.81 for the 
SiC(CH3)3, and the singlet at 8 0.05 for the Si(CH3)2. The Z form of compound 261 
showed the two double triplets at 8 6.41 (J= 11.0 Hz) and at 8 5.30 (J=l 1.0 Hz) for the 
two =CH, the double doublet at 8 4.39 for the -CH2O-, the singlet at 8 0.81 for the 
SiCfCTTO  ^and the singlet at 8 0.05 for the SifCTB)?.
MsCl, DMAP,OTBDMS Et3N, CH2C12
OH
259
/  \  NC v
E : Z  261 
1 : 0.4
-OTBDMS 21 %
Scheme 175
The mesylation of the P-hydroxy nitrile 338 was initiated by the 4- 
dimethylaminopyridine forming a complex with the methanesulphonyl chloride, 
which reacts more efficiently with the hydroxyl group. The formed mesyl group was 
subsequently eliminated from the intermediate 262 when triethylamine attacks the 
most accessible hydrogen next to the nitrile since the hydrogens close to the TBDMS
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ether will be blocked due to steric hindrance, hence, producing the a,p-unsaturated 
nitrile 340 (scheme 176).
O
Scheme 176
The elimination process follows the anti E2 mechanism, where the base attacks the 
proton that is anti periplanar to the leaving group of mesyl derivative 262, to form the 
a,P~unsaturated nitrile 261. When elimination takes place on a compound of the form 
CH3-CABX or CHAB-CGGX, the new alkene does not have cis-trans isomerism, but 
for compounds of the form CHEG-CABX (E and G ± H) 263 and CH2E-CABX 264, 
cis and trans isomers are possible .
G H
For mesyl derivative 262 two conformations (A and B) are possible for the 
transitional state; these lead to different isomers and often both are obtained (scheme 
177). In conformation A the -CH2OTBDMS group is between two hydrogens, 
whereas in conformation B the -CH2OTBDMS group is between the CN and the H. 
In conformation B the electron clouds of the -CH2OTBDMS group and the CN group 
are close enough to repel each other, since conformation A does not have the eclipsing 
effect of B it is more stable and most of the elimination occurs from this conformation. 
However, eclipsing effects are not the only factors that affect the cisttrans ratio in anti
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E2 elimination. Other factors such as the nature of the leaving group, the base, the 
solvent and the substrate also need to be considered.
OMs
A
NC H
H CH2OTBDMS 
Trans (E)
OMs
Newman projection  
form ulae
Scheme 177
2.2.2.4. The benzyl ether.
Since the desired protected a,p-unsaturated nitrile 261 was only obtained in 
low yield (with no improvement after several attempts) it was appropriate to select the 
benzyl group to protect the hydroxyl of glycidol 255, since the spectroscopic analysis 
of the obtained benzyl protected glycidol would be more recognizable due to its 
aromatic characteristics and yields might be more acceptable. Hence, benzylation of 
glycidol 255 using benzyl bromide with sodium hydride in THF afforded a clear 
liquid after distilling at 55-60 °C / 3 mm Hg. The IR analysis showed the C-O bond 
at 1073 cm'1, also the characteristic peak of the aromatic group at 767 and 698 cm' 1 
for the monosubstituted =C-H bend. However, the JHNMR spectrum of the clear 
liquid revealed a 10 H singlet at 5 7.32 of the aromatic group, and a 4 H singlet at 8 
4.58 of two -OCH?- group. Therefore, the clear liquid obtained is dibenzyl ether and 
not of the benzyl protected glycidol. The optimum conditions and the presence of 
water molecules (from the solvent) in the reaction favour the formation of dibenzyl 
ether. Water molecules in the reaction affect the reactivity of sodium hydride toward 
glycidol. The sodium hydride reacts with water as well as the alcohol of glycidol. 
However, the hydroxide ion from the water molecule interacts more favourably with 
the benzyl bromide than the alkoxide ion of the starting material, hence, the formation 
of dibenzyl ether dominated the reaction (scheme 178). Another attempt at 
benzylation of glycidol 255 using benzyl chloride with sodium hydride in DMF
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also failed to form the desired benzyl protected glycidol. The reaction afforded a 
yellow residue after extraction and the IR analysis revealed it to be dibenzyl ether.
Scheme 178
However, the benzylation of glycidol with the addition of tetra-n- 
butylammonium iodide as a catalyst partly overcame the problem of dibenzyl ether 
formation. The reaction of glycidol 255 with benzyl bromide, sodium hydride and 
te^ra-n-butylammonium iodide in THF afforded a light yellow oil in 44 % yield 
after column chromatography purification. However, dibenzyl ether was also 
collected in approximately 50 % yield. The analysis of the oil revealed the aromatic 
C-H stretch at 3031 cm'1, the C-0 bond at 1097 cm'1, and the monosubstituted 
aromatic =C-H bend at 739 and 699 cm*1 on the IR spectrum. Furthermore, the 
!HNMR analysis revealed a multiplet at 5 7.24-7.37 for the 5 H of the phenyl group, 
and the two doublets at 8 4.54 for the hydrogens of -OCH?-Ar. The two double 
doublets at 5 3.42 and at 8 3.77 are due to the two hydrogens of -CH?CK and a 
multiplet at 8 3.16-3.22 for the -CH-. Finally, the triplet at 8 2.80 is one of the 
hydrogen of CH?- and the double doublet at 8 2.61 is due to the other hydrogen of 
CH?-. The analysis indicates that 2-benzyloxymethyloxirane 265 is the obtained light 
yellow oil (scheme 179).
O/
255
BnBr, NaH, (Bu)4N+T, 
THF, N2 atm.
O
265
OBn
44%
Scheme 179
The formation of benzyl protected glycidol 265 was successful because the catalytic 
iodide interacts with the benzyl bromide to generate the more reactive benzyl iodide.
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The catalytic iodide enables the reaction to overcome the sluggish reactivity of 
sterically hindered alcohols toward benzyl bromide, by generating the more reactive 
benzyl iodide in situ. Hence, the benzyl iodide is attacked by the alkoxide ion of 
glycidol and also by the hydroxide ion of water and thus reflects the low yield of the 
benzyl protected glycidol 265 obtained.
The benzyl protected glycidol 265 was subsequently subjected to direct p- 
hydroxy nitrile formation using potassium cyanide and lithium perchlorate in 
CH3CN to afford a brown oil in 85 % yield after extracting with ethyl acetate and 
removal of solvent. The spectroscopic analysis of the brown oil confirmed that it was 
the 4-benzyloxy-3-hydroxybutyronitrile 266 (scheme 180) as indicated by the 
hydroxyl group at 3444 cm'1, the C-0 bond at 1113 cm*1, and the nitrile group 
attached alkyl component at 2255 cm'1. The aromatic C-H stretch at 3032 cm'1, and 
the monosubstituted aromatic =C-H bend at 741 and 700 cm*1 are also shown in the 
IR spectrum. In addition, the 1HNMR revealed a multiplet at 5 7.24-7.40 for the 
phenyl H’s, and the two doublets at 6 4.50 for the -OCH?-Ar. The mutiplet at 5 4.05 
is the -CH-, and the multiplet at 5 3.50 is the -CH?Q-. Finally, the multiplet at 5 2.99 
is the hydroxyl group and the multiplet at 5 2.58 is the -CH?CN. Repeats of the 
reaction afforded p-hydroxyl nitrile 266 in moderate yield.
O
ZA OBn
265
KCN, LiC104, 
CH3CN 85%
crude form
Scheme 180
Attempts at direct dehydration of P-hydroxy nitrile 266 using sodium 
hydroxide in ethanol failed to provide the desired a,p-unsaturated nitrile compound. 
After warming the reaction mixture at 40 °C for 6 h, the IR spectrum of the resulting 
brown oil only showed the presence of starting material. Similarly, the reaction of p- 
hydroxy nitrile 266 with phosphoric acid242, refluxed for 30 min., afforded a dark 
residue after extracting with ether and removal of solvent. The IR spectrum of the 
residue showed no sign of the nitrile group.
Another approach to a,P-unsaturated nitrile formation is via elimination of the 
tosyl group. Therefore, the p-hydroxy nitrile 266 was treated with p-toluenesulphonyl 
chloride247 and pyridine in CHCI3 to give a white semi-solid crude in 77 % yield after 
extracting the reaction mixture with ether and removal of solvent. The IR analysis of
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the crude revealed the C-0 bond at 1121 cm'1, and the nitrile group attached to alkyl 
component at 2254 cm'1. Additionally, the aromatic C-H stretch at 3091 and 3061 
cm'1, the 1,4-disubstituted aromatic =CH bend at 814 cm'1, and the monosubstituted 
aromatic =C-H bend at 751 and 702 cm' 1 are also present. The spectroscopic analysis 
was sufficient to designate the crude product as the 4-benzyloxy-3-(toluene-4- 
sulphonyloxy)butyronitrile 267 (scheme 181).
TsCl, pyridine, 
CHC13
NC OBn
OTs
267
77%
crude form
Scheme 181
Compound 267, when treated with triethylamine249 in CH2CI2 should undergo 
a,(3-unsaturated nitrile formation since the tosyl group will be eliminated as a good 
leaving group. The reaction afforded a brown oil in 77 % yield after column 
chromatography purification. Further purification by distilling a small fraction of the 
brown oil afforded a yellow oil. Analysis of the yellow oil revealed the aromatic C-H 
stretch at 3032 cm'1, the C-0 bond at 1155 and 1116 cm'1, the monosubstituted 
aromatic =C-H bend at 738 and 698 cm'1. More importantly, was the presence of a 
nitrile group attached to a vinyl component at 2223 cm'1, and the C=C bond by the 
peak at 1670 and 1636 cm' 1 on the IR spectrum. The 1HNMR confirmed that the 
yellow oil is 4-benzyloxybut-2-enenitrile 268 (E and Z forms in the ratio of 
approximately 1.5:1) (scheme 182). The E form of compound 268 showed a multiplet 
at 8 7.36 for the 5 H of the phenyl group, also the two double triplets at 8 6.74 (J=16.3 
and 2.4 Hz) and at 8 5.72 (J=16.3 and 2.4 Hz) for the two =CH. The singlet at 8 4.56 
is the -OCIE-Ar-. and the doublet doublet at 8 4.14 (J=1.2 and 2.4 Hz) is the -CH?Q-. 
The Z form of compound 268 showed a multiplet at 8 7.36 for the 5 H of the phenyl 
group, also the two double triplets at 8 6.61 (J=l 1.3 and 1.7 Hz) and at 8 5.46 (J=l 1.3 
and 1.7 Hz) for the two =CH. The singlet at 8 4.56 is the -OCFE-Ar-, finally and the 
doublet doublet at 8 4.35 (J=1.7 and 4.3 Hz) represents the -CH9O-.
Et3N, CH2C12
OBn 7 7 o/ 0
Scheme 182
E '.Z  268 
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In the reaction, the triethylamine attacks the most accessible hydrogen next to the 
nitrile given that the hydrogens close to the benzyl ether will be inaccessible due to 
steric hindrance. The elimination process follows the anti E2 mechanism, where the 
base attacks the proton that is anti periplanar to the leaving group of benzyl derivative 
267, to form the a,p-unsaturated nitrile 268 (scheme 183).
For benzyl derivative 267 two conformations (A and B) are possible for the 
transitional state (scheme 184). Conformation A does not have the eclipsing effect of 
B and therefore A is more stable and most of the elimination occurs from this 
conformation. Hence, the eclipsing effects, and factors such as the nature of the 
leaving group, the base, the solvent and the substrate all have considerable affect on 
the ratio of isomers.
OTs
NC
H
Trans (E)
H
CH2OBn
B
OTs
Newman projection  
form ulae
Scheme 184
NC CH2OBn 
Cis (Z)
Since elimination of tosyl group from compound 267 facilitated by 
triethylamine was so effective, it was anticipated that similar reaction of 4-benzyloxy-
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3-hydroxybutyronitrile 266 using methane sulphonyl chloride249 and 4 - 
dimethylaminopyridine with triethylamine in CH2CI2 in one step would also produce 
the a,p-unsaturated nitrile 268. The reaction afforded a brown oil in 97 % yield after 
column chromatography. Further purification by distilling a small fraction of the 
brown oil afforded a yellow oil. The IR and 1HNMR analysis confirmed that the 
yellow oil is 4-benzyloxybut-2-enenitrile 268 (E and Z forms in the ratio of 
approximately 2:1) (scheme 185).
OH
266
MsCl, DMAP, 
EtjN, CH2C12 OBn 97 %
E \Z  268 
2 : 1
Scheme 185
The 4-benzyloxybut-2-enenitrile 268, as the dienophile, now in hand should 
react with the 4-methyl-5-ethoxyoxazole in the Diels-Alder reaction to form the 
desired substituted pyridine, and therefore a sufficient amount of compound 268 is 
required. The synthesis of a,p-unsaturated nitrile 268 was conducted successfully in 
small scale. Scaling up the reaction caused purification problems, as repetitive 
distillation was required which resulted in a moderately low yield of reasonably pure 
a,p-unsaturated nitrile 268. Therefore, the Wittig-Homer reaction was investigated in 
order to afford the 4-benzyloxybut-2-enenitrile 268 in a more efficient way.
2.2.2.5. The Wittiz-Horner reaction.
One of the most common methods in obtaining an alkene is through the 
reaction of phosphonate anions containing electron-withdrawing groups with 
aldehydes or ketones in an aprotic solvent. Direct conversion of the carbonyl 
compound to a,p-unsaturated nitrile, without isolating and dehydrating the 
intermediate P-hydroxy nitrile, is of considerable interest251’252. Therefore, benzyl 
protected a,P-unsaturated nitrile 268 can, in theory, be obtained by allowing 2 - 
benzyloxyacetaldehyde 272 to react with the Wittig reagent, diethyl 
cyanomethylphosphonate, via the Wittig-Homer reaction (scheme 186).
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Scheme 186
Preparation of the 2-benzyloxyacetaldehyde 272 began with the benzylation of 
2-butene-1,4-diol 269 through the use of benzyl bromide with sodium hydride and 
catalytic amount of te?ra-n-butylammonium iodide in DMF250. The reaction afforded 
a light yellow oil in 90 % yield after extracting the reaction mixture with ether/hexane 
and removal of the solvent. The analysis of the light yellow oil indicated the presence 
of the aromatic C-H stretch at 3030 cm'1, the C-0 bond at 1091 cm'1, and the 
monosubstituted aromatic =C-H bend at 737 and 698 cm'1 on the IR spectrum. The 
1HNMR verified that the oil is l,4-dibenzyloxy-2-butene 270 (scheme 187) by the 
mutiplet at 8 7.31 for the 10 H of the two phenyl groups, and the double triplet at 8 
5.77 (J=3.7 and 1.0 Hz) for the HC=CH. The 4 H singlet at 8 4.46 is the two -OCH2- 
Ar, and the double doublet at 8 4.03 represents the 4 hydrogens of the two -CH?Q-.
BnBr, Nall, ___
HO
269
(Bu)4N+P, DMF OH —— - ------------- BnO
270
OBn
90%
Scheme 187
Without further purification, the obtained benzyl protected alkene 270 was 
subjected to an epoxidation reaction. The compound 270 was treated with m- 
chloroperbenzoic acid250 in CH2CI2 to afford an oily white solid after extracting the 
reaction mixture with ether and removal of solvent. The IR analysis of the solid 
revealed the aromatic C-H stretch at 3064 and 3031 cm'1, the C-0 bond at 1096 cm'1, 
and the monosubstituted aromatic =C-H bend at 738 and 698 cm'1. However, the 
peak for the C=C bond was no longer present. Additionally, the 1HNMR showed the
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10 H mutiplet at 5 7.29-7.38 to be the two phenyl groups, and the doublet at 5 4.61 
(J=l 1.9 Hz) and at 8 4.51 (J=l 1.9 Hz) to be the two -OCH?-Ar. The double doublet 
at 8 3.69 (J=3.9 and 11.3 Hz) and at 8 3.53 (J=6.5 and 11.3 Hz) to be the two -CH?Q-. 
and the multiplet at 8 3.26 to be the -CH-CH-. The 1HNMR analysis confirmed that 
the solid is l,4-benzyloxy-2,3-epoxybutane 271. The reaction proceeds by the ra­
dii oroperbenzoic acid transferring an oxygen atom to the alkene 270 in a cyclic, 
single step mechanism. The result is the syn addition of the oxygen to the alkene, 
with the formation of epoxide 271 and w-chlorobenzoic acid shown in scheme 188.
BnO 270 OBn
MCPBA, CH2C12
O
2 7 1  96 %
crude form
Scheme 188
Oxidative cleavage of epoxide 271 should give the desired 2-benzyloxyacetaldehyde 
272. Therefore, epoxide 271 was treated with periodic acid to afford a yellow 
semi-solid crude after extracting with ether and removal of the solvent. The IR 
analysis of the crude revealed the C-H stretch at 2924 cm'1, the C=0 bond at 1727 
cm' 1 of the aldehyde, the C-0 bond at 1095 cm'1, and the monosubstituted aromatic 
=C-H bend at 736 and 699 cm'1. The IR spectrum of the crude was adequate to 
indicate the presence of 2-benzyloxyacetaldehyde 272 (scheme 189).
BnO ^/A^O Bn ^  ^ , ™ > ^ f °
271 272 H
Scheme 189
Carbonyl derivative 272 is a very sensitive compound, where deprotonation of 
the acidic a-hydrogen can easily occur forming the resonance-stabilised enolate ion 
which is readily capable of aldol condensation (scheme 190).
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Therefore, to minimise the formation of an aldol derivative the carbonyl derivative 
272 was subjected to the Wittig-Homer reaction immediately without further 
purification. The carbonyl compound was treated with diethyl 
cyanomethylphosphonate and powdered potassium hydroxide in THF to afford a dark 
residue after extracting with ether and removal of the solvent. The IR spectrum of the 
residue showed no sign of the nitrile group. Another attempt in the Wittig-Homer 
reaction failed to produce the desired benzyl protected a,p-unsaturated nitrile. It had 
been hoped that the presence of the ether oxygen would render 272 relatively stable 
towards base-catalysed aldol reactions. However, it appears that the reaction 
conditions were probably not optimum for a,p-unsaturated nitrile formation and the 
starting materials may have aldolised during the attempted reaction.
2.2.3. The Diels-Alder reaction.
Although problems were associated with the synthesis of the desired 
dienophile, the satisfactory amount of 4-methyl-5-ethoxyoxazole 222 that had been 
synthesised was used in Diels-Alder cycloaddition with commercially available 
dienophiles as model reactions. 4-Methyl-5-ethoxyoxazole 222 was refluxed with 
dimethyl maleate 273 in toluene to produce a cream solid in 36 % yield after 
column chromatography. The IR spectmm of the cream solid revealed the hydroxyl 
group at 3358 cm*1, the C-H stretch at 2956 cm'1, the C=0 bond at 1743 cm*1, and
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the C-H bend at 1440 cm"1 in the IR spectrum. The IHNMR confirmed that the solid 
is dimethyl 5-hydroxypyridine-3,4-dicarboxylate 274 (scheme 191) having a singlet 
at 8 8.26 for the py-H, a singlet at 8 3.94 for the -CCbCKh a singlet at 8 3.90 for the 
-C0 2 CH3, and a singlet at 8 2.57 for the py-CEb-
h 5c2o
+
-C02CH3
273 c  w
Toluene
Scheme 191
The oxazole 222 and the dienophile 273 react with each other in a concerted addition 
in which both of the new single bonds are formed at the same time. The formation of 
the two new o-bonds occurs by the overlap of molecular 7c-orbitals in a direction 
corresponding to endwise overlap of atomic p-orbitals. The concerted addition gives 
the adduct. The dissociation of the C6-0  bond facilitated the elimination of the - 
OC2H5 group in the 3-position of the adduct and subsequent rearrangement forms the 
corresponding pyridine 274 (scheme 192).
Another Diels-Alder reaction involved 4-methyl-5-ethoxyoxazole 222 with 
excess acrylonitrile254 275. The reaction mixture was stirred at room temperature for 
24 h to afford a light orange solid in 34 % yield after crystallising the residue from 
methanol. The IR analysis of the solid revealed the nitrile peak at 2224 cm"1.
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Additionally the !HNMR verified that the solid is 4-cyano-3-hydroxy-2- 
methylpyridine 276 (scheme 193) with a doublet at 5 8.00 (J=5 Hz) for the py-H, a 
doublet at 8 7.48 (J=5 Hz) for the py-H, and a singlet at 8 2.45 being the py-CITj.
Scheme 193
A general rule for predicting the orientation of the cycloaddition is that the most 
electronegative substituent on the dienophile, in this case the -CN, will occupy the 4- 
position of the adduct. Hence, dissociation of the C6-0  bond facilitated the 
elimination of the -OC2H5 group (leaving group) in the 3-position of the adduct to 
form the desired pyridine 276 (scheme 194).
CN
Thus, the prepared 4-methyl-5-ethoxyoxazole 222 undergoes Diels-Alder 
reaction reasonably effectively with simple, classic, commercially available 
dienophiles. Unfortunately, the yield of the prepared dienophile 4-{tert- 
butyldimethylsilanyloxy)but-2-enenitrile 261 was insufficient to be used in the Diels- 
Alder reaction with oxazole 222.
NC N— OTBDMS
261
Furthermore, attempted cycloaddition of 4-methyl-5-ethoxyoxazole 222 with the 
prepared 4-benzyloxybut-2-enetnitrile 268 was unsuccessful (scheme 195)232. The
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reaction was refluxed in methanol for 24 h and stored in the fridge for 24 h. 
Subsequent addition of ethanol saturated with hydrogen chloride gas to the reaction 
mixture did not produce any precipitate. In addition, the tic analysis of the reaction 
mixture still showed the presence of the oxazole and the reaction was abandoned.
+ NC
268
Hydroquinone, MeOH OBn -------- - -----------------* Unsuccessful
Scheme 195
Repeated attempts with the conditions slightly varied also failed to give the desired 
pyridine 224 with benzyl protection at C5-hydroxymethyl.
CN
c h 2o h
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3. Conclusion
The diversity of manipulating commercially available pyridoxine 
hydrochloride 1 enables many vitamin B6 analogues to be synthesised.
OH
HC1
OBn
127 R = -CH2OH
128 R = -CHO
OHI241 R = —  C—CH3
O
242 R =  — C—CH,
In this study, 3,5’-0-dibenzylpyridoxine 127 allowed selective modification of the 4- 
position to be conducted. The desired derivative 127 was obtained through multiple 
steps. Modifying the derivative 127 by oxidation has transformed the 4-position 
hydroxyl to an aldehyde group (compound 128) in high yield, without interfering with 
neighbouring groups. Subsequent Grignard reaction and hydrolysis afforded the 
derivative 241 in yield as high as 85 %. Furthermore, the alcohol derivative 241 was 
subjected to oxidation to give the corresponding derivative 242 in high yield.
\ / O H
234 R = H 243
235 R = P03H2
Attempts to achieve the desired pyridoxal analogue 234 and its phosphate 
form 235 by removing the benzyl groups were problematic. Pyridoxal and its 
derivatives have the tendency to exist in its cyclic hemiacetal form and the fact that 
vitamin B6 are highly soluble in water have made the task of isolating the desired 
derivative 234 difficult. Hence, repeated attempts in achieving the pyridoxal 
derivative 234 were unproductive. However, the attempt of removing the benzyl 
groups of compound 241 afforded pyridoxine derivative 243 in 75 % yield and since 
the pyridoxine and its derivatives does not have the problem with cyclic hemiacetal 
forms, the pyridoxine derivative 243 were easier to isolate. Attempts at 
phosphorylating the pyridoxine derivative 243 failed to achieve the desired phosphate
161
Conclusion
form and further progress on phosphorylation was abandoned due to the shortage of 
starting material.
The Diels-Alder reaction of oxazole 222 with dienophile, a,p-unsaturated 
nitrile 223, was another approach adopted for preparing vitamin B6 analogues. The 
Robinson-Gabriel cyclodehydration of a-acylamino carbonyl compound produced the 
oxazole 222 in good yield. However, difficulties were associated with synthesising 
the a,P~unsaturated nitrile 223. The a,p-unsaturated nitrile 223 is an extremely 
reactive and unstable compound that has the tendency to convert to its by-products, 
2:5-biscyanomethyl 1:4-dioxan 252 and 2-aminofuran 253.
Therefore, addition of protective groups to the P-hydroxy nitrile prior to the formation 
of a,p-unsaturated nitriles was investigated and did produce a more stable derivative 
in the form of 4-(fer/l-butyldimethylsilanyloxy)but-2-enenitrile 261 and 4- 
benzyloxybut-2-enenitrile 268. In addition, alternative approach in the attempts to 
form the protected a,p-unsaturated nitrile via the Wittig-Homer reaction was 
investigated, however, the reaction were unsuccessful.
/NC
261
OTBDMS OBn
The Diels-Alder reaction of oxazole 222 with commercially available 
dienophiles, dimethyl maleate and acrylonitrile, was attempted as model reactions. 
The model reactions afforded dimethyl 5-hydroxypyridine-3,4-dicarboxyl ate 274 in 
36% yield and 4-cyano-3-hydroxy-2-methylpyridine 276 in 34 % yield. However, 
Diels-Alder reaction of oxazole 222 with dienophile 268 failed to give the desired 
pyridine as tic analysis showed only the presence of oxazole and repeated attempts 
with the condition slightly varied were unsuccessful. Since the starting materials, 
oxazole and dienophile, are lacking further progress on Diels-Alder reaction was 
discontinued.
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274 276
Due to the lack of starting materials, further progress in the two approaches to 
achieve the desired vitamin B6 analogues 220 was discontinued. The desired vitamin 
B6 analogues 220 could be use to examine biological systems such as the enzymatic 
binding sites of the mammalian multifunctional polypeptide CAD that is involved in 
the pyrimidine biosynthesis in mammalian cells. The biosynthesis of pyrimidine is 
essential for most growing cells and analogues could provide information on the 
binding sites in the mammalian multifunctional polypeptide CAD for the development 
of antiproliferative agents.
R = CH3, C2H5 or longer chain. 
R1 = H or P03H2
220
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4. Experimental
Commercially available reagents were used throughout without further 
purification. Dried solvents were prepared by standard procedure. The drying agent 
used in the routine work up was anhydrous magnesium sulphate, unless stated 
otherwise. Analytical thin layer chromatography was carried out using Merck 
Kieselgel 60 F254 aluminium-backed plates, which were visualised either under ultra­
violet light or with iodine vapour. Column chromatography was accomplished using 
pressurised short path columns with Merck Kieselgel 60H silica, eluted with stated 
solvents. Melting points were determined using an Electrothermal melting point 
apparatus and are uncorrected. IR spectra were recorded in the range 4000-500 cm' 1 
using a Perkin-Elmer Paragon 1600 FT-IR spectrometer. 1HNMR spectra were 
recorded using a Bruker DPX-300 at 300MHz or a Jeol JMN PMX60si spectrometer 
at 60MHz.
4.1. Modification o f vvridoxine.
Isopropylidenylation of pyridoxine hydrochloride.132
Dry acetone (100 mL) was saturated with hydrogen chloride gas, with cooling 
on an ice-bath to 0 °C, until the clear solvent turned yellow. Pyridoxine 
hydrochloride 1 (5 g, 24.31 mmol) was added to the stirred acetone, with a continuous 
flow of hydrogen chloride gas until the mixture turned golden yellow. The flask was 
sealed with a glass stopper and the mixture was stirred at room temperature for 75 
min. The mixture was then placed in the fridge for 2 days. Ether (150 mL) was 
added to the chilled suspension, the white solid formed was
over CaCL, to afford 3,4'-0-isopropylidenepyridoxine 85 (4.68 g, 92 %) as a white 
solid with mp 99-103 °C (lit. mp 110-111 °C').
filtered and converted to the free base by mixing it with excess 
saturated NaHC0 3 . The solid was filtered and washed with cold 
water until the pH of washings were about 6 . The white solid was 
dried in a vacuum oven at 50 °C, then in a vacuum desiccator 85
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IR(KBr) v3106, 1414,1054 cm'1.
‘HNMR (300MHz, CDC13) 5 1.55 (6H, s, isopropylidene CH3), 2.37 (3H, s, 2-CH3), 
4.55 (2H, s, 4 -CH2OC-), 4.94 (2H, s, 5-CH2OH), 7.82 (1H, s, 6-H).
Benzvlation of 3.4’-0-isopropvlidenepyridoxine.
Dry DMF (100 mL) was added to sodium hydride (1.38 g, 57.36 mmol) and 
te?ra-n-butylammonium iodide (0.1 g) at 0 °C under a N2 atmosphere. 3,4'-0- 
Isopropylidenepyridoxine 85 (3 g, 14.34 mmol) in dry DMF (20 mL) was added to the 
suspended mixture. The reaction mixture was gradually heated to 65 °C and then 
cooled to 45 °C over a 90 min period. The mixture was cooled on ice to 0 °C and 
benzyl chloride (3.63 g, 28.68 mmol) was added dropwise and stirred overnight at 
room temperature. Water was added to the mixture, followed by extraction with ethyl 
acetate. The combined extracts were washed with water and dried. The solvent was 
removed in vacuo and the residue subjected to column 
chromatography (10-20 % ethyl acetate/hexane) to 
afford 3,4'-0-isopropylidene-5'-0-benzylpyridoxine 
229 (3.06 g, 71 %) as a yellow oil. 229IR(neat) v2942,1604, 1454, 1143, 739, 699 cm'1.
‘HNMR (300MHz, CDC13) 8 1.52 (6H, s, isopropylidene CH3), 2.41 (3H, s, 2-CFb), 
4.43 (2H, s, -OCHj-Ar), 4.49 (2H, s, 4-CH2OC-), 4.87 (2H, s, S-CHzOBn), 7.22-7.42 
(5H, m, Ar-H), 7.98 (1H, s, 6-H).
Acidic cleavage of 3,4'-6Msopropylidene-5'-(9-beiizvIpvridoxine with formic 
acid.216
Formic acid, 98 % (10 mL) was added to a solution of 3,4'-0-isopropylidene- 
5'-0-benzylpyridoxine 229 (5 g, 16.70 mmol) in distilled water (10 mL). The mixture 
was stirred at 50 °C for 24 h. The mixture was adjusted 
to neutral with saturated NaHCCb, extracted several 
times with CH2CI2 (30 mL). The organic extracts were 
dried and concentrated in vacuo, followed by column 230
chromatography (70 % ethyl acetate/petrol) to afford 5'-O-benzylpyridoxine 230 (2.91 
g, 67 %) as a yellow solid with mp 112-114 °C (lit. mp 117-118 °C1).
IR(KBr) v3032,1420,1121.6,728.2 cm'1.
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1HNMR (300MHz, CDC13) 5 2.42 (3H, s, 2 -CH3), 4.40 (2H, s, -OCFh-Ar), 4.45 (2H, 
s, 4 -CH2OH), 5.00 (2H, s, 5 -CH2OB11), 7.20-7.40 (5H, m, Ar-H), 7.79 (1H, s, 6-H), 
8.40 (1H, br s, 3-OH).
N-Oxidation of 3,4'-0-isopropvlidene-5'-0-benzvlpvridoxine.217
A solution of m-chloroperbenzoic acid (2.77 g, 16.04 mmol, 50 % pure) in 
CHCI3 (50 mL) was added to a stirred solution of 3,4'-0-isopropylidene-5'-0- 
benzylpyridoxine 229 (2 g, 6.68 mmol) in CHCI3 (25 mL) over a 10 min period. The 
reaction mixture was left stirring at room temperature for 1 h, diluted with CHCI3 and 
shaken with 10 % sodium metabisulphite solution (to : 
destroy the peracid) followed by saturated NaHCC^.
The organic extracts were washed with brine, water, ; 
and dried. The solvent was removed in vacuo to give 1 o _crude 3,4'-0-isopropylidene-5'-0-benzylpyridoxine N- 23 i
oxide 231 (2.02 g, 96 %) as a partly crystallising brown solid.
A small amount of the crude product was re-crystallised from acetone to give a white 
solid for spectroscopic analysis, mp 151-153 °C.
IR (KBr) v2997,1451,1209, 1097,754,700.0 cm’1.
‘HNMR (300MHz, CDCI3) 8 1.58 (6H, s, isopropylidene CH3), 2.50 (3H, s, 2 -CH3), 
4.47 (2H, s, -OCHj-Ar), 4.56 (2H, s, 4-CH2OC-), 4.87 (2H, s, 5 -CH2OB11), 7.22-7.44 
(5H, m, Ar-H), 8.18 (1H, s, 6-H).
Acidic cleavage of 3,4'-fl-isopropvlidene-5f-0-benzvIpyridoxine N-oxide with 
formic acid.216
Formic acid, 98 % (15 mL) was added to a solution of 3,4'-0-isopropylidene- 
5'-0-benzylpyridoxine N-oxide 231 (2 g, 6.34 mmol) in distilled water (15 mL). The 
solution was stirred at 50 °C for 2 days. The solution was then adjusted to neutral 
with saturated NaHC0 3 , and the white solid formed 
was filtered, then dried in vacuum oven at 50 °C, to 
give 5'-(9-benzylpyridoxine N-oxide 232 (0.2 g, 11 %)
T +as a white solid with mp 116-125 °C. 0 -
IR (KBr) v 3030, 1364,1109,741 cm’1. 232
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’HNMR (300MHz, CDC13) 5 2.38 (3H, s, 2 -CH3), 4.20 (2H, s, -OCH2-Ar), 4.49 (2H, 
s, 4 -CH2OH), 4.76 (2H, s, 5 -CH2OB11), 7.66 (1H, s, 6-H), 7.00-7.49 (5H, m, Ar-H), 
9.80 (1H, br s, 3-OH).
Benzylation of 5'-0-benzylpyridoxine using reagent benzyldimethylphenvl-
ammonium chloride.216
*y-i oA solution of benzyldimethylphenylammonium chloride (2.96 g, 11.96 
mmol) in dry MeOH (25 mL) was added to a solution of anhydrous sodium 
methoxide (0.83 g, 15.43 mmol) in dry MeOH (25 mL) at 0 °C under N2 atmosphere. 
A solution of 5'-0-benzylpyridoxine 230 (1.40 g, 5.40 mmol) in dry MeOH (25 mL) 
was added to the reaction mixture. After stirring for 2 h at room temperature, the 
resultant mixture was transferred to a separating funnel and was dripped, over a 30 
min period, into hot toluene (100 mL). During the addition, gentle heat was provided 
so that the MeOH was slowly distilled via a condenser to a receiving flask. The 
mixture was cooled, and the excess toluene was 
evaporated under reduced pressure to leave a 
brown residue. The residue was dissolved in 
saturated NH4CI solution and extracted with 
CH2CI2. The organic extracts were dried and 
concentrated in vacuo, followed by column 
chromatography (40-50 % ethyl acetate/petrol) to afford 3,5'-0-dibenzylpyridoxine 
127 (1.61 g, 85 %) as a yellow solid with mp 62-66 °C (lit. mp 64-69 °C1).
IR(KBr) v 3125,3032,2925,1450,1100,744.4,696.1 cm'1.
’HNMR (300MHz, CDC13) S 2.54 (3H, s, 2-CHj), 3.34 (1H, br s, -OH), 4.62 (2H, s, 
-OCH2-Ar), 4.64 (2H, s, -OCHj-Ar), 4.71 (2H, s, 4 -CH2OH), 4.98 (2H, s, 5- 
CEhOBn), 7.28-7.50 (10H, m, Ar-H), 8.23 (1H, s, 6-H).
Oxidation of 3,5'-Q-dibenzyIpyridoxine.
Oxidation of 3,5'-<9-dibenzyIpyridoxine with activated Mn02.
Activated Mn02 (0.50 g, 5.71 mmol) in dry CH2CI2 (40 mL) was added to a 
stirred and cooled (ice bath) solution of 3,5'-0-dibenzylpyridoxine 127 (0.5 g, 1.43 
mmol) in dry CH2CI2 (40 mL). The reaction mixture was stirred at room temperature
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for 2  days. The mixture was filtered through a Celite pad and washed with CH2 CI2  
(50 mL). The filtrate was concentrated in vacuo  and the residue purified by column 
chromatography (ethyl acetate/petrol) to give 3,5'-0-dibenzylpyridoxal 128 (0.05 g, 
1 0  %) as a light yellow solid.
*yi £Oxidation of 3,5'-0-dibenzyIpyridoxine with pyridinium dichromate.
Pyridinium dichromate (0.43 g, 1.14 mmol), anhydrous sodium acetate (0.02 
g, 0.23 mmol) and powdered 3-A molecular sieves (0.05 g) in dry CH2 CI2  (30 mL) 
was stirred at 0 °C under N2  atmosphere. 3,5'-ODibenzylpyridoxine 127 (0.2 g, 0.57 
mmol) in dry CH2 CI2 ( 1 0  mL) was added to the suspension. The reaction mixture was 
stirred at room temperature for 24 h and then an equal volume of anhydrous ether was 
added to the mixture and stirring continued for 
an additional of 30 min. The mixture was 
concentrated in vacuo  and purified by column 
chromatography (ethyl acetate/petrol) to give 
3,5'-0-dibenzylpyridoxal 128 (0.19 g, 96 %) as a 
light yellow solid.
IR (KBr) v 2874, 1697, 1362, 1062, 740, 698 cm'1.
'HNMR (300MHz, CDC13) 6  2.62 (3H, s, 2 -CH3>, 4.64 (2H, s, -OCHj-Ar), 4.83 (2H, 
s, -OCEh-Ar), 4.98 (2H, s, 5 -CH2 OB11), 7.12-7.48 (10H, m, Ar-H), 8.65 (1H, s, 6-H),
10.37 (1H, s, 4-CHO).
Grignard reaction of 3,5'-0-dibenzvlpyridoxal with methylmagnesium 
bromide.223
Methylmagnesium bromide (5 mL, 15.50 mmol, of a 3 M solution in Et2 0 ) 
was added to a cooled and stirred suspension of 3,5'-0-dibenzylpyridoxal 128 (3 g, 
8.64 mmol) in anhydrous Et2 0  (100 mL) under N2  atmosphere. The grey mixture was 
stirred for a further 4 h at room temperature. Then ice-cold saturated NH4 CI solution 
(25 mL) was added carefully and allowed to stand 
for 10 min. The reaction mixture was extracted 
with Et2 0  and washed with water. The combined 
extracts were dried and solvent removed in vacuo  
to afford 4 ,-methyl-3,5’-0-dibenzylpyridoxine 241
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(2.68 g, 85 %) as a yellow oil.
IR (neat) v 3246,2927, 1454,1069, 737, 697 cm'1.
‘HNMR (300MHz, CDC13) 5 1.53 (3H, d, J=6.7Hz, -C- CHj), 2.58 (3H, s, 2-CHj), 
4.60 (2H, s, -OCH2-Ar), 4.78 (2H, s, -OCH2-Ar), 4.92 (2H, s, 5-CH20Bn), 5.27 (1H, 
q, J=6.7Hz, 4-CHOH), 7.28-7.45 (10H, m, Ar-H), 8.20 (1H, s, 6-H).
Oxidation of 4,-methvl-3,5’-0-dibenzvlpyridoxine with pyridinium 
dichromate.216
Pyridinium dichromate (2.48 g, 6.6 mmol), anhydrous sodium acetate (0.16 g, 
1.98 mmol) and powdered 3-A molecular sieves (0.05 g) in dry CH2CI2 (40 mL) was 
stirred at 0 °C under N2 atmosphere. 4’-Methyl-3,5 ’-O-dibenzylpyridoxine 241 (1.2 
g, 3.3 mmol) in dry CH2CI2 (10 mL) was added to 
the suspension. The reaction mixture was stirred at 
room temperature for 24 h. The solvent was 
evaporated in vacuo and the residue purified by 
column chromatography (ethyl acetate/petrol) to 
afford 4’-methyl-3,5’-0-dibenzylpyridoxal 242 
(1.15 g, 96 %) as a yellow oil.
IR (neat) v 3032, 2925, 1706, 1353, 1091, 738, 699 cm'1.
'HNMR (300MHz, CDC13) 8 2.47 (3H, s, 2 -CH3), 2.53 (3H, s, 4 -COCH3), 4.51 (4H, 
s, -OCHh-Ar), 4.81 (2H, s, S-CifcOBn), 7.29-7.40 (10H, m, Ar-H), 8.25 (1H, s, 6-H).
Attempted reaction of 4,-methyl-3,5’-Q-dibenzyIpvridoxal with trifluoroacetic 
acid.148
4’-Methyl-3,5’-O-dibenzylpyridoxal 242 (0.46 g, 1.27 mmol) and
trifluoroacetic acid (15 mL) was stirred at room temperature for 24 h and then 
refluxed for 10 h. The excess trifluoroacetic acid was removed in vacuo and the 
residue dissolved into a small amount of water, which was passed through an 
Amberlite CG-50 column eluting with water. The effluent fractions with similar UV 
absorption were combined and the water was removed in vacuo. The oily residue was 
taken up in a small amount of EtOH. Precipitation did not occur when Et20 
containing HC1 (g) was added to the mixture, but it remained as a thick oily residue.
2 42
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The IR spectrum of the residue remained ambiguous, therefore, the reaction 
abandoned.
Reaction of 4’-methvl-3,5,-0-dibenzvlpvridoxine with trifluoroacetic acid.148
4’-Methyl-3,5’-0-dibenzylpyridoxine 241 (1.07 g, 2.94 mmol) and
trifluoroacetic acid (20 mL) was stirred at room temperature for 24 h and then 
refluxed for 10 h. The excess trifluoroacetic acid was removed in vacuo and the 
residue dissolved into a small amount of water, which was passed through an 
Amberlite CG-50 column eluting with water. The effluent fractions with similar UV 
absorption were combined and the water was removed in vacuo.
The oily residue was taken up in a small amount of EtOH. 4’- 
Methylpyridoxine 243 (0.48 g, 75 %) with mp 176-177 °C (lit. 
mp 177-178 °C ) was obtained as a cream coloured 
hydrochloride salt on the addition of Et20 containing HC1 (g). .
IR (KBr) v3326,2968,1394 cm'1.
*HNMR (300MHz, DMSO-d6) 8 1.43 (3H, d, J=6.7 Hz, -CH-CHj), 2.58 (3H, s, 
2-CHj), 4.69 (2H, s, 5 -CH2-), 5.38 (1H, q, J=6.7 Hz, 4-CH-), 8.16 (1H, s, 6-H).
OH
Attempted phosphorylation of 4’-methyIpyridoxine.24
4’-Methylpyridoxine 243 (0.2 g, 0.91 mmol) and a phosphorylating mixture (1 
mL), consisting of 1 part of P2O5 and 1.3 part of H3PO4 (by weight), was stirred for 4 
h in an oil bath at 60 °C. The mixture was passed through an Amberlite CG-50 
column eluting with water. The collected fractions were combined and the water was 
removed by freeze-drying to give a small amount of crystals. The IR spectrum of the 
crystals was ambiguous, therefore the reaction abandoned.
4.2. Total syntheses of vitamin analogues.
N-Formylation of (+)-alanine.225
A mixture of 98% formic acid (30 mL) and acetic anhydride (60 mL) was 
heated at a temperature of 50-60 °C for 2 h in a dry atmosphere of N2. The mixture 
was cooled to room temperature and (+)-alanine 246 (8.9 g, 0.1 mol) in formic acid 
(20 mL) was added gradually over a period of 15 min with the temperature being
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maintained below 35 °C and stirred was for a further 40 min. The 
temperature was raised to room temperature and stirred for a further 
80 min. Cold water (80 mL) was added to the mixture and it was 
concentrated in vacuo. Crystallisation using ethyl acetate/ethanol 
gives N-formyl-(±)-alanine 247 (6.88 g, 59%) as a white solid with mp 142-147 °C
(lit. mp 145-148 °C226).
IR (nujol) v 3355, 2924,2854, 1702 cm'1.
228Esterification of (±)-alanine.
Thionyl chloride (35.7 g, 0.3 mol) was added dropwise to a cooled, stirred 
suspension of (±)-alanine 246 (17.8 g, 0.2 mol) in 95 % EtOH (150 mL), at such a rate 
that the reaction mixture refluxes lightly. The mixture was refluxed 
for 2 h, then the solvent evaporated in vacuo and the residue 
dissolved in EtOH (100 mL). Ether was added to precipitate the h2n' ^ 'Vs^  
hydrochloride, which was collected by filtration, washed with ether 
and dried over CaCL to give (±)-alanine ethyl ester hydrochloride 248 
(30 g, 98 %) as a white solid, mp 78-82 °C (lit. mp 87-88 °C229).
IR (nujol) v 2924, 2854, 1746, 1462, 1377 cm'1.
o
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Synthesis of N-formvl-(±)-alanine ethyl ester.
227Esterification of N-formyl-(±)-aIanine using ethanol under acidic condition.
N-Formyl-(±)-alanine 247 (3g, 25.6 mmol) in 95% EtOH (30 mL) with 3-5 
drops of concentrated H2SO4 was refluxed gently for 6 h. The reaction mixture was 
cooled and EtOH was removed in vauco. The residue was dissolved 
in water and extracted with ethyl acetate. The combined extracts 
were washed with water, brine, saturated NaHC0 3 , and dried. The 
solvent was evaporated in vacuo and residue distilled at 110 °C / 3 
mm Hg (lit. bp 100 °C / 1 mm Hg226) to give N-formyl-(±)-alanine 
ethyl ester 245 (1.11 g, 30 %) as a clear oil.
IR (neat) v 3300, 2986, 1740,1205 cm'1.
!HNMR (300MHz, CDC13) 8 1.30 (3H, t, CH3CH2-), 1.45 (3H, d, CH3CH-), 4.22 (2H, 
q, -CH2-), 4.65 (1H, q, -CH-), 7.08 (1H, br, -NH-), 8.20 (1H, s, -CHO).
2 4 5
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N-formylation of (+)-alanine ethyl ester hydrochloride with a mixture of formic 
acid and acetic anhydride.225
A mixture of 98% formic acid (1.5 mL) and acetic anhydride (3 mL) was 
heated at a temperature of 50-60 °C for 2 h in dry atmosphere. (±)-Alanine ethyl ester 
hydrochloride 248 (1 g, 6.5 mmol) in formic acid (1.5 mL) was added gradually to the 
mixture over a period of 15 min with temperature maintained below 35 °C and stirred 
for a further 3 h. The mixture was concentrated in vacuo and residue distilled at 110 
°C / 3 mm Hg to give a very small amount of clear oil (0.4 g), which the tic and IR 
spectrum indicated to be N-formyl-(±)-alanine ethyl ester 245.
N-formylation of (±)-alanine ethyl ester hydrochloride with triethylamine and p-
230toluenesulphonic acid monohydrate.
Triethylamine (1.1 lg, 0.11 mol) was added to a stirred mixture of (±)-alanine 
ethyl ester hydrochloride 248 (15.4 g, 0.1 mol) and /?-toluenesulphonic acid 
monohydrate (0.01 g, 0.05 mmol) in ethyl formate (50 mL). The mixture was refluxed 
for 20 h and then cooled to room temperature. The triethylamine hydrochloride salt 
was removed by filtration and filtrate concentrated to 15 mL. On cooling to -5°C, 
more triethylamine hydrochloride salt formed and was removed. Distillation of the 
filtrate at 110 °C / 3 mm Hg afforded a very small amount of clear oil (0.2 g) and the 
IR spectrum indicated that it was N-formyl-(±)-alanine ethyl ester 245.
N-formylation of (±)-alanine ethyl ester hydrochloride with formamide.231
A mixture of (±)-alanine ethyl ester hydrochloride 248 (15 g, 95.7 mmol) and 
formamide (4.2 g, 3.7 mL, 93.3 mmol) was heated slowly to 105 °C over a period of 
45 min. After heating at 105 °C for 10 min, toluene (30 mL) was added, the mixture 
was kept at room temperature overnight and then refluxed for 6 h. The solution was 
cooled and the NH4CI formed was removed by filtration and the filtrate collected. 
The filtrate was concentrated to a residue and distilled at 110 °C / 3 mm Hg to give N- 
formyl-(±)-alanine ethyl ester 245 (11.87 g, 85 %) as a clear oil.
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Synthesis of 4-methvl-5-ethoxyoxazole.
Robinson-Gabriel reaction of N-formyl-(±)-aIanine ethyl ester with phosphorus 
pentoxide.232
To a 250 mL, 3-necked round-bottom flask equipped with a Hershberg stirrer 
and a reflux condenser was added N-formyl-(±)-alanine ethyl ester 245 (5 g, 34.5 
mmol), phosphorus pentoxide (19.6 g, 137.9 mmol) and dry CHCI3 (100 mL). The 
resulting suspension was refluxed in a dry N2  atmosphere with vigorous stirring for 1 2  
h. Then ice-cold 10 % NaHC0 3  solution (100 mL) was added, to decompose 
unreacted phosphorus pentoxide, and the pH was adjusted to 
neutral with concentrated NaOH. After extraction with CH2 CI2  
and washing with brine and water, the organic extracts were
2 2 2dried, concentrated and purified by distillation at 75-80 °C / 50
mm Hg (lit. bp 78-80 °C / 50 mm Hg232) to afford 4-methyl-5-ethoxyoxazole 222
(2.36 g, 54 %) as a clear liquid.
IR (neat) v 2929, 1336,1221 cm'1.
'HNMR (300MHz, CDC13) 5 1.38 (3H, t, CH3 -CH2 -), 2.04 (3H, s, CH3 -), 4.12 (2H, q, 
-CH2O-), 7.40 (1H, s, -OCH-).
Attempted cyclisation of N-formyl-(±)-alanine ethyl ester using triphenyl 
phosphine and iodine under basic conditions.233
A solution of N-formyl-(±)-alanine ethyl ester 245 (5.41 g, 37.29 mmol) in dry 
CH2 CI2  (10 mL) and triethylamine (15.47 g, 152.9 mmol) were added sequentially to 
a stirred solution of triphenyl phosphine (19.56 g, 74.57 mmol) and iodine (18.93 g, 
74.58 mmol) in dry CH2 CI2  (40 mL) at room temperature under N 2  atmosphere. The 
reaction mixture was stirred for 24 h. The dark mixture was then washed with of 
saturated Na2 S2 C>3 solution (60mL) and subsequently extracted with ether. The 
organic phase was dried and solvent removed in vacuo leaving a dark residue. 
Vacuum distillation of the residue afforded clear oil, but the IR and ^nm r spectra of 
the oil showed no trace of the desired oxazole.
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Reaction of epichlorohydrin with p-toluenesulphonic acid.234
Epichlorohydrin 249 (25 g, 0.27 mol) was added dropwise over 30 min to a
stirred solution of /?-toluenesulphonic acid (47.5 g, 0.25 mol) in CH2CI2 (200 mL) at
5-10 °C. The reaction mixture was refluxed for 3 h cooled
and then the mixture was washed twice with saturated 0\V °NaHCC>3 solution (200 mL), followed by extraction with 
CH2CI2 and dried. The solvent was removed in vacuo and ' 
the residue purified by column chromatography (10-5:1 250
hexane/acetone) to give l-chloro-3-(toluene-4-sulphonyl)propan-2-ol 250 (51.71 g, 72 
%) as a yellow oil.
IR (neat) v 3515,2959,1358, 815 cm'1.
'HNMR (300MHz, CDC13) 5 2.45 (3H, s, CHr Ar), 2.80 (1H, d, -OH), 3.50-4.20 (5H, 
m, -CH2CH(OH)CH2-), 7.32,7.80 (each 2H, d, Ar-H).
Reaction of l-chloro-3-(toluene-4-suIphonyDpropan-2-ol with KCN in
methanol. 235
Potassium cyanide (16 g, 0.25 mol) was added to a mixture of l-Chloro-3- 
(toluene-4-sulphonyl)propan-2-ol 250 (65 g, 0.25 mol) in MeOH (350 mL) and stirred 
for 40 h at room temperature. The potassium tosylate formed was ~ 
removed by filtration and the product distilled at 115 °C / 4 mm Hg (lit. NC- 
bp 134-136 °C / 13 mm Hg221) to give 3-chloro-2-hydroxybutyronitrile ?
251 (3.58 g, 12 %) as a clear yellow liquid.
IR (neat) v 3430, 2962, 2256, 1415 cm'1.
'HNMR (300MHz, CDC13) 8 2.70 (2H, m, CHjCN), 3.50 (1H, s, -OH), 3.65 (2H, d, 
CH2CI), 4.28 (1H, m, CHOH).
Reaction of 3-chloro-2-hvdroxvbutyronitrile with NaOH.236
3-Chloro-2-hydroxybutyronitrile 251 (1 g, 8.36 mmol) and NaOH (50 mL,
0.96 M) was stirred at room temperature for a period of 90 min. The reaction mixture 
was subjected to continuous extraction with ethyl acetate using a n c  
continuous extraction apparatus. The organic extracts were dried and 
concentrated in vacuo. The residue was distilled at 136-145 °C / 15 ' 223
mm Hg (lit. bp 119-120 °C / 13 mm Hg236) to give 4-hydroxybut-2-enenitrile 223
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(0.21 g, 30 %) as a yellow liquid. The liquid partly crystallised after standing for 
several days at room temperature.
IR (neat) v 3430,2920,2227,1639 cm'1.
‘HNMR (300MHz, CDC13) E form 6 3.89 (1H, s, -OH), 4.20 (2H, s, -CH2-), 5.68 (1H, 
d, J=16 Hz, =CH), 6.92 (1H, d, J=16 Hz, =CH).
Reaction of epichlorohydrin with alkali cyanides.
A solution of epichlorohydrin 249 (30 g, 0.32 mol) in ethanol (65 mL) with a 
few drops of thymol-blue was stirred at room temperature. Sodium cyanide (8.3 g,
0.17 mol) and potassium cyanide (11.1 g, 0.17 mol) in water (75 mL) was added 
gradually to the solution over a period of 30 min with cooling. Neutrality was 
maintained throughout by the drop-wise addition of dilute acetic acid and for an 
additional 30 min after all the cyanide had been added. The solution was set aside for 
1 h at 0 °C, and continuously extracted with ethyl acetate. The organic phase was 
dried and solvent removed in vacuo to afford a residue, which was vacuum distilled at 
136-145 °C / 15 mm Hg to give 0.98 g of yellow liquid. The IR spectrum indicated a 
presence of a mixture of 3-chloro-2-hydroxybutyronitrile 251 and 4-hydroxybut-2- 
enenitrile 223. The liquid partly crystallised after standing for several days, which 
indicate dimerisation have occurred.
Reaction of glvcidol with methoxvethoxvmethyl chloride.238
Glycidol 255 (4 g, 54 mmol) was added dropwise to a stirred mixture of 
sodium hydride (1.56 g, 64.80 mmol) in dry THF (50 mL) at 0 °C in a dry 
atmosphere. 2-Methoxyethoxymethyl chloride (8.07 g, 64.80 mmol) was added 
dropwise to the mixture at 0 °C and stirred for 15 min. The reaction mixture was 
stirred at room temperature for 2 h and left to stand overnight. Water was added to 
decompose excess sodium hydride and the mixture extracted with o 
ethyl acetate. The combined extracts were washed with brine, 
followed by water, and dried. The solvent was removed in vacuo to 
give crude 2-(2-methoxyethoxymethoxy)oxirane 256 (3.24 g, 37 %) 
as a light yellow oil.
IR (neat) v 2886, 1458, 1047 cm-1.
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Reaction of 2-(2-methoxvethoxvmethoxy)oxirane with KCN.239
2-(2-Methoxyethoxymethoxy)oxirane 256 (3.24 g, 19.98 mmol) in CH3CN (80 
mL) was treated with anhydrous lithium perchlorate (3.19 g, 29.97 mmol) and 
potassium cyanide (2.08 g, 31.96 mmol). The reaction mixture 
was stirred overnight at 70 °C and then cooled to room 
temperature. The mixture was diluted with water and extracted 
with ether. The combined extracts were washed with saturated 
NaHCCb, followed by water, and dried. The solvent was 
removed in vacuo to give crude 2-hydroxy-4-(2- 
methoxyethoxymethoxy)butyronitrile 257 (0.21 g, 5.6 %) as a 
yellow oil.
IR (neat) v 3448, 2934,2252,1039 cm'1.
Synthesis of l-0-/g/-/-butvldimethvIsiIyl-2,3-epoxvpropane.
Attempted reaction of glycidol with fert-butyldimethylsilyl chloride and 
imidazole in DMF.240
Imidazole (4.6 g, 67.5 mmol) and fert-butyldimethylsilyl chloride (4.88 g, 32.4 
mmol) was added to a stirred solution of glycidol 255 (2 g, 27 mmol) in DMF (4 mL) 
at room temperature. The reaction mixture was stirred for 24 h. The mixture was 
diluted with water and extracted with ethyl acetate. The organic phase was dried and 
concentrated in vacuo to give an oil, which was vacuum distilled at 175 °C / 2 mm Hg 
to afford a thick oil, which tic indicated to consist of two components. Further 
purification by column chromatography (hexane/acetone) afforded a yellow oil (0.5 
g). The ^ n m r spectrum showed no trace of the desired product, but showed a strong 
presence of the silyl component.
Reaction of glycidol with tert-butyldimethylsilyl chloride, 4- 
dimethylaminopyridine and EtjN in CH2 CI2 .241
A mixture of 4-dimethylaminopyridine (0.13 g, 1.08 mmol), tert- 
butyldimethylsilyl chloride (4.48 g, 29.70 mmol) and Et3N (3 g, 4.14 mL, 29.70 
mmol) was stirred at room temperature under N2 atmosphere. Glycidol 255 (2 g, 27 
mmol) in CH2CI2 (10 mL) was added to the mxiture and stirring continued for 24 h.
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The mixture was washed with water, followed by saturated 
NH4CI, and dried. The solvent was removed in vacuo and 
product distilled at 75-80 °C / 2 mm Hg to give 1 -O-tert- 
butyldimethylsilyl-2,3-epoxypropane 258 (4.22 g, 83 %) as a 
clear oil.
IR (neat) v 2930, 1472, 1098 cm'1.
1HNMR (300MHz, CDC13) 8 0.05 (6H, s, Si(CH3)2), 0.8 (9H, s, SiC(CH3)3), 2.55 (1H, 
dd, J=2.7, 5.2Hz, CH2CH-), 2.69 (1H, t, J=5Hz, CH2CH-), 2.98 -3.04 (1H, m, 
CH2CH-), 3.57 (1H, dd, J=4.8, 11.9Hz, -CH2O-), 3.77 (1H, dd, J=3.1, 11.9Hz, 
-CHbO-).
Reaction of l-fl-fert-butvldimethvlsilvI-2,3-epoxypropane with KCN.239
A solution of l-O-fert-butyldimethylsilyl-2,3-epoxypropane 258 (1 g, 5.31 
mmol) in CH3CN (10 mL) was treated with anhydrous lithium perchlorate (0.80 g, 
7.50 mmol) and potassium cyanide (0.38 g, 5.84 mmol). The 
reaction mixture was stirred at 70 °C for 8 h and then cooled . 
to room temperature. The mixture was diluted with water, NC
extracted with ethyl acetate and dried. Removal of the solvent 
in vacuo followed by distillation at 125-130 °C / 3 mm Hg 259
afforded 4-(fer/‘-butyldimethylsilanyloxy)-3-hydroxybutyronitrile 259 (0.8 g, 70 %) as 
a clear yellow oil.
IR (neat) v 3453,2931,2255,1468,1122 cm'1.
‘HNMR (300MHz, CDC13) 5 0 .02  (6H, s, Si(CH3)2), 0.85 (9H, s, SiC(CH3)3), 2.5 (2 H, 
m, -CHjCN), 2.72 (1H, d, -OH), 3.7 (2H, m, -CH2O-), 3.9 (1H, m, CHOH).
Attempted reaction of 4-(fer/-butvldimethvIsilanvloxvV3-hydroxvbutvronitrile 
with phosphoric acid.242
4-(7ert-butyldimethylsilanyloxy)-3-hydroxybutyronitrile 259 (0.25 g, 1.16 
mmol) and 85 % phosphoric acid (1 mL) was heated in an oil bath to about 200 °C for 
30 min. The reaction mixture was cooled to room temperature and neutralised with 
dilute NaOH solution. The mixture was extracted with ethyl acetate. The organic 
extracts were washed with brine, dried, and the solvent removed in vacuo to give a 
residue. The dark residue was vacuum distilled at 130-145 °C / 3 mm Hg to afford a
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clear liquid, however, the peak of the nitrile group were absent from the IR spectrum, 
so the reaction abandoned.
Attempted reaction of 4 - f e ,/-butvldimethvlsilanvloxv)-3-hvdroxvbutyronitrile 
with thionyl chloride.243
Thionyl chloride (3.3 g, 27.42 mmol) was added drop-wise to a stirred solution 
of 4-(ter/-butyldimethylsilanyloxy)-3-hydroxybutyronitrile 259 (0.05 g, 0.23 mmol) in 
pyridine (1 mL) at room temperature under N2 atmosphere. The reaction mixture was 
stirred for 1 h and then quenched with ice water followed by extraction with ethyl 
acetate. The organic extracts were dried and concentrated in vacuo. The residue was 
vacuum distilled at 70-100 °C / 4 mm Hg to afford a small amount of a clear liquid. 
The IR spectrum for the clear liquid showed no indication of a nitrile group, therefore, 
the reaction was discontinued.
Attempted reaction of 4-(fert-butvIdimethvlsiIanvloxv)-3-hvdroxvbutvronitrile 
with phosphoryl chloride.244
A solution of 4-(fer/l-butyldimethylsilanyloxy)-3-hydroxybutyronitrile 259 (0.7 
g, 3.25 mmol) in dry pyridine (2 mL) was cooled to 0 °C and phosphoryl chloride (5 
mL, 53.64 mmol) was added drop-wise. The reaction mixture was stirred at room 
temperature for 24 h, then diluted with water, followed by extraction with ether. The 
ether extracts were washed with dilute HC1 solution, saturated NaHC0 3  solution, 
water, and then dried. The solvent removed in vacuo to afford a small amount of 
thick dark brown crude oil. The IR spectrum indicated the absence of a nitrile group, 
thus the reaction was abandoned.
Attempted reaction of 4-(Vgrt-butvIdimethvIsiIanvloxv)-3-hvdroxvbutvronitrile 
with p-toluenesulphonic acid monohydrate.245
A solution of 4-(ter/-butyldimethylsilanyloxy)-3-hydroxybutyronitrile 259 
(0.25 g, 1.16 mmol) with p-toluenesulphonic acid monohydrate (0.22g, 1.16 mmol) in 
dry toluene (60 mL) was refluxed for 2 h. The mixture was cooled to room 
temperature and washed with water. The toluene extracts were dried and concentrated
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in vacuo to afford a very small amount of thick brown crude oil, which showed no 
sign of expected product in the IR spectrum and, therefore, the crude reaction mixture 
was discarded.
Attempted reaction of 4-(Vgrt-butvldimethvlsilanvIoxv)-3-hvdroxvbutvronitrile 
with p-toluenesulphonic acid adsorbed on silica gel.246
A solution of 4-(/er/-butyldimethylsilanyloxy)-3-hydroxybutyronitrile 259 
(0.12 g, 0.56 mmol) in dry toluene (25 mL) was added to /7-toluenesulphonic acid 
adsorbed on silica gel (2 g) and the mixture was stirred for 3 h under reflux. The 
reaction mixture was cooled to room temperature and petroleum spirit (30-50 °C, 25 
mL) was added. The slushy mixture was purified by column chromatography (9:1 
petrol/ethyl acetate) to give a yellow liquid which was vacuum distillated at 120-150 
°C / 4 mm Hg to afford a clear liquid. The IR spectrum for the clear liquid revealed 
that the peak for the nitrile group was absent and, therefore, the liquid was discarded.
Reaction of 4-(fert-butvldimethvlsilanvloxv)-3-hvdroxvbutvronitrile with v -  
toluenesulphonyl chloride.247
Pyridine (0.2 g, 0.2 mL, 2.3 mmol) and p-toluenesulphonyl chloride (0.3 g, 1.7 
mmol) was added to a stirred mixture of 4-(tert-Butyl-dimethyl-silanyloxy)-3- 
hydroxy-butyronitrile 259 (0.3 g, 1.2 mmol) in CHCI3 (5 mL) at 0 °C. The reaction 
mixture was stirred at room temperature for 24 h. The mixture 
was diluted with water and extracted with ether. The organic 
extracts were washed with dilute HC1, saturated NaHCC>3 
solution, water, and dried. The solvent was evaporated in vacuo 
to give a crude 4-(/er/-butyldimethylsilanyloxy)-3-(toluene-4- 
sulphonyl)butyronitrile 260 (0.32 g, 75 %) as a white solid.
IR (KBr) v 2926,2855,2254,1463,1377, 1120, 839 cm'1.
'HNMR (300MHz, CDClj) 5 0.02 (6H, s, Si(CH3)2), 0.89 (9H, s, SiC(CH3)3), 2.52 
(3H, s, Ar-CHj), 2.61 (2H, m, -CH2CN), 3.6 (2H, m, -CH2O-), 3.8 (1H, m, -CH-), 
7.30,7.91 (each 2H, d, Ar-H).
//
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Attempted reaction of 4-(tert-butvldimethvlsiIanvloxv)-3-(toIuene-4- 
sulphonvDbutvronitrile with potassium hydroxide.248
Potassium hydroxide (0.6 g, 10.69 mmol) in ethanol (15 mL) and 4-{tert- 
butyldimethylsilanyloxy)-3-(toluene-4-sulphonyl)butyronitrile 260 (0.28 g, 0.76 
mmol) was stirred at room temperature for 1 h after which tic showed the starting 
material remained. Therefore, the reaction mixture was warmed to 40 °C for 1 h and 
stirring continued at room temperature for 2 days. Random interval of tic analysis 
revealed the starting material still remained and, therefore, the reaction mixture was 
abandoned.
Reaction of 4-(Vgrt-butvldimethvlsilanvloxv)-3-hvdroxvbutvronitrile with  
methanesulphonyl chloride.249
A mixture of 4-dimethylaminopyridine (1 g, 8.7 mmol) and triethylamine (15 
mL) in CH2CI2 (20 mL), was maintained in low temperature with an ice-water bath. 
To the stirred mixture, a solution of 4-(/er/-butyldimethylsilanyloxy)-3- 
hydroxybutyronitrile 259 (1.9 g, 8.7 mmol) in CH2CI2 (20 mL) was added in 
dropwise. Methanesulphonyl chloride (2.5 g, 21.8 mmol) was added in dropwise with 
the temperature maintained between 10-20 °C and stirred for 1 h. The reaction 
mixture was stirred for a further 24 h at room temperature. The 
mixture was quenched with saturated NaHC03 solution and 
extracted with CH2CI2. The organic extracts were dried and 
concentrated in vacuo. The residue was purified by distillation to 
afford 4-(ter/-butyldimethylsilanyloxy)-but-2-enenitrile 261 (0.4 g,
21 %) as a yellow oil.
IR (neat) v 2929, 2858, 2225, 1642, 1472, 1379, 1134 cm’1.
1HNMR (300MHz, CDC13) E:Z (1:0.4)
E form 5 0.05 (6H, s, Si(CH3)2), 0.81 (9H, s, SiC(CH3)3), 4.28 (2H, dd, -CH2O-), 5.68 
(1H, dt, J=16.3 Hz, =CH), 6.78 (1H, dt, J= 16.3 Hz, =CH).
Z form 5 0.05 (6H, s, Si(CH3)2), 0.81 (9H, s, SiC(CH3)3), 4.39 (2H, dd, -CH2O-), 5.30 
(1H, dt, J=11.0 Hz, =CH), 6.41 (1H, dt, J= 11.0 Hz, =CH).
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Attempted reaction of glycidol and benzyl bromide with sodium hydride in 
THF.216
Under N2 atmosphere, the dry THF (100 mL) was added to sodium hydride 
(2.11 g, 52.8 mmol, 60 % dispersion in mineral oil) at 0 °C. Glycidol 255 (5 g, 67.5 
mmol) in dry THF (50 mL) was added was to the suspended mixture and stirred for 
30 min at room temperature. The mixture was cooled to 0 °C and benzyl chloride 
(11.11 g, 87.7 mmol) was added. After stirring for 4 h at room temperature, the 
mixture was quenched with saturated NH4CI solution and extracted with ethyl acetate. 
The combine extracts were washed with water, followed by brine, and dried. The 
solvent was removed in vacuo and the residue was vacuum distilled at 55-60 °C / 3 
mm Hg to afford a clear liquid (8.05 g) which the ir and ’Hnmr spectrum indicated to 
be dibenzyl ether.
IR (neat) v 3066, 3033,2962,1455,1073,767, 698 cm'1.
'HNMR (300 MHz, CDC13) 4.58 (4H, s, -OCH,-Ar), 7.32 (10H, s, Ar-H),
Attempted reaction of glycidol and benzyl chloride with sodium hydride in 
DMF.216
Under N2 atmosphere, the dry DMF (100 mL) was added to sodium hydride 
(2.11 g, 52.8 mmol, 60 % dispersion in mineral oil) at 0 °C. Glycidol 255 (5 g, 67.5 
mmol) in dry DMF (50 mL) was added to the suspended mixture and stirred for 30 
min at room temperature. The mixture was cooled to 0 °C and benzyl chloride (11.11 
g, 87.7 mmol) was added. After stirring for 12 h at room temperature, the mixture 
was quenched with saturated NH4CI solution and extracted with ethyl acetate. The 
combine extracts were washed with water, followed by brine, and dried. The solvent 
was removed in vacuo and to give a yellow residue, which the tic and IR spectrum 
indicated to be dibenzyl ether.
Benzylation of gylcidol using benzyl bromide, sodium hydride with tetra-n- 
butvlammonhim iodide in THF.250
Under N2 atmosphere, the dry THF (100 mL) was added to the sodium hydride 
(2.24 g, 56 mmol, 60 % dispersion in mineral oil) and te/ra-n-butylammonium iodide 
(0.21 g, 0.57 mmol) at 0 °C. Glycidol 255 (4 g, 54 mmol) in dry THF (40 mL) was
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added to the suspended mixture and stirred for 30 min. The mixture was cooled to 0 
°C and benzyl bromide (9.54 g, 55.8 mmol) was added. After stirring for 1 h at room 
temperature, the mixture was quenched with saturated NH4CI solution and extracted 
with ethyl acetate. The combine extracts were washed with water, 
followed by brine, and dried. The solvent was removed in vacuo and 
the residue was subjected to column chromatography (5:1 petrol/ethyl 
acetate) to afford 2-benzyloxymethyloxirane 265 (3.90 g, 44 %) as a 
light yellow oil.
IR (neat) v 3031,2861,1454,1097,739, 699 cm'1.
‘HNMR (300MHz, CDCI3) 8 2.61 (1H, dd, J=2.7, 5Hz, CH2CH-), 2.80 (1H, t, J=5Hz, 
CH2CH-), 3.16 -3.22 (1H, m, -CH-), 3.42 (1H, dd, J=5.9, 11.4Hz, -CH2O-), 3.77 (1H, 
dd, J=3, 11.4Hz, -CH2O-), 4.54 & 4.61 (each 1H, d, J=12Hz, -OCfch-Ar), 7.24 -7.37 
(5H, m, Ar-H).
Reaction of 2-benzvloxvmethvIoxirane with KCN.239
A solution of 2-benzyloxymethyloxirane 265 (3.50 g, 21.31 mmol) in CH3CN 
(80 mL) was treated with anhydrous lithium perchlorate (3.40 g, 31.97 mmol) and 
potassium cyanide (2.08 g, 31.97 mmol). The reaction mixture was stirred at 70 °C 
for 24 h in dry atmosphere and then cooled to room temperature. The mixture was 
diluted with water, extracted with ethyl acetate and dried.
The solvent was removed in vacuo to afford the crude 4- ,h 
benzyloxy-3-hydroxybutyronitrile 266 (3.46 g, 85 %) as a ■ 
brown oil.
IR (neat) v 3444, 3032,2926,2255, 1454,1113,741, 700 cm'1.
'HNMR (300MHz, CDC13) 5 2.58 (2H, m, -C|i>CN), 2.99 (1H, m, -OH), 3.50 (2H, m, 
-CH2O-), 4.05 (1H, m, CHOH), 4.50 (2H, dd, -OCHj-Ar), 7.24-7.40 (5H, m, Ar-H).
Attempted reaction of 4-benzyloxv-3-hvdroxvbutvronitrile with sodium 
hydroxide in ethanol.
Sodium hydroxide (1 g, 25 mmol) in ethanol (10 mL) was added to the stirred 
solution of 4-benzyloxy-3-hydroxybutyronitrile 266 (0.5 g, 2.62 mmol) in ethanol (10 
mL). The reaction mixture was stirred at 40 °C for 6 h. Diluted hydrochloric acid 
solution was added to neutralise the reaction mixture and then the mixture was
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extracted with CH2CI2. The organic extracts were dried and concentrated in vacuo to 
afford a brown oil (0.52 g). The IR spectrum for the brown oil revealed that the 
starting material still remained and, therefore, the reaction was discontinued.
Attempted reaction of 4-benzyloxv-3-hvdroxvbutvronitrile with phosphoric 
acid.242
4-Benzyloxy-3-hydroxybutyronitrile 266 (0.5 g, 2.62 mmol) and 85 % 
phosphoric acid (40 mL) was refluxed for 30 min. The reaction mixture was cooled 
to room temperature and neutralised with dilute NaOH solution. The mixture was 
extracted with ether. The organic extracts were washed with brine and dried. The 
solvent was removed in vacuo to give a dark residue. The IR spectrum of the dark 
residue indicated the absence of a nitrile group, thus, the reaction was abandoned.
Tosylation of 4-benzvloxv-3-hvdroxybutvronitrile.247
Pyridine (0.8 g, 0.8 mL, 10.5 mmol) and /?-toluenesulphonyl chloride (1.5 g,
7.8 mmol) was added to a stirred mixture of 4-benzyloxy-3-hydroxy-butyronitrile 266 
(1 g, 5.2 mmol) in CHCI3 at 0 °C. The reaction mixture was stirred at room 
temperature for 24 h. The mixture was diluted with water 
and extracted with ether. The organic extracts were washed , 
with dilute HC1, saturated NaHCCL solution, water, and then 
dried. The solvent was evaporated in vacuo to give a crude
4-benzyloxy-3 -(toluene-4-sulphonyloxy)butyronitrile 267
(1.42 g, 77 %) as a white semi-solid.
IR (neat) v 3091, 3061, 2925, 2254, 1455, 1373, 1121,814, 702, 751cm"1.
Synthesis of 4-benzyloxybut-2-enenitrile.
Reaction of 4-benzyloxy-3-(toluene-4-sulphonyloxy)butyronitrile with 
triethylamine.249
4-Benzyloxy-3-(toluene-4-sulphonyloxy)butyronitrile 267 (1.8 g, 5.2 mmol) 
and triethylamine (2 mL) in CH2CI2 (25 mL) was stirred at room temperature for 24 h. 
The reaction mixture was concentrated to a dark residue and purified by column
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chromatography (60-80 % ethyl acetate/petrol) to give 
4-benzyloxybut-2-enenitrile 268 (0.7 g, 77 %) as a 
brown oil.
A small fraction was further purified by kugelrohr 
distillation to afford yellow oil for analysis.
r1NCI 268
IR (neat) v 3032,2870,2223, 1670,1636, 1456, 1334, 1155,1116,738, 698 cm'1. 
*HNMR (300MHz, CDC13)E:Z (1.5:1)
E form 5 4.14 (2H, dd, J= 1.2 and 2.4 Hz, -QfcO-), 4.56 (2H, s, -OCH2-Ar), 5.72 (1H, 
dt, J=16.3 and 2.4 Hz, =CH), 6.74 (1H, dt, J=16.3 and 2.4 Hz, =CH), 7.36 (5H, m, Ar- 
H).
Z form 8 4.35 (2H, dd, J= 1.7 and 4.3 Hz, -CH2O-), 4.56 (2H, s, -OQfc-Ar), 5.46 (1H, 
dt, J=11.3 and 1.7Hz,=CH), 6.61 (1H, dt, J=11.3 and 1.7Hz,=CH), 7.36 (5H, m, Ar­
il).
Reaction of 4-benzyloxy-3-hydroxybutyronitrile with methanesulphonyl 
chloride.249
A solution of 4-benzyloxy-3-hydroxybutyronitrile 266 (5.5 g, 28.8 mmol) in 
CH2CI2 (20 mL) was added to a stirred mixture of 4-dimethylaminopyridine (3.5 g,
28.7 mmol) and triethylamine (35 mL) in CH2CI2 (20 mL), at 5-10 °C. 
Methanesulphonyl chloride (16.5 g, 143.8 mmol) was added with the temperature 
maintained between 10-20 °C and stirred for 1 h. The reaction mixture was stirred for 
a further 24 h at room temperature. The mixture was quenched with saturated 
NaHCC>3 solution and extracted with CH2CI2. The organic extracts were dried and 
concentrated in vacuo. The residue was subjected to column chromatography (70 % 
ethyl acetate/petrol) to afford 4-benzyloxybut-2-enenitrile 268 (4.82 g, 97 %) as 
brown oil.
A small fraction was further purified by kugelrohr distillation to afford yellow oil for 
analysis.
IR (neat) v 3033,2859,2224, 1668,1640,1455,1116,1028, 738,699 cm'1.
‘HNMR (300MHz, CDC13) E:Z (2:1)
E form 8 4.16 (2H, dd, J= 1.2 and 2.3 Hz, -CTfcO-), 4.57 (2H, s, -OCHj-Ar), 5.75 (1H, 
dt, J=16.2 and 2.3 Hz, =CH), 6.76 (1H, dt, J=16.2 and 2.3 Hz, =CH), 7.32 (5H, m, Ar- 
H).
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Z form 6 4.36 (2H, dd, J=1.7 and 4.2 Hz, -CH2O-), 4.57 (2H, s, -OCfcL-Ar), 5.48 (1H, 
dt, J=11.3 and 1.7 Hz, =CH), 6.62 (1H, dt, J=11.3 and 1.7 Hz, =CH), 7.32 (5H, m, Ar- 
H).
Benzylation of 2-butene-l,4-diol with benzyl bromide.250
Dry DMF (100 mL) was added to a stirred mixture of sodium hydride (4.54 g,
113.49 mmol, 60 % dispersion in mineral oil) and fe^ra-n-butylammonium iodide 
(0.21 g, 0.567 mmol), which was cooled in an ice-water bath under N2 dropwise 
atmosphere. To the suspension, 2-butene- 1,4-diol 269 (5 g, 56.75 mmol) was added 
with the temperature maintained between 5-10 °C. Then benzyl bromide (19.41 g,
113.49 mmol) was added dropwise with the temperature maintained below 40 °C.
The reaction mixture was stirred for a further 24 h at room temperature. The mixture 
was cooled and diluted with water (50 mL), followed by extraction with 1:1 
Et2 0 /hexane (3 x ~50 mL). The combined ............ .... * ' .....  '
to give crude l,4-dibenzyloxy-2-butene 270 ........  ..........
(13.71 g, 90 %) as a light yellow oil.
IR (neat) v 3030,2855,1455,1091, 737,698 cm'1.
'HNMR (300MHz, CDC13) 5 4.03 (4H, dd, -CHjO-), 4.46 (4H, s, -OCHj-Ar), 5.77 
(2H, dt, J=3.7 and 1.0Hz, HC=CH), 7.31 (10H, m, Ar-H).
Epoxidation of 1.4-dibenzvloxv-2-butene with m-chloroperbenzoic acid.250
1,4-Dibenzyloxy-2-butene 270 (13.25 g, 49.38 mmol) in CH2CI2 (175 mL) 
was placed in a 500 mL round-bottom flask equipped with a dropping funnel and 
CaCL drying tube. A solution of m-chloroperbenzoic acid (34.09 g, 197.54 mmol, 50 
% pure) in CH2CI2 (175 mL) was slowly added. The mixture was stirred at room
temperature for 24 h. Saturated sodium metabisulphite .................... .. .. .......
solution was added to the mixture (to destroy the
peracid) followed by saturated NaHCCb solution, and // V__/° °'N
extracted with ether. The organic extracts were ; '
271 Iwashed with brine, water, and dried. The solvent was
removed in vacuo to give crude l,4-benzyloxy-2,3-epoxybutane 271 (13.51 g, 96 %) 
as an oily white solid.
extracts were dried and concentrated in vacuo
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IR (neat) v 3064,3031, 2859,1454,1096,738,698 cm'1.
‘iINMR (300MHz, CDC13) 8 3.26 (2H, m, -CH-CH-), 3.53 (2H, dd, J=6.5 and 
11,3Hz, -CH2O-), 3.69 (2H, dd, J=3.9 and 11,3Hz, -CH2O-), 4.51 (2H, d, J=11.9 Hz, - 
OCHz-Ar), 4.61 (2H, d, J=11.9Hz, -OCth-Ar), 7.29-7.38 (10H, m, Ar-H).
Oxidative cleavage of 1.4-benzvloxv-2.3-epoxvbutane with periodic acid.250
l,4-Benzyloxy-2,3-epoxybutane 271 (5 g, 17.58 mmol) in THF (100 mL) was 
stirred at room temperature and periodic acid (4 g, 17.58 mmol) was added in one 
portion to this mixture. The resulting yellow solution was stirred for 24 h. The 
reaction mixture was washed with water and extracted with ether.
The combined layers were washed with water, brine, and dried.
The solvent removed in vacuo gave a yellow semi-solid crude 
(11.59 g) which IR analysis revealed to be 2- 
benzyloxyacetaldehyde 272. The crude was used without further 
purification.
IR (neat) v 2924, 1727, 1454, 1428, 1095, 736, 699 cm'1.
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Attempted Wittig-Horner reaction of 2-benzyloxvacetaIdehyde with diethyl 
cvanomethanephosphonate.252
A solution of diethyl cyanomethanephosphonate (1.96 g, 11.06 mmol) in THF 
(10 mL) was added to a stirred suspension of powdered potassium hydroxide (1.24 g, 
22. 11 mmol) in THF (10 mL) at 0 °C. 2-Benzyloxyacetaldehyde 272 (1.7 g, 11.06 
mmol) in THF (10 mL) was added to the reaction mixture at 0 °C. The reaction 
mixture was stirred at room temperature for 12 h. The mixture was washed with 
water and extracted with ether. The organic extracts were dried and concentrated in 
vacuo to afford a dark residue. The IR spectrum of the residue revealed that the peak 
for the nitrile group was absent and, therefore, the reaction was abandoned.
253Diels-Alder reaction of 4-methvl-5-ethoxvoxazole with dimethyl maleate.
4-Methyl-5-ethoxyoxazole 222 (0.7 g, 5.1 mmol) and dimethyl maleate 273 
(1.4 g, 10 mmol) in toluene (10 mL) was refluxed for 24 h. The ; 
reaction mixture was concentrated to a residue and purified by
186
Experimental
column chromatography (CHCI3) to give dimethyl 5-hydroxypyridine-3,4- 
dicarboxylate 274 (0.4 g, 36 %) as a cream solid with mp 128-132 °C (lit mp 140-141
o^253^
IR (KBr) v 3358, 2956, 1744, 1440 cm'1.
!HNMR (60MHz, CDCI3) 6 2.57 (3H, s, 2 -CH3), 3.90 (3H, s, -CO2CH3), 3.94 (3H, s, - 
CO2CH3), 8.26 (1H, s, 6-H).
MS [m/z (relative intensity)] 225 (M+, 33), 193 (100).
Diels-Alder reaction of 4-methyl-5-ethoxvoxazole with acrylonitrile.254
4-Methyl-5-ethoxyoxazole 222 (0.65 g, 5.1 mmol) and acrylonitrile 275 (10 
mL) was stirred at room temperature for 24 h. The excess acrylonitrile 
was removed in vacuo and the residue was crystallised from methanol HO> 
to give 4-cyano-3-hydroxy-2-methylpyridine 276 (0.23 g, 34%) as a 
light orange solid with mp 235-240 °C (lit mp 235-237 °C254).
IR (KBr) v 2223.5 cm'1.
!HNMR (300MHz, DMSO-dg) 6 2.45 (3H, s, py-CILO, 7.48 (1H, d, J=5 Hz, py-H),
8.00 (1H, d, J=5 Hz, py-H).
MS [m/z (relative intensity)] 134 (M+, 100).
Attempted Diels-Alder reaction of 4-methyl-5-ethoxvoxazole with 4-benzyIoxy- 
but-2-enenitrile.232
4-Methyl-5-ethoxyoxazole 222 (0.6 g, 4.96 mmol), 4-benzyloxybut-2- 
enenitrile 268 (0.8 g, 4.23 mmol) and hydroquinone (0.05 g) in methanol (15 mL) was 
refluxed for 24 h. The reaction mixture was kept in the fridge for 24 h, followed by 
addition of ethanol saturated with hydrochloride gas (25 mL). The mixture was stand 
for 3 h on ice and then acetone (10 mL) was added to precipitates the salt. However, 
no precipitation occurred and the tic showed the present of the oxazole, therefore, the 
reaction was discontinued.
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